Michael Lim, MD

4.8/5

Michael Lim, M.D.

Neurosurgeon

Stanford Medicine Endowed Chair of the Department of Neurosurgery, Professor of Neurosurgery and, by courtesy, of Radiation Oncology, of Medicine, of Otolaryngology - Head & Neck Surgery (OHNS) and of Neurology and Neurological Sciences

View Professional Summary

Insurance Coverage

Resources for Referring Physicians

Biography

Dr. Lim is the Chair of the Department of Neurosurgery and a board-certified neurosurgeon specializing in brain tumors and trigeminal neuralgia.

Dr. Lim鈥檚 clinical interests include the treatment of benign and malignant brain tumors, with special interest in gliomas, meningiomas, metastatic tumors, and skull base tumors. Dr. Lim also specializes in surgical treatments for trigeminal neuralgia. During his time at Johns Hopkins, Dr. Lim built one of the largest brain tumor and trigeminal neuralgia practices and utilized the most advanced surgical technologies and techniques for his patients. As a passionate voice for patient experience, he has been recognized by his peers and patients for his integrity and compassionate care, including a Service Excellence Award from HealthNetwork Foundation.

As a mentor, he has garnered numerous teaching awards, including being honored as an outstanding teacher by Johns Hopkins University School of Medicine. He is actively involved in shaping education for neurosurgery and oncology across the United States and around the world. He is the recipient of the prestigious 2023 Abhijit Guha Award in Neuro-Oncology.

Dr. Lim鈥檚蓝莓视频 interests focus on harnessing the immune system to fight cancer. His laboratory focuses on understanding mechanisms of immune evasion by cancer cells. He has successfully translated his findings from the laboratory to the clinics and has conducted and led several large national immunotherapy clinical trials for brain tumors.

Dr. Lim鈥檚 bibliography contains well over 300 articles on topics such as immunotherapy for glioblastoma, long-term survival of glioma patients treated with stereotactic radiation, and treatment of neuropathic pain. His work has appeared in Science Translational Medicine, Clinical Cancer Research, Lancet Oncology, Nature Immunology, and many more publications. He also has written 20 book chapters and monographs.

Dr. Lim is a world leader in immunotherapy for brain tumors. In addition to being invited world-wide to give lectures and seminars, he has given platform presentations on the topics of immunotherapy for brain tumors, neurosurgical techniques and management of brain tumors at the American Society of Clinical Oncologists, American Academy of Neurological Surgeons, Radiological Society of North America, Annual Symposium on Brain and Spine Metastases, Congress of Neurological Surgeons, and other meetings. In addition, he has served as platform chairman of the CNS session at the American Society for Clinical Oncology conference.

Dr. Lim is a member of the American Society for Clinical Oncology, Congress of Neurological Surgeons, American Association of Neurological Surgeons, and Society for Neuro-Oncology. Dr. Lim served as the program co-chair of the Society for Neuro-Oncology and CNS section of the American Society for Clinical Oncology. He also served on many executive committees, including the Executive Committee for the Joint Tumor Section of the American Association of Neurological Surgeons and Congress of Neurological Surgeons.

Trigeminal neuralgia treatment: https://www.youtube.com/watch?v=-n8nvwkwZik

Trigeminal neuralgia patient stories: https://www.youtube.com/watch?v=kClePRPYlQs&t=1s

View Full Biography

Professional Summary

Education & Certifications

Residency: Stanford University Dept of Neurosurgery (2007) CA
Board Certification: American Board of Neurological Surgery, Neurosurgery (2012)
Medical Education: Johns Hopkins University School of Medicine (2000) MD

Honors & Awards

Abhijit Guha Award, AANS/CNS Section on Tumors and Society of Neuro-Oncology (September 2023)

Memberships

Co-Chair, SNO Scientific Program Committee (2018 - 2020)
Member, NCI Brain Malignancy Steering Committee (2021 - Present)

Publications

The efficacy of linear accelerator stereotactic radiosurgery in treating glomus jugulare tumors
Lim, M., Gibbs, I. C., Adler, J. R., Martin, D. P., & Chang, S. D. (2003). The efficacy of linear accelerator stereotactic radiosurgery in treating glomus jugulare tumors. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2(3), 261鈥�65.
Efficacy and safety of stereotactic radiosurgery for glomus jugulare tumors.
Lim, M., Gibbs, I. C., Adler, J. R., & Chang, S. D. (2004). Efficacy and safety of stereotactic radiosurgery for glomus jugulare tumors. Neurosurgical Focus, 17(2), E11-?
CyberKnife radiosurgery for idiopathic trigeminal neuralgia.
Lim, M., Villavicencio, A. T., Burneikiene, S., Chang, S. D., Romanelli, P., McNeely, L., 鈥� Adler, J. R. (2005). CyberKnife radiosurgery for idiopathic trigeminal neuralgia. Neurosurgical Focus, 18(5), E9-?
- Characterization of the integrin alpha v beta 3 in arteriovenous malformations and cavernous malformations
  Lim, M., Haddix, T., Harsh, G. R., Vogel, H., Steinberg, G. K., & Guccione, S. (2005). Characterization of the integrin alpha v beta 3 in arteriovenous malformations and cavernous malformations. CEREBROVASCULAR DISEASES, 20(1), 23鈥�27.
- alpha(v)beta(3) integrin in central nervous system tumors
  Lim, M., Guccione, S., Haddix, T., Sims, L., Cheshier, S., Chu, P., 鈥� Harsh, G. (2005). alpha(v)beta(3) integrin in central nervous system tumors. HUMAN PATHOLOGY, 36(6), 665鈥�69.
- Visual field preservation after curative multi-modality treatment of occipital lobe artemovenous malformations
  Sinclair, J., Marks, M. P., Levy, R. P., Adler, J. R., Chang, S. D., Lopez, J. R., 鈥� Steinberg, G. K. (2005). Visual field preservation after curative multi-modality treatment of occipital lobe artemovenous malformations. NEUROSURGERY, 57(4), 655鈥�66.
- Stereotactic radiosurgery using CT cisternography and non-isocentric planning for the treatment of trigeminal neuralgia.
  Lim, M., Cotrutz, C., Romanelli, P., Schaal, D., Gibbs, I., Chang, S. D., & Adler, J. R. (2006). Stereotactic radiosurgery using CT cisternography and non-isocentric planning for the treatment of trigeminal neuralgia. Computer Aided Surgery , 11(1), 11鈥�20.
- CyberKnife radiosurgery for extremity schwannomas: Technical note and case report
  Lim, M., & Adler, J. R. (2006). CyberKnife radiosurgery for extremity schwannomas: Technical note and case report. STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, 84(2-3), 60鈥�63.
- New vessel formation in the central nervous system during tumor growth, vascular malformations, and Moyamoya
  Lim, M., Cheshier, S., & Steinberg, G. K. (2006). New vessel formation in the central nervous system during tumor growth, vascular malformations, and Moyamoya. CURRENT NEUROVASCULAR RESEARCH, 3(3), 237鈥�45.
- Cerebral perfusion imaging in vasospasm.
  Lad, S. P., Guzman, R., Kelly, M. E., Li, G., Lim, M., Lovbald, K., & Steinberg, G. K. (2006). Cerebral perfusion imaging in vasospasm. Neurosurgical Focus, 21(3), E7-?
- Radiosurgery for glomus Jugulare tumors
  Lim, M., Bower, R., Nangiana, J. S., Adler, J. R., & Chang, S. D. (2007). Radiosurgery for glomus Jugulare tumors. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 6(5), 419鈥�23.
- Irradiation of glomus jugulare tumors: a historical perspective.
  Li, G., Chang, S., Adler, J. R., & Lim, M. (2007). Irradiation of glomus jugulare tumors: a historical perspective. Neurosurgical Focus, 23(6), E13-?
- CyberKnife radiosurgical rhizotomy for the treatment of atypical trigeminal nerve pain.
  Patil, C. G., Veeravagu, A., Bower, R. S., Li, G., Chang, S. D., Lim, M., & Adler, J. R. (2007). CyberKnife radiosurgical rhizotomy for the treatment of atypical trigeminal nerve pain. Neurosurgical Focus, 23(6), E9-?
- Cyberknife radiosurgery for trigeminal neuralgia treatment: A preliminary multicenter experience
  Villavicencio, A. T., Lim, M., Burneikiene, S., Romanelli, P., Adler, J. R., McNeely, L., 鈥� Thramann, J. J. (2008). Cyberknife radiosurgery for trigeminal neuralgia treatment: A preliminary multicenter experience. NEUROSURGERY, 62(3), 647鈥�54.
- Suprasellar giant cell ependymoma: a rare neoplasm in a unique location
  Sangoi, A. R., Lim, M., Dulai, M. S., Vogel, H., & Chang, S. D. (2008). Suprasellar giant cell ependymoma: a rare neoplasm in a unique location. HUMAN PATHOLOGY, 39(9), 1396鈥�1401.
- A VIRTUAL FRAME SYSTEM FOR STEREOTACTIC RADIOSURGERY PLANNING
  Ford, E., Purger, D., Tryggestad, E., McNutt, T., Christodouleas, J., Rigamonti, D., 鈥� Kleinberg, L. (2008). A VIRTUAL FRAME SYSTEM FOR STEREOTACTIC RADIOSURGERY PLANNING. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 72(4), 1244鈥�49.
- NONISOCENTRIC RADIOSURGICAL RHIZOTOMY FOR TRIGEMINAL NEURALGIA
  Adler, J. R., Bower, R., Gupta, G., Lim, M., Efron, A., Gibbs, I. C., 鈥� Soltys, S. G. (2009). NONISOCENTRIC RADIOSURGICAL RHIZOTOMY FOR TRIGEMINAL NEURALGIA. NEUROSURGERY, 64(2), A84鈥揂90.
- A NEUROSURGEON'S GUIDE TO STEM CELLS, CANCER STEM CELLS, AND BRAIN TUMOR STEM CELLS
  Cheshier, S. H., Kalani, M. Y. S., Lim, M., Ailles, L., Huhn, S. L., & Weissman, I. L. (2009). A NEUROSURGEON'S GUIDE TO STEM CELLS, CANCER STEM CELLS, AND BRAIN TUMOR STEM CELLS. NEUROSURGERY, 65(2), 237鈥�49.
- Radiosurgery for glomus jugulare: history and recent progress
  Guss, Z. D., Batra, S., Li, G., Chang, S. D., Parsa, A. T., Rigamont, D., 鈥� Lim, M. (2009). Radiosurgery for glomus jugulare: history and recent progress. NEUROSURGICAL FOCUS, 27(6).
- RADIOSURGERY OF GLOMUS JUGULARE TUMORS: A META-ANALYSIS
  Guss, Z. D., Batra, S., Limb, C. J., Li, G., Sughrue, M. E., Redmond, K., 鈥� Lim, M. (2011). RADIOSURGERY OF GLOMUS JUGULARE TUMORS: A META-ANALYSIS. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(4), E497鈥揈502.
- The predictive value of serum myeloperoxidase for vasospasm in patients with aneurysmal subarachnoid hemorrhage
  Lim, M., Bower, R. S., Wang, Y., Sims, L., Bower, M. R., Camara-Quintana, J., 鈥� Guccione, S. (2012). The predictive value of serum myeloperoxidase for vasospasm in patients with aneurysmal subarachnoid hemorrhage. NEUROSURGICAL REVIEW, 35(3), 413鈥�19.
- Perspectives on key articles in neurosurgery.
  Lim, M., Sherman, J. H., Wang, V. Y., Smith, Z. A., Cho, J. M., Colen, C. B., 鈥� Yang, I. (2012). Perspectives on key articles in neurosurgery. Surgical Neurology International, 3, 58-?
- Anti-angiogenic targeted therapy in a rat model for glioblastoma multiforme tumor with temporal MRI and pet studies
  Lim, M., Yang, Y.-S., Sims, L., Choi, S., Wang, Y., & Guccione, S. (2006). Anti-angiogenic targeted therapy in a rat model for glioblastoma multiforme tumor with temporal MRI and pet studies. NEURO-ONCOLOGY, 8(4), 415鈥�15.
- Flow cytometric analysis of neural stem cell markers on pediatric brain tumors
  Cheshier, S. H., Ailles, L. E., Lim, M., Laddis, P., Tse, V., Weissman, I. L., & Huhn, S. (2006). Flow cytometric analysis of neural stem cell markers on pediatric brain tumors. NEURO-ONCOLOGY, 8(4), 466鈥�66.
- CD90 expression segregates tumor-sphere forming cells in human glioblastoma multiforme
  Cheshier, S. H., Ailles, L., Higgins, D. M. O., Lim, M., Kalani, M. Y. S., Bababeygy, S., & Weissman, I. L. (2006). CD90 expression segregates tumor-sphere forming cells in human glioblastoma multiforme. NEURO-ONCOLOGY, 8(4), 471鈥�71.
- LEVERAGING EXPRESSION OF A5/GABA-A RECEPTOR IN MEDULLOBLASTOMA AS A NOVEL THERAPEUTIC TARGET
  Sengupta, S., Weeraratne, S. D., Phallen, J., Sun, H., Rallapalli, S., Amani, V., 鈥� Cho, Y.-J. (2012). LEVERAGING EXPRESSION OF A5/GABA-A RECEPTOR IN MEDULLOBLASTOMA AS A NOVEL THERAPEUTIC TARGET. Presented at the 15th International Symposium on Pediatric Neuro-Oncology (ISPNO), TORONTO,CANADA,CANADA,CANADA,CANADA: OXFORD UNIV PRESS INC.
- DEVELOPMENT AND VALIDATION OF A PRE-OPERATIVE PROGNOSTIC SCORING SYSTEM FOR PATIENTS WITH GLIOBLASTOMA
  Chaichana, K., Pendleton, C., Chambless, L., Nathan, J., Camara-Quintana, J., Li, G., 鈥� Quinones-Hinojosa, A. (2011). DEVELOPMENT AND VALIDATION OF A PRE-OPERATIVE PROGNOSTIC SCORING SYSTEM FOR PATIENTS WITH GLIOBLASTOMA. Presented at the 16th Annual Scientific Meeting of the Society-for-Neuro-Oncology (SNO)/AANS/CNS Section on Tumors, CA: OXFORD UNIV PRESS INC.
- Multi-institutional validation of a preoperative scoring system which predicts survival for patients with glioblastoma.
  Chaichana, K. L., Pendleton, C., Chambless, L., Camara-Quintana, J., Nathan, J. K., Hassam-Malani, L., 鈥� Quinones-Hinojosa, A. (2013). Multi-institutional validation of a preoperative scoring system which predicts survival for patients with glioblastoma. Journal of Clinical Neuroscience , 20(10), 1422鈥�26.
- alpha 5-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth
  Sengupta, S., Weeraratne, S. D., Sun, H., Phallen, J., Rallapalli, S. K., Teider, N., 鈥� Cho, Y.-J. (2014). alpha 5-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth. ACTA NEUROPATHOLOGICA, 127(4), 593鈥�603.
- Current Vaccine Trials in Glioblastoma: A Review
  Xu, L. W., Chow, K. K., Lim, M., & Li, G. (2014). Current Vaccine Trials in Glioblastoma: A Review. JOURNAL OF IMMUNOLOGY RESEARCH.
- The future of glioblastoma therapy: synergism of standard of care and immunotherapy.
  Patel, M. A., Kim, J. E., Ruzevick, J., Li, G., & Lim, M. (2014). The future of glioblastoma therapy: synergism of standard of care and immunotherapy. Cancers, 6(4), 1953鈥�85.
- Neurosurgery concepts: Key perspectives on dendritic cell vaccines, metastatic tumor treatment, and radiosurgery.
  Li, G., Sherman, J. H., Cho, J. M., Lim, M., Khalessi, A. A., Colen, C. B., 鈥� Yang, I. (2015). Neurosurgery concepts: Key perspectives on dendritic cell vaccines, metastatic tumor treatment, and radiosurgery. Surgical Neurology International, 6, 6.
- Combining immunotherapy with radiation for the treatment of glioblastoma.
  Chow, K. K., Hara, W., Lim, M., & Li, G. (2015). Combining immunotherapy with radiation for the treatment of glioblastoma. Journal of Neuro-Oncology, 123(3), 459鈥�64.
- Neurosurgery concepts: Key perspectives on imaging characteristics of spinal metastases, surgery for low back pain, anesthesia for disc surgery, and laminectomy versus laminectomy and fusion for lumbar spondylolisthesis.
  Lagman, C., Chung, L. K., Macyszyn, L., Choy, W., Smith, Z. A., Dahdaleh, N. S., 鈥� Yang, I. (2017). Neurosurgery concepts: Key perspectives on imaging characteristics of spinal metastases, surgery for low back pain, anesthesia for disc surgery, and laminectomy versus laminectomy and fusion for lumbar spondylolisthesis. Surgical Neurology International, 8, 9.
- Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell Lines
  Binder, Z. A., Wilson, K. M., Salmasi, V., Orr, B. A., Eberhart, C. G., Siu, I.-M., 鈥� Gallia, G. L. (2016). Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell Lines. PLOS ONE, 11(3).
- Neurosurgery concepts: Key perspectives on endoscopic versus microscopic resection for pituitary adenomas, surgical decision-making in tuberculum sellae meningiomas, optic nerve mobilization during resection of craniopharyngiomas, and evaluation of headache and quality of life after endoscopic transphenoidal surgery for pituitary adenomas.
  Germanwala, A. V., Hofler, R., Lagman, C., Chung, L. K., Khalessi, A. A., Zada, G., 鈥� Yang, I. (2017). Neurosurgery concepts: Key perspectives on endoscopic versus microscopic resection for pituitary adenomas, surgical decision-making in tuberculum sellae meningiomas, optic nerve mobilization during resection of craniopharyngiomas, and evaluation of headache and quality of life after endoscopic transphenoidal surgery for pituitary adenomas. Surgical Neurology International, 8, 52.
- The Future of Glioblastoma Therapy: Synergism of Standard of Care and Immunotherapy
  Patel, M. A., Kim, J. E., Ruzevick, J., Li, G., & Lim, M. (2014). The Future of Glioblastoma Therapy: Synergism of Standard of Care and Immunotherapy. CANCERS, 6(4), 1953鈥�85.
- Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
  Weller, M., Butowski, N., Tran, D. D., Recht, L. D., Lim, M., Hirte, H., 鈥� Sampson, J. H. (2017). Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial. LANCET ONCOLOGY, 18(10), 1373鈥�85.
- Go, no-go decision making for phase 3 clinical trials: ACT IV revisited Reply
  Weller, M., Butowski, N., Tran, D. D., Recht, L. D., Lim, M., Hirte, H., 鈥� Sampson, J. H. (2017). Go, no-go decision making for phase 3 clinical trials: ACT IV revisited Reply. LANCET ONCOLOGY, 18(12), E709鈥揈710.
- Growth of human glioblastoma multiforme and medulloblastoma tumors in RAG 2 and common cytokine receptor gamma chain double knockout mice: A new model for in vivo study of GBM
  Cheshier, S. H., Ailles, L., Tse, V., Skirboll, S., Huhn, S., & Weissman, I. (2006). Growth of human glioblastoma multiforme and medulloblastoma tumors in RAG 2 and common cytokine receptor gamma chain double knockout mice: A new model for in vivo study of GBM. NEURO-ONCOLOGY, 8(4), 471.
- Immunotherapy for glioma: promises and challenges.
  Han, S. J., Zygourakis, C., Lim, M., & Parsa, A. T. (2012). Immunotherapy for glioma: promises and challenges. Neurosurgery Clinics of North America, 23(3), 357鈥�70.
- ACT IV: AN INTERNATIONAL, DOUBLE-BLIND, PHASE 3 TRIAL OF RINDOPEPIMUT IN NEWLY DIAGNOSED, EGFRvIII-EXPRESSING GLIOBLASTOMA
  Weller, M., Butowski, N., Tran, D., Recht, L., Lim, M., Hirte, H., 鈥� Sampson, J. (2016). ACT IV: AN INTERNATIONAL, DOUBLE-BLIND, PHASE 3 TRIAL OF RINDOPEPIMUT IN NEWLY DIAGNOSED, EGFRvIII-EXPRESSING GLIOBLASTOMA. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- Go, no-go decision making for phase 3 clinical trials: ACT IV revisited - Authors' reply.
  Weller, M., Butowski, N., Tran, D. D., Recht, L. D., Lim, M., Hirte, H., 鈥� Sampson, J. H. (2017). Go, no-go decision making for phase 3 clinical trials: ACT IV revisited - Authors' reply. The Lancet. Oncology, 18(12), e709鈥揺710.
- Combination anti-CXCR4 and anti-PD-1 immunotherapy provides survival benefit in glioblastoma through immune cell modulation of tumor microenvironment.
  Wu, A., Maxwell, R., Xia, Y., Cardarelli, P., Oyasu, M., Belcaid, Z., 鈥� Lim, M. (2019). Combination anti-CXCR4 and anti-PD-1 immunotherapy provides survival benefit in glioblastoma through immune cell modulation of tumor microenvironment. Journal of Neuro-Oncology.
- Phase I/II trial of an allogeneic cellular immunotherapy in hormone-naive prostate cancer
  Simons, J. W., Carducci, M. A., Mikhak, B., Lim, M., Biedrzycki, B., Borellini, F., 鈥� Nelson, W. G. (2006). Phase I/II trial of an allogeneic cellular immunotherapy in hormone-naive prostate cancer. CLINICAL CANCER RESEARCH, 12(11), 3394鈥�3401.
- Alternative Checkpoints as Targets for Immunotherapy.
  Pant, A., Medikonda, R., & Lim, M. (2020). Alternative Checkpoints as Targets for Immunotherapy. Current Oncology Reports, 22(12), 126.
- A Dose-Response Model of Local Tumor Control Probability After Stereotactic Radiosurgery for Brain Metastases Resection Cavities.
  Gui, C., Grimm, J., Kleinberg, L. R., Zaki, P., Spoleti, N., Mukherjee, D., 鈥� Redmond, K. J. (2020). A Dose-Response Model of Local Tumor Control Probability After Stereotactic Radiosurgery for Brain Metastases Resection Cavities. Advances in Radiation Oncology, 5(5), 840鈥�49.
- Updated safety phase I trial of anti-LAG-3 alone and in combination with anti-PD-1 in patients with recurrent GBM.
  Lim, M., Ye, X., Piotrowski, A. F., Desai, A. S., Ahluwalia, M. S., Walbert, T., 鈥� Grossman, S. A. (2020). Updated safety phase I trial of anti-LAG-3 alone and in combination with anti-PD-1 in patients with recurrent GBM. JOURNAL OF CLINICAL ONCOLOGY, 38(15).
- Scalp Invasion by Atypical or Anaplastic Meningioma Is a Risk Factor for Development of Systemic Metastasis
  Garzon-Muvdi, T., Maxwell, R., Luksik, A., Kessler, R., Weingart, J., Olivi, A., 鈥� Lim, M. (2020). Scalp Invasion by Atypical or Anaplastic Meningioma Is a Risk Factor for Development of Systemic Metastasis. WORLD NEUROSURGERY, 142, E133鈥揈139.
- Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma
  Sa, J. K., Chang, N., Lee, H. W., Cho, H. J., Ceccarelli, M., Cerulo, L., 鈥� Nam, D.-H. (2020). Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma. GENOME BIOLOGY, 21(1), 216.
- Investigating in vivo synergistic effect of checkpoint blockade and radiation therapy against chordomas in a humanized mouse model
  Ishida, W., McCormick, K. L., Mahajan, A., Feldstein, E., Lim, M., Bruce, J. N., 鈥� Lo, S.-fu L. (2019). Investigating in vivo synergistic effect of checkpoint blockade and radiation therapy against chordomas in a humanized mouse model. CANCER IMMUNOLOGY RESEARCH, 7(2).
- The Effects of Postoperative Neurological Deficits on Survival in Patients With Single Brain Metastasis.
  Medikonda, R., Jackson, C. M., Feghali, J., & Lim, M. (2020). The Effects of Postoperative Neurological Deficits on Survival in Patients With Single Brain Metastasis. Operative Neurosurgery (Hagerstown, Md.).
- Low-dose oncolytic adenovirus therapy overcomes tumor-induced immune suppression and sensitizes intracranial gliomas to anti-PD-1 therapy.
  Belcaid, Z., Berrevoets, C., Choi, J., van Beelen, E., Stavrakaki, E., Pierson, T., 鈥� Lamfers, M. L. (2020). Low-dose oncolytic adenovirus therapy overcomes tumor-induced immune suppression and sensitizes intracranial gliomas to anti-PD-1 therapy. Neuro-Oncology Advances, 2(1), vdaa011.
- A systematic review and meta-analysis of supratotal versus gross total resection for glioblastoma
  Jackson, C., Choi, J., Khalafallah, A. M., Price, C., Bettegowda, C., Lim, M., 鈥� Mukherjee, D. (2020). A systematic review and meta-analysis of supratotal versus gross total resection for glioblastoma. JOURNAL OF NEURO-ONCOLOGY, 148(3), 419鈥�31.
- Hemophagocytic Lymphohistiocytosis Secondary to PD-1 and IDO Inhibition in a Patient with Refractory Glioblastoma
  Thummalapalli, R., Heumann, T., Stein, J., Khan, S., Priemer, D. S., Duffield, A. S., 鈥� Holdhoff, M. (2020). Hemophagocytic Lymphohistiocytosis Secondary to PD-1 and IDO Inhibition in a Patient with Refractory Glioblastoma. CASE REPORTS IN ONCOLOGY, 13(2), 508鈥�14.
- Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma The CheckMate 143 Phase 3 Randomized Clinical Trial
  Reardon, D. A., Brandes, A. A., Omuro, A., Mulholland, P., Lim, M., Wick, A., 鈥� Weller, M. (2020). Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma The CheckMate 143 Phase 3 Randomized Clinical Trial. JAMA ONCOLOGY, 6(7), 1003鈥�10.
- ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma
  Tong, L., Li, J., Li, Q., Wang, X., Medikonda, R., Zhao, T., 鈥� Yang, X. (2020). ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma. THERANOSTICS, 10(13), 5943鈥�56.
- Adult immuno-oncology: using past failures to inform the future.
  Rahman, M., Sawyer, W. G., Lindhorst, S., Deleyrolle, L. P., Harrison, J. K., Karachi, A., 鈥� Reardon, D. A. (2020). Adult immuno-oncology: using past failures to inform the future. Neuro-Oncology, 22(9), 1249鈥�61.
- Cottonoid Sliders: A Simple and Cost-Effective Tool for Retractorless Intracranial Surgery.
  Shao, J., Borghei-Razavi, H., Kshettry, V. R., Lim, M., & Recinos, P. F. (2020). Cottonoid Sliders: A Simple and Cost-Effective Tool for Retractorless Intracranial Surgery. Operative Neurosurgery (Hagerstown, Md.), 19(4), E428鈥揈431.
- Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.
  Wen, P. Y., Weller, M., Lee, E. Q., Alexander, B. M., Barnholtz-Sloan, J. S., Barthel, F. P., 鈥� van den Bent, M. J. (2020). Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro-Oncology, 22(8), 1073鈥�1113.
- Understanding innate immune response in glioblastoma in search of a way forward
  Pant, A., & Lim, M. (2020). Understanding innate immune response in glioblastoma in search of a way forward. NEURO-ONCOLOGY, 22(4), 444鈥�45.
- A review of glioblastoma immunotherapy
  Medikonda, R., Dunn, G., Rahman, M., Fecci, P., & Lim, M. (2020). A review of glioblastoma immunotherapy. JOURNAL OF NEURO-ONCOLOGY.
- Characterizing patterns of cytokine coexpression with immune checkpoint markers in CD4 and CD8 tumor-infiltrating lymphocytes.
  Jackson, C. M., Dinalankara, W., Choi, J., Nirschl, T. R., Kochel, C. M., Pant, A., 鈥� Lim, M. (2020). Characterizing patterns of cytokine coexpression with immune checkpoint markers in CD4 and CD8 tumor-infiltrating lymphocytes. CANCER IMMUNOLOGY RESEARCH, 8(3), 47鈥�48.
- New Prospects for Molecular Targets for Chordomas
  Ozair, M. Z., Shah, P. P., Mathios, D., Lim, M., & Moss, N. S. (2020). New Prospects for Molecular Targets for Chordomas. NEUROSURGERY CLINICS OF NORTH AMERICA, 31(2), 289-+.
- Integrin alpha 6 signaling induces STAT3-TET3-mediated hydroxymethylation of genes critical for maintenance of glioma stem cells
  Herrmann, A., Lahtz, C., Song, J., Aftabizadeh, M., Cherryholmes, G. A., Xin, H., 鈥� Yu, H. (2020). Integrin alpha 6 signaling induces STAT3-TET3-mediated hydroxymethylation of genes critical for maintenance of glioma stem cells. ONCOGENE, 39(10), 2156鈥�69.
- PD-L1 EXPRESSION IS NEGATIVELY CORRELATED TO OUTCOMES IN PATIENTS WITH MGMT METHYLATED PROMOTERS IN GBM
  Srivastava, S., Choi, J., & Lim, M. (2019). PD-L1 EXPRESSION IS NEGATIVELY CORRELATED TO OUTCOMES IN PATIENTS WITH MGMT METHYLATED PROMOTERS IN GBM. NEURO-ONCOLOGY, 21, 250.
- MULTI-TIME POINT EVALUATION OF PERIPHERAL BLOOD MYELOID-DERIVED SUPPRESSOR CELL AND LYMPHOCYTE POPULATIONS IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA RECEIVING ADJUVANT THERAPY
  Sloan, L., Sen, R., Doucet, M., Blosser, L., Shpitser, I., Sherman, E., 鈥� Kleinberg, L. (2019). MULTI-TIME POINT EVALUATION OF PERIPHERAL BLOOD MYELOID-DERIVED SUPPRESSOR CELL AND LYMPHOCYTE POPULATIONS IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA RECEIVING ADJUVANT THERAPY. NEURO-ONCOLOGY, 21, 283.
- NIVOLUMAB VS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA: EXPLORATORY ANALYSIS OF MGMT METHYLATION STATUS AND BASELINE CORTICOSTEROID USE
  Weller, M., Reardon, D., Brandes, A., Sampson, J., Mulholland, P., Wick, A., 鈥� Lim, M. (2019). NIVOLUMAB VS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA: EXPLORATORY ANALYSIS OF MGMT METHYLATION STATUS AND BASELINE CORTICOSTEROID USE. NEURO-ONCOLOGY, 21, 12.
- SUPRATOTAL VERSUS GROSS TOTAL RESECTION OF GLIOBLASTOMA: A SYSTEMATIC REVIEW
  Jackson, C., Choi, J., Price, C., Bettegowda, C., Lim, M., Gallia, G., 鈥� Mukherjee, D. (2019). SUPRATOTAL VERSUS GROSS TOTAL RESECTION OF GLIOBLASTOMA: A SYSTEMATIC REVIEW. NEURO-ONCOLOGY, 21, 243.
- IMMUNOGENOMIC RESPONDER PHENOTYPE FROM A PHASE I TRIAL OF ANTI-LAG3 OR ANTI-CD137 ALONE AND IN COMBINATION WITH ANTI-PD-1 IN PATIENTS WITH RECURRENT GBM
  Jackson, C., Choi, J., Zhang, J. J., Piotrowski, A., Walbert, T., Desai, A., 鈥� Lim, M. (2019). IMMUNOGENOMIC RESPONDER PHENOTYPE FROM A PHASE I TRIAL OF ANTI-LAG3 OR ANTI-CD137 ALONE AND IN COMBINATION WITH ANTI-PD-1 IN PATIENTS WITH RECURRENT GBM. NEURO-ONCOLOGY, 21, 122.
- TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM
  Hung, A. L., Maxwell, R., Theodros, D., Belcaid, Z., Mathios, D., Luksik, A. S., 鈥� Lim, M. (2018). TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM. ONCOIMMUNOLOGY, 7(8), e1466769.
- Tumor-Treating Field Arrays Do Not Reduce Target Volume Coverage for Glioblastoma Radiation Therapy
  Stachelek, G. C., Grimm, J., Moore, J., Huang, E., Spoleti, N., Redmond, K. J., 鈥� Kleinberg, L. (2020). Tumor-Treating Field Arrays Do Not Reduce Target Volume Coverage for Glioblastoma Radiation Therapy. ADVANCES IN RADIATION ONCOLOGY, 5(1), 62鈥�69.
- PD-L1, PD-1, LAG-3, and TIM-3 in Melanoma: Expression in Brain Metastases Compared to Corresponding Extracranial Tumors
  Wang, J. J., Burger, P., Taube, J., Soni, A., Chaichana, K., Sheu, M., 鈥� Lim, M. (2019). PD-L1, PD-1, LAG-3, and TIM-3 in Melanoma: Expression in Brain Metastases Compared to Corresponding Extracranial Tumors. CUREUS, 11(12), e6352.
- Carboxylated branched poly(beta-amino ester) nanoparticles enable robust cytosolic protein delivery and CRISPR-Cas9 gene editing
  Rui, Y., Wilson, D. R., Choi, J., Varanasi, M., Sanders, K., Karlsson, J., 鈥� Green, J. J. (2019). Carboxylated branched poly(beta-amino ester) nanoparticles enable robust cytosolic protein delivery and CRISPR-Cas9 gene editing. SCIENCE ADVANCES, 5(12), eaay3255.
- PD-L1 Expression in Pediatric Low-Grade Gliomas Is Independent of BRAF V600E Mutational Status
  Martin, A. M., Bell, W. R., Yuan, M., Harris, L., Poore, B., Arnold, A., 鈥� Eberhart, C. G. (2020). PD-L1 Expression in Pediatric Low-Grade Gliomas Is Independent of BRAF V600E Mutational Status. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 79(1), 74鈥�85.
- In Vivo Bioluminescence Tomography Center of Mass-Guided Conformal Irradiation
  Deng, Z., Xu, X., Garzon-Muvdi, T., Xia, Y., Kim, E., Belcaid, Z., 鈥� Wang, K. K.-H. (2020). In Vivo Bioluminescence Tomography Center of Mass-Guided Conformal Irradiation. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 106(3), 612鈥�20.
- A Phase 2 Study of Post-Operative Stereotactic Body Radiation Therapy (SBRT) for Solid Tumor Spine Metastases
  Redmond, K. J., Sciubba, D., Khan, M., Gui, C., Lo, S.-fu L., Gokaslan, Z. L., 鈥� Lim, M. (2020). A Phase 2 Study of Post-Operative Stereotactic Body Radiation Therapy (SBRT) for Solid Tumor Spine Metastases. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 106(2), 261鈥�68.
- CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with glioma
  Tong, L., Li, J., Choi, J., Pant, A., Xia, Y., Jackson, C., 鈥� Yang, X. (2020). CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with glioma. CANCER GENE THERAPY, 27(9), 669鈥�79.
- Updated phase I trial of anti-LAG-3 or anti-CD137 alone and in combination with anti-PD-1 in patients with recurrent GBM.
  Lim, M., Ye, X., Piotrowski, A. F., Desai, A. S., Ahluwalia, M. S., Walbert, T., 鈥� Grossman, S. A. (2019). Updated phase I trial of anti-LAG-3 or anti-CD137 alone and in combination with anti-PD-1 in patients with recurrent GBM. JOURNAL OF CLINICAL ONCOLOGY, 37(15).
- Phase II study to evaluate safety and efficacy of MEDI4736 (durvalumab) plus radiotherapy in patients with newly diagnosed unmethylated MGMT glioblastoma (new unmeth GBM).
  Reardon, D. A., Kaley, T. J., Dietrich, J., Clarke, J. L., Dunn, G., Lim, M., 鈥� Venhaus, R. R. (2019). Phase II study to evaluate safety and efficacy of MEDI4736 (durvalumab) plus radiotherapy in patients with newly diagnosed unmethylated MGMT glioblastoma (new unmeth GBM). JOURNAL OF CLINICAL ONCOLOGY, 37(15).
- Updated risk models demonstrate low risk of symptomatic radionecrosis following stereotactic radiosurgery for brain metastases.
  Peng, L., Grimm, J., Gui, C., Shen, C. J., Redmond, K. J., Sloan, L., 鈥� Kleinberg, L. R. (2019). Updated risk models demonstrate low risk of symptomatic radionecrosis following stereotactic radiosurgery for brain metastases. Surgical Neurology International, 10, 32.
- Targeting Myeloid Cells in Combination Treatments for Glioma and Other Tumors
  Ding, A. S., Routkevitch, D., Jackson, C., & Lim, M. (2019). Targeting Myeloid Cells in Combination Treatments for Glioma and Other Tumors. FRONTIERS IN IMMUNOLOGY, 10, 1715.
- Genome-wide investigation of intragenic DNA methylation identifies ZMIZ1 gene as a prognostic marker in glioblastoma and multiple cancer types
  Mathios, D., Hwang, T., Xia, Y., Phallen, J., Rui, Y., See, A. P., 鈥� Lim, M. (2019). Genome-wide investigation of intragenic DNA methylation identifies ZMIZ1 gene as a prognostic marker in glioblastoma and multiple cancer types. INTERNATIONAL JOURNAL OF CANCER, 145(12), 3425鈥�35.
- Mechanisms of immunotherapy resistance: lessons from glioblastoma
  Jackson, C. M., Choi, J., & Lim, M. (2019). Mechanisms of immunotherapy resistance: lessons from glioblastoma. NATURE IMMUNOLOGY, 20(9), 1100鈥�1109.
- Radiotherapy, Lymphopenia, and Host Immune Capacity in Glioblastoma: A Potentially Actionable Toxicity Associated With Reduced Efficacy of Radiotherapy
  Kleinberg, L., Sloan, L., Grossman, S., & Lim, M. (2019). Radiotherapy, Lymphopenia, and Host Immune Capacity in Glioblastoma: A Potentially Actionable Toxicity Associated With Reduced Efficacy of Radiotherapy. NEUROSURGERY, 85(4), 441鈥�53.
- Absence of Ischemic Injury after Sacrificing the Superior Petrosal Vein during Microvascular Decompression.
  Xia, Y., Kim, T. Y., Mashouf, L. A., Patel, K. K., Xu, R., Casaos, J., 鈥� Lim, M. (2020). Absence of Ischemic Injury after Sacrificing the Superior Petrosal Vein during Microvascular Decompression. Operative Neurosurgery (Hagerstown, Md.), 18(3), 316鈥�20.
- Targeting DDX3 in medulloblastoma by RK-33
  Tantravedi, S., Vesuna, F., Martin, A., Lim, M., Eberhart, C. G. E. G., van Diest, P. J., & Raman, V. (2018). Targeting DDX3 in medulloblastoma by RK-33. CANCER RESEARCH, 78(13).
- Integrative analysis of DNA methylation suggests down-regulation of oncogenic pathways and reduced somatic mutation rates in survival outliers of glioblastoma
  Hwang, T., Mathios, D., McDonald, K. L., Daris, I., Park, S.-H., Burger, P. C., 鈥� Park, C.-K. (2019). Integrative analysis of DNA methylation suggests down-regulation of oncogenic pathways and reduced somatic mutation rates in survival outliers of glioblastoma. ACTA NEUROPATHOLOGICA COMMUNICATIONS, 7, 88.
- Assessing the Effectiveness of Systemic Therapy after Stereotactic Radiosurgery on Cancer Recurrence and All-Cause Mortality
  Al-Khindi, T., Shen, C. J., Peng, L., Redmond, K. J., Lim, M., Kleinberg, L. R., & Bettegowda, C. (2019). Assessing the Effectiveness of Systemic Therapy after Stereotactic Radiosurgery on Cancer Recurrence and All-Cause Mortality. WORLD NEUROSURGERY, 129, E572鈥揈581.
- The combination of CXCR4 and checkpoint receptor inhibition improves survival in an orthotopic murine glioma model
  Wu, A., Cardarelli, P., Oyasu, M., Menezes, D., Ponath, P., Cogswell, J., 鈥� Lim, M. (2018). The combination of CXCR4 and checkpoint receptor inhibition improves survival in an orthotopic murine glioma model. CANCER RESEARCH, 78(13).
- Association Between Radiofrequency Rhizotomy Parameters and Duration of Pain Relief in Trigeminal Neuralgia Patients with Recurrent Pain
  Xie, E., Garzon-Muvdi, T., Bender, M., Doshi, T., Carson, B., Lim, M., & Bettegowda, C. (2019). Association Between Radiofrequency Rhizotomy Parameters and Duration of Pain Relief in Trigeminal Neuralgia Patients with Recurrent Pain. WORLD NEUROSURGERY, 129, E128鈥揈133.
- Utilization of the Nasoseptal Flap for Repair of Cerebrospinal Fluid Leak after Endoscopic Endonasal Approach for Resection of Pituitary Tumors.
  Kessler, R. A., Garzon-Muvdi, T., Kim, E., Ramanathan, M., & Lim, M. (2019). Utilization of the Nasoseptal Flap for Repair of Cerebrospinal Fluid Leak after Endoscopic Endonasal Approach for Resection of Pituitary Tumors. Brain Tumor Research and Treatment, 7(1), 10鈥�15.
- A Characterization of Dendritic Cells and Their Role in Immunotherapy in Glioblastoma: From Preclinical Studies to Clinical Trials
  Srivastava, S., Jackson, C., Kim, T., Choi, J., & Lim, M. (2019). A Characterization of Dendritic Cells and Their Role in Immunotherapy in Glioblastoma: From Preclinical Studies to Clinical Trials. CANCERS, 11(4).
- Extracranial Abscopal Responses after Radiation Therapy for Intracranial Metastases: A Review of the Clinical Literature and Commentary on Mechanism
  Gui, C., Kleinberg, L. R., Lim, M., & Redmond, K. J. (2019). Extracranial Abscopal Responses after Radiation Therapy for Intracranial Metastases: A Review of the Clinical Literature and Commentary on Mechanism. CUREUS, 11(3), e4207.
- Bespoke immunotherapy: how close are we?
  Jackson, C., & Lim, M. (2019). Bespoke immunotherapy: how close are we? NEURO-ONCOLOGY, 21(3), 289鈥�90.
- Surgical Resection for Primary Central Nervous System Lymphoma: A Systematic Review
  Labak, C. M., Holdhoff, M., Bettegowda, C., Gallia, G. L., Lim, M., Weingart, J. D., & Mukherjee, D. (2019). Surgical Resection for Primary Central Nervous System Lymphoma: A Systematic Review. WORLD NEUROSURGERY, 126, E1436鈥揈1448.
- TUMOR-TREATING FIELDS THERAPY IS COMPATIBLE WITH STANDARD CHEMORADIOTHERAPY FOR GLIOBLASTOMA
  Stachelek, G., Grimm, J., Lim, M., Bettegowda, C., Redmond, K., & Kleinberg, L. (2018). TUMOR-TREATING FIELDS THERAPY IS COMPATIBLE WITH STANDARD CHEMORADIOTHERAPY FOR GLIOBLASTOMA. NEURO-ONCOLOGY, 20, 228.
- UPDATED RESULTS OF A PHASE I TRIAL OF ANTI-LAG-3 OR ANTI-CD137 ALONE AND IN COMBINATION WITH ANTI-PD-1 IN PATIENTS WITH RECURRENT GBM
  Lim, M., Ye, X., Nabors, L. B., Piotrowski, A., Ahluwalia, M., Desai, A., 鈥� Grossman, S. (2018). UPDATED RESULTS OF A PHASE I TRIAL OF ANTI-LAG-3 OR ANTI-CD137 ALONE AND IN COMBINATION WITH ANTI-PD-1 IN PATIENTS WITH RECURRENT GBM. NEURO-ONCOLOGY, 20, 5.
- PHASE 2 STUDY TO EVALUATE THE CLINICAL EFFICACY AND SAFETY OF MEDI4736 (DURVALUMAB, DURVA) plus BEVACIZUMAB (BEV) IN BEV-NAIVE PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM)
  Reardon, D., Kaley, T., Dietrich, J., Clarke, J., Dunn, G., Lim, M., 鈥� Venhaus, R. (2018). PHASE 2 STUDY TO EVALUATE THE CLINICAL EFFICACY AND SAFETY OF MEDI4736 (DURVALUMAB, DURVA) plus BEVACIZUMAB (BEV) IN BEV-NAIVE PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM). NEURO-ONCOLOGY, 20, 10.
- LOCAL ONCOLYTIC ADENOVIRUS TREATMENT AFFECTS BOTH THE INNATE AND ADAPTIVE ARMS OF THE IMMUNE SYSTEM AND PROVIDES AN AVENUE FOR ENHANCING IMMUNOTHERAPIES FOR GBM
  Lamfers, M., Belcaid, Z., van den Bossche, W., Kleijn, A., Berrevoets, C., Lamers, C., 鈥� Dirven, C. (2018). LOCAL ONCOLYTIC ADENOVIRUS TREATMENT AFFECTS BOTH THE INNATE AND ADAPTIVE ARMS OF THE IMMUNE SYSTEM AND PROVIDES AN AVENUE FOR ENHANCING IMMUNOTHERAPIES FOR GBM. NEURO-ONCOLOGY, 20, 85.
- IN VIVO SYNERGISTIC EFFECT OF CHECKPOINT BLOCKADE AND RADIATION THERAPY AGAINST CHORDOMAS IN A HUMANIZED MOUSE MODEL
  Ishida, W., McCormick, K., Mahajan, A., Feldstein, E., Lim, M., Bruce, J., 鈥� Lo, S.-fu. (2018). IN VIVO SYNERGISTIC EFFECT OF CHECKPOINT BLOCKADE AND RADIATION THERAPY AGAINST CHORDOMAS IN A HUMANIZED MOUSE MODEL. NEURO-ONCOLOGY, 20, 276.
- Retrosigmoid approach for glycerin rhizotomy in the treatment of trigeminal neuralgia without overt arterial compression: updated case series
  Kim, T. Y., Jackson, C. M., Xia, Y., Mashouf, L. A., Patel, K. K., Kim, E. S., 鈥� Lim, M. (2020). Retrosigmoid approach for glycerin rhizotomy in the treatment of trigeminal neuralgia without overt arterial compression: updated case series. JOURNAL OF NEUROSURGERY, 132(4), 1227鈥�33.
- Why is immunotherapy for glioblastoma "Lag"-ging.
  Mathios, D., & Lim, M. (2019). Why is immunotherapy for glioblastoma "Lag"-ging. Oncotarget, 10(12), 1228鈥�29.
- Risk of Developing Postoperative Deficits Based on Tumor Location after Surgical Resection of an Intracranial Meningioma
  Ehresman, J. S., Garzon-Muvdi, T., Rogers, D., Lim, M., Gallia, G. L., Weingart, J., 鈥� Chaichana, K. L. (2019). Risk of Developing Postoperative Deficits Based on Tumor Location after Surgical Resection of an Intracranial Meningioma. JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 80(1), 59鈥�66.
- Deferred Radiotherapy After Debulking of Non-functioning Pituitary Macroadenomas: Clinical Outcomes
  Nicholas, S. E., Salvatori, R., Quinones-Hinojosa, A., Redmond, K., Gallia, G., Lim, M., 鈥� Kleinberg, L. (2019). Deferred Radiotherapy After Debulking of Non-functioning Pituitary Macroadenomas: Clinical Outcomes. FRONTIERS IN ONCOLOGY, 8, 660.
- Current State of Immune-Based Therapies for Glioblastoma.
  Lim, M., Weller, M., & Chiocca, E. A. (2016). Current State of Immune-Based Therapies for Glioblastoma. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting, (36), e132鈥揺139.
- Contrasting impact of corticosteroids on anti-PD-1 immunotherapy efficacy for tumor histologies located within or outside the central nervous system
  Maxwell, R., Luksik, A. S., Garzon-Muvdi, T., Hung, A. L., Kim, E. S., Wu, A., 鈥� Lim, M. (2018). Contrasting impact of corticosteroids on anti-PD-1 immunotherapy efficacy for tumor histologies located within or outside the central nervous system. ONCOIMMUNOLOGY, 7(12), e1500108.
- Identifying Recurrent Malignant Glioma after Treatment Using Amide Proton Transfer-Weighted MR Imaging: A Validation Study with Image-Guided Stereotactic Biopsy
  Jiang, S., Eberhart, C. G., Lim, M., Heo, H.-Y., Zhang, Y., Blair, L., 鈥� Zhou, J. (2019). Identifying Recurrent Malignant Glioma after Treatment Using Amide Proton Transfer-Weighted MR Imaging: A Validation Study with Image-Guided Stereotactic Biopsy. CLINICAL CANCER RESEARCH, 25(2), 552鈥�61.
- Distinguishing True Progression From Radionecrosis After Stereotactic Radiation Therapy for Brain Metastases With Machine Learning and Radiomics
  Peng, L., Parekh, V., Huang, P., Lin, D. D., Sheikh, K., Baker, B., 鈥� Kleinberg, L. (2018). Distinguishing True Progression From Radionecrosis After Stereotactic Radiation Therapy for Brain Metastases With Machine Learning and Radiomics. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102(4), 1236鈥�43.
- Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33
  Tantravedi, S., Vesuna, F., Winnard, P. T., Martin, A., Lim, M., Eberhart, C. G., 鈥� Raman, V. (2019). Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33. TRANSLATIONAL ONCOLOGY, 12(1), 96鈥�105.
- Outcomes of Metastatic Brain Lesions Treated with Radioactive Cs-131 Seeds after Surgery: Experience from One Institution
  Xia, Y., Mashouf, L. A., Baker, B. R., Maxwell, R., Bettegowda, C., Redmond, K. J., 鈥� Lim, M. (2018). Outcomes of Metastatic Brain Lesions Treated with Radioactive Cs-131 Seeds after Surgery: Experience from One Institution. CUREUS, 10(7), e3075.
- Expression of LAG-3 and efficacy of combination treatment with anti-LAG-3 and anti-PD-1 monoclonal antibodies in glioblastoma
  Harris-Bookman, S., Mathios, D., Martin, A. M., Xia, Y., Kim, E., Xu, H., 鈥� Lim, M. (2018). Expression of LAG-3 and efficacy of combination treatment with anti-LAG-3 and anti-PD-1 monoclonal antibodies in glioblastoma. INTERNATIONAL JOURNAL OF CANCER, 143(12), 3201鈥�8.
- REPLY TO HAFFNER ET AL.: DNA hypomethylation renders tumors more immunogenic
  Stone, M. L., Chiappinelli, K. B., Li, H., Murphy, L. M., Travers, M. E., Topper, M. J., 鈥� Zahnow, C. A. (2018). REPLY TO HAFFNER ET AL.: DNA hypomethylation renders tumors more immunogenic. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 115(37), E8583鈥揈8584.
- Prior ablative procedure: a prognostic factor for poor outcome of microvascular decompression? Response
  Theodros, D., & Lim, M. (2018). Prior ablative procedure: a prognostic factor for poor outcome of microvascular decompression? Response. JOURNAL OF NEUROSURGERY, 128(6), 1905.
- Adjuvant radiotherapy and outcomes of presumed hemorrhagic melanoma brain metastases without malignant cells.
  Xia, Y., Mashouf, L. A., Maxwell, R., Peng, L. C., Lipson, E. J., Sharfman, W. H., 鈥� Lim, M. (2018). Adjuvant radiotherapy and outcomes of presumed hemorrhagic melanoma brain metastases without malignant cells. Surgical Neurology International, 9, 146.
- Local recurrence patterns after postoperative stereotactic radiation surgery to resected brain metastases: A quantitative analysis to guide target delineation
  Gui, C., Moore, J., Grimm, J., Kleinberg, L., McNutt, T., Shen, C., 鈥� Redmond, K. J. (2018). Local recurrence patterns after postoperative stereotactic radiation surgery to resected brain metastases: A quantitative analysis to guide target delineation. PRACTICAL RADIATION ONCOLOGY, 8(6), 388鈥�96.
- Absence of host NF-kappa B p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarization
  Barberi, T., Martin, A., Suresh, R., Barakat, D. J., Harris-Bookman, S., Drake, C. G., 鈥� Friedman, A. D. (2018). Absence of host NF-kappa B p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarization. CANCER IMMUNOLOGY IMMUNOTHERAPY, 67(10), 1491鈥�1503.
- Commentary: Does Stereotactic Radiosurgery Have a Role in the Management of Patients Presenting With 4 or More Brain Metastases?
  Kleinberg, L., & Lim, M. (2019). Commentary: Does Stereotactic Radiosurgery Have a Role in the Management of Patients Presenting With 4 or More Brain Metastases? NEUROSURGERY, 84(3), 567鈥�68.
- Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
  Kim, J. E., Patel, M. A., Mangraviti, A., Kim, E. S., Theodros, D., Velarde, E., 鈥� Lim, M. (2017). Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas. CLINICAL CANCER RESEARCH, 23(1), 124鈥�36.
- Concurrent Immune Checkpoint Inhibitors and Radiation Therapy Reply
  Chen, L., Redmond, K., & Lim, M. (2018). Concurrent Immune Checkpoint Inhibitors and Radiation Therapy Reply. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 101(4), 998鈥�99.
- Immediate and Long-Term Outcomes of Microvascular Decompression for Mixed Trigeminal Neuralgia
  Wu, A., Doshi, T., Hung, A., Garzon-Muvdi, T., Bender, M. T., Bettegowda, C., & Lim, M. (2018). Immediate and Long-Term Outcomes of Microvascular Decompression for Mixed Trigeminal Neuralgia. WORLD NEUROSURGERY, 117, E300鈥揈307.
- Adult Cranioplasty Reconstruction With Customized Cranial Implants: Preferred Technique, Timing, and Biomaterials
  Wolff, A., Santiago, G. F., Belzberg, M., Huggins, C., Lim, M., Weingart, J., 鈥� Gordon, C. (2018). Adult Cranioplasty Reconstruction With Customized Cranial Implants: Preferred Technique, Timing, and Biomaterials. JOURNAL OF CRANIOFACIAL SURGERY, 29(4), 887鈥�94.
- Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma.
  Garzon-Muvdi, T., Theodros, D., Luksik, A. S., Maxwell, R., Kim, E., Jackson, C. M., 鈥� Lim, M. (2018). Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma. Oncotarget, 9(29), 20681鈥�97.
- PD-L1 expression in medulloblastoma: an evaluation by subgroup.
  Martin, A. M., Nirschl, C. J., Polanczyk, M. J., Bell, W. R., Nirschl, T. R., Harris-Bookman, S., 鈥� Lim, M. (2018). PD-L1 expression in medulloblastoma: an evaluation by subgroup. Oncotarget, 9(27), 19177鈥�91.
- Immunotherapy for Glioblastoma: Playing Chess, Not Checkers
  Jackson, C. M., & Lim, M. (2018). Immunotherapy for Glioblastoma: Playing Chess, Not Checkers. CLINICAL CANCER RESEARCH, 24(17), 4059鈥�61.
- Current state of immunotherapy for glioblastoma
  Lim, M., Xia, Y., Bettegowda, C., & Weller, M. (2018). Current state of immunotherapy for glioblastoma. NATURE REVIEWS CLINICAL ONCOLOGY, 15(7), 422鈥�42.
- Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143
  Omuro, A., Vlahovic, G., Lim, M., Sahebjam, S., Baehring, J., Cloughesy, T., 鈥� Sampson, J. H. (2018). Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143. NEURO-ONCOLOGY, 20(5), 674鈥�86.
- Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
  Chen, L., Douglass, J., Kleinberg, L., Ye, X., Marciscano, A. E., Forde, P. M., 鈥� Redmond, K. J. (2018). Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 100(4), 916鈥�25.
- A Patient with HIV Treated with Ipilimumab and Stereotactic Radiosurgery for Melanoma Metastases to the Brain
  Ruzevick, J., Nicholas, S., Redmond, K., Kleinberg, L., Lipson, E. J., & Lim, M. (2013). A Patient with HIV Treated with Ipilimumab and Stereotactic Radiosurgery for Melanoma Metastases to the Brain. CASE REPORTS IN ONCOLOGICAL MEDICINE, 946392.
- The Relevance of Simpson Grade Resections in Modern Neurosurgical Treatment of World Health Organization Grade I, II, and III Meningiomas
  Ehresman, J. S., Garzon-Muvdi, T., Rogers, D., Lim, M., Gallia, G. L., Weingart, J., 鈥� Chaichana, K. L. (2018). The Relevance of Simpson Grade Resections in Modern Neurosurgical Treatment of World Health Organization Grade I, II, and III Meningiomas. WORLD NEUROSURGERY, 109, E588鈥揈593.
- Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden
  Stone, M. L., Chiappinelli, K. B., Li, H., Murphy, L. M., Travers, M. E., Topper, M. J., 鈥� Zahnow, C. A. (2017). Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 114(51), E10981鈥揈10990.
- Targeting cytokines for treatment of neuropathic pain
  Hung, A. L., Lim, M., & Doshi, T. L. (2017). Targeting cytokines for treatment of neuropathic pain. SCANDINAVIAN JOURNAL OF PAIN, 17, 287鈥�93.
- Postoperative sinonasal morbidity in sellar reconstruction: mucosal autograft versus acellular dermal allograft
  Roxbury, C. R., Magruder, J. T., Ramanathan, M., Lim, M., Gallia, G. L., Ishii, M., & Reh, D. D. (2017). Postoperative sinonasal morbidity in sellar reconstruction: mucosal autograft versus acellular dermal allograft. INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 7(12), 1178鈥�85.
- PHASE I TRIAL OF ANTI-LAG-3 OR ANTI-CD137 ALONE AND IN COMBINATION WITH ANTI-PD-1 IN PATIENTS WITH RECURRENT GBM
  Lim, M., Ye, X., Nabors, B., Piotrowski, A. F., Fisher, J., Desideri, S., 鈥� Grossman, S. A. (2017). PHASE I TRIAL OF ANTI-LAG-3 OR ANTI-CD137 ALONE AND IN COMBINATION WITH ANTI-PD-1 IN PATIENTS WITH RECURRENT GBM. NEURO-ONCOLOGY, 19, 31.
- A PILOT STUDY OF STEREOTACTIC RADIOSURGERY (SRS) COMBINED WITH IPILIMUMAB PROLONGED SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED MELANOMA BRAIN METASTASES
  Lim, M., Kleinberg, L., Ye, X., Nicholas, S., Lin, D., Redmond, K., 鈥� Lipson, E. (2017). A PILOT STUDY OF STEREOTACTIC RADIOSURGERY (SRS) COMBINED WITH IPILIMUMAB PROLONGED SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED MELANOMA BRAIN METASTASES. NEURO-ONCOLOGY, 19, 27.
- PHASE 2 STUDY TO EVALUATE THE CLINICAL EFFICACY AND SAFETY OF MEDI4736 (DURVALUMAB [DUR]) IN PATIENTS WITH BEVACIZUMAB (BEV)-REFRACTORY RECURRENT GLIOBLASTOMA (GBM)
  Reardon, D., Kaley, T., Dietrich, J., Clarke, J. L., Dunn, G. P., Lim, M., 鈥� Venhaus, R. (2017). PHASE 2 STUDY TO EVALUATE THE CLINICAL EFFICACY AND SAFETY OF MEDI4736 (DURVALUMAB [DUR]) IN PATIENTS WITH BEVACIZUMAB (BEV)-REFRACTORY RECURRENT GLIOBLASTOMA (GBM). NEURO-ONCOLOGY, 19, 28.
- POPULATION PHARMACOKINETIC (PPK) ANALYSIS OF NIVOLUMAB FLAT AND WEIGHT-BASED DOSING REGIMENS AND ASSOCIATIONS WITH SAFETY IN PATIENTS WITH RECURRENT GLIOBLASTOMA (RGBM) TREATED IN CHECKMATE 143
  Shen, J., Hruska, M., Zwirtes, R., Potter, V., Paliwal, P., Roy, A., 鈥� Lim, M. (2017). POPULATION PHARMACOKINETIC (PPK) ANALYSIS OF NIVOLUMAB FLAT AND WEIGHT-BASED DOSING REGIMENS AND ASSOCIATIONS WITH SAFETY IN PATIENTS WITH RECURRENT GLIOBLASTOMA (RGBM) TREATED IN CHECKMATE 143. NEURO-ONCOLOGY, 19, 30.
- The Role of Immune Checkpoint Inhibition in the Treatment of Brain Tumors
  Luksik, A. S., Maxwell, R., Garzon-Muvdi, T., & Lim, M. (2017). The Role of Immune Checkpoint Inhibition in the Treatment of Brain Tumors. NEUROTHERAPEUTICS, 14(4), 1049鈥�65.
- Histopathologic review of suspected disease progression in patients with recurrent glioblastoma (GBM) receiving nivolumab +/- ipilimumab: CheckMate 143.
  Sahebjam, S., Ramkissoon, S., Baehring, J. M., Mulholland, P. J., Grauer, O. M., Cloughesy, T. F., 鈥� Ligon, K. L. (2017). Histopathologic review of suspected disease progression in patients with recurrent glioblastoma (GBM) receiving nivolumab +/- ipilimumab: CheckMate 143. JOURNAL OF CLINICAL ONCOLOGY, 35.
- Immunotherapy and radiation in glioblastoma
  Sahebjam, S., Sharabi, A., Lim, M., Kesarwani, P., & Chinnaiyan, P. (2017). Immunotherapy and radiation in glioblastoma. JOURNAL OF NEURO-ONCOLOGY, 134(3), 531鈥�39.
- Management of Cerebral Brain Metastasis
  Patel, M. A., Ruzevick, J., & Lim, M. (2014). Management of Cerebral Brain Metastasis. CURRENT SURGERY REPORTS, 2(12).
- Long-term Treatment Response and Patient Outcomes for Vestibular Schwannoma Patients Treated with Hypofractionated Stereotactic Radiotherapy
  Patel, M. A., Marciscano, A. E., Hu, C., Jusue-Torres, I., Garg, R., Rashid, A., 鈥� Kleinberg, L. R. (2017). Long-term Treatment Response and Patient Outcomes for Vestibular Schwannoma Patients Treated with Hypofractionated Stereotactic Radiotherapy. FRONTIERS IN ONCOLOGY, 7, 200.
- Clinical Trials Investigating Immune Checkpoint Blockade in Glioblastoma
  Maxwell, R., Jackson, C. M., & Lim, M. (2017). Clinical Trials Investigating Immune Checkpoint Blockade in Glioblastoma. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 18(8), 51.
- Risk Factors for Preoperative Seizures and Loss of Seizure Control in Patients Undergoing Surgery for Metastatic Brain Tumors
  Wu, A., Weingart, J. D., Gallia, G. L., Lim, M., Brem, H., Bettegowda, C., & Chaichana, K. L. (2017). Risk Factors for Preoperative Seizures and Loss of Seizure Control in Patients Undergoing Surgery for Metastatic Brain Tumors. WORLD NEUROSURGERY, 104, 120鈥�28.
- Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas
  Jiang, S., Eberhart, C. G., Zhang, Y., Heo, H.-Y., Wen, Z., Blair, L., 鈥� Zhou, J. (2017). Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas. EUROPEAN JOURNAL OF CANCER, 83, 9鈥�18.
- Induction of immunity to prostate cancer antigens: Results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer
  Simons, J. W., Mikhak, B., Chang, J. F., DeMarzo, A. M., Carducci, M. A., Lim, M., 鈥� Nelson, W. G. (1999). Induction of immunity to prostate cancer antigens: Results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer. CANCER RESEARCH, 59(20), 5160鈥�68.
- Autologous Heat Shock Protein Peptide Vaccination for Newly Diagnosed Glioblastoma: Impact of Peripheral PD-L1 Expression on Response to Therapy
  Bloch, O., Lim, M., Sughrue, M. E., Komotar, R. J., Abrahams, J. M., O'Rourke, D. M., 鈥� Parsa, A. T. (2017). Autologous Heat Shock Protein Peptide Vaccination for Newly Diagnosed Glioblastoma: Impact of Peripheral PD-L1 Expression on Response to Therapy. CLINICAL CANCER RESEARCH, 23(14), 3575鈥�84.
- Phase 2 study to evaluate the clinical efficacy and safety of MEDI4736 (durvalumab) in patients with glioblastoma (GBM).
  Reardon, D. A., Kaley, T. J., Dietrich, J., Lim, M., Dunn, G. P., Gan, H. K., 鈥� Venhaus, R. R. (2016). Phase 2 study to evaluate the clinical efficacy and safety of MEDI4736 (durvalumab) in patients with glioblastoma (GBM). JOURNAL OF CLINICAL ONCOLOGY, 34(15).
- A randomized, phase 3, open-label study of nivolumab versus temozolomide (TMZ) in combination with radiotherapy (RT) in adult patients (pts) with newly diagnosed, O-6-methylguanine DNA methyltransferase (MGMT)-unmethylated glioblastoma (GBM): CheckMate-498.
  Sampson, J. H., Omuro, A. M. P., Preusser, M., Lim, M., Butowski, N. A., Cloughesy, T. F., 鈥� Reardon, D. A. (2016). A randomized, phase 3, open-label study of nivolumab versus temozolomide (TMZ) in combination with radiotherapy (RT) in adult patients (pts) with newly diagnosed, O-6-methylguanine DNA methyltransferase (MGMT)-unmethylated glioblastoma (GBM): CheckMate-498. JOURNAL OF CLINICAL ONCOLOGY, 34(15).
- Spontaneous Intracranial Hypotension after Vestibular Schwannoma Resection Due to an Unexpected Pathology: Tarlov Cysts
  Pross, S. E., Sharon, J. D., Lim, M., Moghekar, A., Rao, A., & Carey, J. P. (2017). Spontaneous Intracranial Hypotension after Vestibular Schwannoma Resection Due to an Unexpected Pathology: Tarlov Cysts. CUREUS, 9(5), e1261.
- Long-term Outcomes With Planned Multistage Reduced Dose Repeat Stereotactic Radiosurgery for Treatment of Inoperable High-Grade Arteriovenous Malformations: An Observational Retrospective Cohort Study
  Marciscano, A. E., Huang, J., Tamargo, R. J., Hu, C., Khattab, M. H., Aggarwal, S., 鈥� Kleinberg, L. R. (2017). Long-term Outcomes With Planned Multistage Reduced Dose Repeat Stereotactic Radiosurgery for Treatment of Inoperable High-Grade Arteriovenous Malformations: An Observational Retrospective Cohort Study. NEUROSURGERY, 81(1), 136鈥�46.
- Use of Stereotactic Radiosurgery in Elderly and Very Elderly Patients With Brain Metastases to Limit Toxicity Associated With Whole Brain Radiation Therapy
  Chen, L., Shen, C., Redmond, K. J., Page, B. R., Kummerlowe, M., Mcnutt, T., 鈥� Kleinberg, L. (2017). Use of Stereotactic Radiosurgery in Elderly and Very Elderly Patients With Brain Metastases to Limit Toxicity Associated With Whole Brain Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 98(4), 939鈥�47.
- Biomarkers and Immunotherapeutic Targets in Glioblastoma
  Hung, A. L., Garzon-Muvdi, T., & Lim, M. (2017). Biomarkers and Immunotherapeutic Targets in Glioblastoma. WORLD NEUROSURGERY, 102, 494鈥�506.
- Metastatic Atypical and Anaplastic Meningioma: A Case Series and Review of the Literature
  Kessler, R. A., Garzon-Muvdi, T., Yang, W., Weingart, J., Olivi, A., Huang, J., 鈥� Lim, M. (2017). Metastatic Atypical and Anaplastic Meningioma: A Case Series and Review of the Literature. WORLD NEUROSURGERY, 101, 47鈥�56.
- The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma-Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses
  Maxwell, R., Luksik, A. S., Garzon-Muvdi, T., & Lim, M. (2017). The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma-Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 17(6), 50.
- Efficacy of primary microvascular decompression versus subsequent microvascular decompression for trigeminal neuralgia
  Theodros, D., Goodwin, C. R., Bender, M. T., Zhou, X., Garzon-Muvdi, T., De la Garza-Ramos, R., 鈥� Lim, M. (2017). Efficacy of primary microvascular decompression versus subsequent microvascular decompression for trigeminal neuralgia. JOURNAL OF NEUROSURGERY, 126(5), 1691鈥�97.
- BRAF-V600 mutational status affects recurrence patterns of melanoma brain metastasis
  Maxwell, R., Garzon-Muvdi, T., Lipson, E. J., Sharfman, W. H., Bettegowda, C., Redmond, K. J., 鈥� Lim, M. (2017). BRAF-V600 mutational status affects recurrence patterns of melanoma brain metastasis. INTERNATIONAL JOURNAL OF CANCER, 140(12), 2716鈥�27.
- MODULATING THE MYELOID COMPARTMENT TO POTENTIATE ANTI-PD1 MEDIATED IMMUNOTHERAPY AGAINST GLIOBLASTOMA
  Muvdi, T. G., Theodros, D., Carrera-Haro, M., Kim, E., Jackson, C., Luksik, A., 鈥� Lim, M. (2016). MODULATING THE MYELOID COMPARTMENT TO POTENTIATE ANTI-PD1 MEDIATED IMMUNOTHERAPY AGAINST GLIOBLASTOMA. NEURO-ONCOLOGY, 18, 99.
- PHASE 2 STUDY TO EVALUATE THE CLINICAL EFFICACY AND SAFETY OF MEDI4736 (DURVALUMAB [DUR]) IN PATIENTS WITH GLIOBLASTOMA (GBM): RESULTS FOR COHORT B (DUR MONOTHERAPY), BEVACIZUMAB (BEV) NAIVE PATIENTS WITH RECURRENT GBM
  Reardon, D., Kaley, T., Dietrich, J., Lim, M., Dunn, G., Gan, H., 鈥� Venhaus, R. (2016). PHASE 2 STUDY TO EVALUATE THE CLINICAL EFFICACY AND SAFETY OF MEDI4736 (DURVALUMAB [DUR]) IN PATIENTS WITH GLIOBLASTOMA (GBM): RESULTS FOR COHORT B (DUR MONOTHERAPY), BEVACIZUMAB (BEV) NAIVE PATIENTS WITH RECURRENT GBM. NEURO-ONCOLOGY, 18, 18.
- NIVOLUMAB COMBINED WITH RADIOTHERAPY WITH OR WITHOUT TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA: RESULTS FROM PHASE 1 SAFETY COHORTS IN CHECKMATE 143
  Omuro, A., Vlahovic, G., Baehring, J., Butowski, N. A., Reardon, D. A., Cloughesy, T., 鈥� Sampson, J. (2016). NIVOLUMAB COMBINED WITH RADIOTHERAPY WITH OR WITHOUT TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA: RESULTS FROM PHASE 1 SAFETY COHORTS IN CHECKMATE 143. NEURO-ONCOLOGY, 18, 21.
- Progressive Low-Grade Glioma: Assessment of Prognostic Importance of Histologic Reassessment and MRI Findings
  Narang, A. K., Chaichana, K. L., Weingart, J. D., Redmond, K. J., Lim, M., Olivi, A., 鈥� Kleinberg, L. R. (2017). Progressive Low-Grade Glioma: Assessment of Prognostic Importance of Histologic Reassessment and MRI Findings. WORLD NEUROSURGERY, 99, 751鈥�57.
- Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM
  Mathios, D., Kim, J. E., Mangraviti, A., Phallen, J., Park, C.-K., Jackson, C. M., 鈥� Lim, M. (2016). Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM. SCIENCE TRANSLATIONAL MEDICINE, 8(370), 370ra180.
- Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma (vol 4, 28, 2016)
  Patel, M. A., Kim, J. E., Theodros, D., Tam, A., Velarde, E., Kochel, C. M., 鈥� Lim, M. (2016). Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma (vol 4, 28, 2016). JOURNAL FOR IMMUNOTHERAPY OF CANCER, 4, 74.
- Influence of Insurance Status on Survival of Adults With Glioblastoma Multiforme: A Population-Based Study
  Rong, X., Yang, W., Garzon-Muvdi, T., Caplan, J. M., Hui, X., Lim, M., & Huang, J. (2016). Influence of Insurance Status on Survival of Adults With Glioblastoma Multiforme: A Population-Based Study. CANCER, 122(20), 3157鈥�65.
- Layered sellar reconstruction with avascular free grafts: Acceptable alternative to the nasoseptal flap for repair of low-volume intraoperative cerebrospinal fluid leak
  Roxbury, C. R., Saavedra, T., Ramanathan, M., Lim, M., Ishii, M., Gallia, G. L., & Reh, D. D. (2016). Layered sellar reconstruction with avascular free grafts: Acceptable alternative to the nasoseptal flap for repair of low-volume intraoperative cerebrospinal fluid leak. AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 30(5), 367鈥�71.
- Discussion on: Usefulness of an Osteotomy Template for Skull Tumorectomy and Simultaneous Skull Reconstruction
  Gordon, C. R., Murphy, R. J., Armand, M., Liacouras, P., Weingart, J., Huang, J., 鈥� Lim, M. (2016). Discussion on: Usefulness of an Osteotomy Template for Skull Tumorectomy and Simultaneous Skull Reconstruction. JOURNAL OF CRANIOFACIAL SURGERY, 27(6), 1568鈥�70.
- The strategy of repeat stereotactic radiosurgery without whole brain radiation treatment for new brain metastases: Outcomes and implications for follow-up monitoring
  Shen, C. J., Rigamonti, D., Redmond, K. J., Kummerlowe, M. N., Lim, M., & Kleinberg, L. R. (2016). The strategy of repeat stereotactic radiosurgery without whole brain radiation treatment for new brain metastases: Outcomes and implications for follow-up monitoring. PRACTICAL RADIATION ONCOLOGY, 6(6), 409鈥�16.
- Timely stereotactic body radiotherapy (SBRT) for spine metastases using a rapidly deployable automated planning algorithm
  Mian, O. Y., Thomas, O., Lee, J. J. Y., Le, Y., McNutt, T., Lim, M., 鈥� Kleinberg, L. (2016). Timely stereotactic body radiotherapy (SBRT) for spine metastases using a rapidly deployable automated planning algorithm. SPRINGERPLUS, 5, 1337.
- Current trends in glioblastoma multiforme treatment: radiation therapy and immune checkpoint inhibitors.
  Nicholas, S., Mathios, D., Ruzevick, J., Jackson, C., Yang, I., & Lim, M. (2013). Current trends in glioblastoma multiforme treatment: radiation therapy and immune checkpoint inhibitors. Brain Tumor Research and Treatment, 1(1), 2鈥�8.
- Controversies in the Therapy of Brain Metastases: Shifting Paradigms in an Era of Effective Systemic Therapy and Longer-Term Survivorship
  Shen, C. J., Lim, M., & Kleinberg, L. R. (2016). Controversies in the Therapy of Brain Metastases: Shifting Paradigms in an Era of Effective Systemic Therapy and Longer-Term Survivorship. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 17(9), 46.
- A Systematic Analysis of the Reliability of Diffusion Tensor Imaging Tractography for Facial Nerve Imaging in Patients with Vestibular Schwannoma
  Ung, N., Mathur, M., Chung, L. K., Cremer, N., Pelargos, P., Frew, A., 鈥� Yang, I. (2016). A Systematic Analysis of the Reliability of Diffusion Tensor Imaging Tractography for Facial Nerve Imaging in Patients with Vestibular Schwannoma. JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 77(4), 314鈥�18.
- Next-generation sequencing in neuropathologic diagnosis of infections of the nervous system
  Salzberg, S. L., Breitwieser, F. P., Kumar, A., Hao, H., Burger, P., Rodriguez, F. J., 鈥� Pardo, C. A. (2016). Next-generation sequencing in neuropathologic diagnosis of infections of the nervous system. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 3(4), e251.
- Preface
  Lee, J. Y. K., & Lim, M. (2016). Preface. NEUROSURGERY CLINICS OF NORTH AMERICA, 27(3), IX.
- Current State of Immune-Based Therapies for Glioblastoma.
  Lim, M., Weller, M., & Chiocca, E. A. (2016). Current State of Immune-Based Therapies for Glioblastoma. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting, 35, e132鈥�9.
- Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma
  Patel, M. A., Kim, J. E., Theodros, D., Tam, A., Velarde, E., Kochel, C. M., 鈥� Lim, M. (2016). Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 4, 28.
- PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment (vol 121, pg 251, 2015)
  Mathios, D., Ruzevick, J., Jackson, C. M., Xu, H., Shah, S. R., Taube, J. M., 鈥� Lim, M. (2016). PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment (vol 121, pg 251, 2015). JOURNAL OF NEURO-ONCOLOGY, 128(1), 183.
- Ganetespib radiosensitization for liver cancer therapy
  Chettiar, S. T., Malek, R., Annadanam, A., Nugent, K. M., Kato, Y., Wang, H., 鈥� Tran, P. T. (2016). Ganetespib radiosensitization for liver cancer therapy. CANCER BIOLOGY & THERAPY, 17(4), 457鈥�66.
- Phase 2 study to evaluate the clinical efficacy and safety of MEDI4736 in patients with glioblastoma (GBM)
  Reardon, D. A., Dietrich, J., Kaley, T., Gan, H., Dunn, G. P., Cloughesy, T., 鈥� Venhaus, R. (2016). Phase 2 study to evaluate the clinical efficacy and safety of MEDI4736 in patients with glioblastoma (GBM). CANCER IMMUNOLOGY RESEARCH, 4(1).
- Stereotactic Radiosurgery: Treatment of Brain Metastasis Without Interruption of Systemic Therapy
  Shen, C. J., Kummerlowe, M. N., Redmond, K. J., Rigamonti, D., Lim, M. K., & Kleinberg, L. R. (2016). Stereotactic Radiosurgery: Treatment of Brain Metastasis Without Interruption of Systemic Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 95(2), 735鈥�42.
- Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination
  Jackson, C. M., Kochel, C. M., Nirschl, C. J., Durham, N. M., Ruzevick, J., Alme, A., 鈥� Drake, C. G. (2016). Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination. CLINICAL CANCER RESEARCH, 22(5), 1161鈥�72.
- Oligometastatic Adenocarcinoma of the Lung: A Therapeutic Opportunity for Long-Term Survival
  Yarchoan, M., Lim, M., Brahmer, J. R., & Ettinger, D. (2015). Oligometastatic Adenocarcinoma of the Lung: A Therapeutic Opportunity for Long-Term Survival. CUREUS, 7(12), e409.
- Laser speckle imaging to improve clinical outcomes for patients with trigeminal neuralgia undergoing radiofrequency thermocoagulation
  Ringkamp, M., Wooten, M., Carson, B. S., Lim, M., Hartke, T., & Guarnieri, M. (2016). Laser speckle imaging to improve clinical outcomes for patients with trigeminal neuralgia undergoing radiofrequency thermocoagulation. JOURNAL OF NEUROSURGERY, 124(2), 422鈥�28.
- Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium
  Kim, E. S., Kim, J. E., Patel, M. A., Mangraviti, A., Ruzevick, J., & Lim, M. (2016). Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium. JOURNAL OF IMMUNOLOGY RESEARCH, 2016, 4683607.
- Technical Nuances of Microvascular Decompression of the Posterior Fossa Cranial Nerves: 3-Dimensional Operative Video
  Binning, M. J., & Veznedaroglu, E. (2014). Technical Nuances of Microvascular Decompression of the Posterior Fossa Cranial Nerves: 3-Dimensional Operative Video. OPERATIVE NEUROSURGERY, 10(3), 487.
- Antiangiogenic Therapies and Extracranial Metastasis in Glioblastoma: A Case Report and Review of the Literature
  Khattab, M. H., Marciscano, A. E., Lo, S. S., Lim, M., Laterra, J. J., Kleinberg, L. R., & Redmond, K. J. (2015). Antiangiogenic Therapies and Extracranial Metastasis in Glioblastoma: A Case Report and Review of the Literature. CASE REPORTS IN ONCOLOGICAL MEDICINE, 431819.
- Metastatic Extrapulmonary Small Cell Carcinoma to the Cerebellopontine Angle: A Case Report and Review of the Literature
  Theodros, D., Goodwin, C. R., Crane, G. M., Liauw, J., Kleinberg, L., & Lim, M. (2015). Metastatic Extrapulmonary Small Cell Carcinoma to the Cerebellopontine Angle: A Case Report and Review of the Literature. CASE REPORTS IN ONCOLOGICAL MEDICINE, 847058.
- Reduced CSF leak in complete calvarial reconstructions of microvascular decompression craniectomies using calcium phosphate cement
  Eseonu, C. I., Goodwin, C. R., Zhou, X., Theodros, D., Bender, M. T., Mathios, D., 鈥� Lim, M. (2015). Reduced CSF leak in complete calvarial reconstructions of microvascular decompression craniectomies using calcium phosphate cement. JOURNAL OF NEUROSURGERY, 123(6), 1476鈥�79.
- Pituitary adenomas: historical perspective, surgical management and future directions.
  Theodros, D., Patel, M., Ruzevick, J., Lim, M., & Bettegowda, C. (2015). Pituitary adenomas: historical perspective, surgical management and future directions. CNS Oncology, 4(6), 411鈥�29.
- Prognostic factors associated with pain palliation after spine stereotactic body radiation therapy
  Puvanesarajah, V., Lo, S.-fu L., Aygun, N., Liauw, J. A., Jusue-Torres, I., Lina, I. A., 鈥� Lim, M. (2015). Prognostic factors associated with pain palliation after spine stereotactic body radiation therapy. JOURNAL OF NEUROSURGERY-SPINE, 23(5), 620鈥�29.
- Immunomodulation: checkpoint blockade etc.
  Curry, W. T., & Lim, M. (2015). Immunomodulation: checkpoint blockade etc. NEURO-ONCOLOGY, 17, 26鈥�31.
- Therapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model
  Mathios, D., Park, C.-K., Marcus, W. D., Alter, S., Rhode, P. R., Jeng, E. K., 鈥� Lim, M. (2016). Therapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model. INTERNATIONAL JOURNAL OF CANCER, 138(1), 187鈥�94.
- Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy
  Sharabi, A. B., Lim, M., DeWeese, T. L., & Drake, C. G. (2015). Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy. LANCET ONCOLOGY, 16(13), E498鈥揈509.
- Prospects of immune checkpoint modulators in the treatment of glioblastoma
  Preusser, M., Lim, M., Hafler, D. A., Reardon, D. A., & Sampson, J. H. (2015). Prospects of immune checkpoint modulators in the treatment of glioblastoma. NATURE REVIEWS NEUROLOGY, 11(9), 504鈥�14.
- Phase II study to evaluate the clinical efficacy and safety of MEDI4736 in patients with glioblastoma (GBM).
  Reardon, D. A., Dietrich, J., Kaley, T. J., Gan, H. K., Dunn, G. P., Cloughesy, T. F., 鈥� Venhaus, R. R. (2015). Phase II study to evaluate the clinical efficacy and safety of MEDI4736 in patients with glioblastoma (GBM). JOURNAL OF CLINICAL ONCOLOGY, 33(15).
- Preliminary safety and activity of nivolumab and its combination with ipilimumab in recurrent glioblastoma (GBM): CHECKMATE-143.
  Sampson, J. H., Vlahovic, G., Sahebjam, S., Omuro, A. M. P., Baehring, J. M., Hafler, D. A., 鈥� Reardon, D. A. (2015). Preliminary safety and activity of nivolumab and its combination with ipilimumab in recurrent glioblastoma (GBM): CHECKMATE-143. JOURNAL OF CLINICAL ONCOLOGY, 33(15).
- Newly diagnosed glioblastoma patients treated with an autologous heat shock protein peptide vaccine: PD-L1 expression and response to therapy
  Bloch, O., Raizer, J. J., Lim, M., Sughrue, M., Komotar, R., Abrahams, J., 鈥� Parsa, A. (2015). Newly diagnosed glioblastoma patients treated with an autologous heat shock protein peptide vaccine: PD-L1 expression and response to therapy. JOURNAL OF CLINICAL ONCOLOGY, 33(15).
- Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord
  Wang, Y., Springer, S., Zhang, M., McMahon, K. W., Kinde, I., Dobbyn, L., 鈥� Bettegowda, C. (2015). Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 112(31), 9704鈥�9.
- Immunosuppressive mechanisms of malignant gliomas: parallels at non-CNS sites
  Perng, P., & Lim, M. (2015). Immunosuppressive mechanisms of malignant gliomas: parallels at non-CNS sites. FRONTIERS IN ONCOLOGY, 5, 153.
- Immediate Single-Stage Cranioplasty Following Calvarial Resection for Benign and Malignant Skull Neoplasms Using Customized Craniofacial Implants
  Berli, J. U., Thomaier, L., Zhong, S., Huang, J., Quinones, A., Lim, M., 鈥� Gordon, C. R. (2015). Immediate Single-Stage Cranioplasty Following Calvarial Resection for Benign and Malignant Skull Neoplasms Using Customized Craniofacial Implants. JOURNAL OF CRANIOFACIAL SURGERY, 26(5), 1456鈥�62.
- Introduction: brain tumor immunotherapy
  Lim, M., & Liau, L. M. (2015). Introduction: brain tumor immunotherapy. JOURNAL OF NEURO-ONCOLOGY, 123(3), 321鈥�22.
- The role of checkpoints in the treatment of GBM
  Kim, J. E., & Lim, M. (2015). The role of checkpoints in the treatment of GBM. JOURNAL OF NEURO-ONCOLOGY, 123(3), 413鈥�23.
- Risk of surgical site infection in 401 consecutive patients with glioblastoma with and without carmustine wafer implantation
  Chaichana, K. L., Kone, L., Bettegowda, C., Weingart, J. D., Olivi, A., Lim, M., 鈥� Brem, H. (2015). Risk of surgical site infection in 401 consecutive patients with glioblastoma with and without carmustine wafer implantation. NEUROLOGICAL RESEARCH, 37(8), 717鈥�26.
- Technical note: Orbitozygomatic craniotomy using an ultrasonic osteotome for precise osteotomies
  Ruzevick, J., Raza, S. M., Recinos, P. F., Chaichana, K., Pradilla, G., Kim, J. E., 鈥� Lim, M. (2015). Technical note: Orbitozygomatic craniotomy using an ultrasonic osteotome for precise osteotomies. CLINICAL NEUROLOGY AND NEUROSURGERY, 134, 24鈥�27.
- Stereotactic Radiation Therapy Combined With Immunotherapy: Augmenting the Role of Radiation in Local and Systemic Treatment
  Sharabi, A. B., Tran, P. T., Lim, M., Drake, C. G., & DeWeese, T. L. (2015). Stereotactic Radiation Therapy Combined With Immunotherapy: Augmenting the Role of Radiation in Local and Systemic Treatment. ONCOLOGY-NEW YORK, 29(5), 331鈥�40.
- Immunotherapy for glioblastoma: are we finally getting closer?
  Lim, M. (2015). Immunotherapy for glioblastoma: are we finally getting closer? NEURO-ONCOLOGY, 17(6), 771鈥�72.
- PD-1 BLOCKADE SHOWS SYNERGISTIC SURVIVAL, ANTI-TUMOR IMMUNE RESPONSE AND LONG-TERM MEMORY WITH INTERSTITIAL BUT NOT SYSTEMIC CHEMOTHERAPY: STUDY IN A MURINE GLIOBLASTOMA MODEL
  Mathios, D., Phallen, J., Park, C.-K., Jackson, C., Nicholas, S., Tyler, B., 鈥� Lim, M. (2014). PD-1 BLOCKADE SHOWS SYNERGISTIC SURVIVAL, ANTI-TUMOR IMMUNE RESPONSE AND LONG-TERM MEMORY WITH INTERSTITIAL BUT NOT SYSTEMIC CHEMOTHERAPY: STUDY IN A MURINE GLIOBLASTOMA MODEL. NEURO-ONCOLOGY, 16.
- PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment
  Mathios, D., Ruzevick, J., Jackson, C. M., Xu, H., Shah, S., Taube, J. M., 鈥� Lim, M. (2015). PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment. JOURNAL OF NEURO-ONCOLOGY, 121(2), 251鈥�59.
- Neurocytoma of the Spinal Cord
  Kim, J. E., & Lim, M. (2015). Neurocytoma of the Spinal Cord. NEUROSURGERY CLINICS OF NORTH AMERICA, 26(1), 109-+.
- Identifying Better Surgical Candidates Among Recursive Partitioning Analysis Class 2 Patients who Underwent Surgery for Intracranial Metastases
  Chaichana, K. L., Acharya, S., Flores, M., Wijesekera, O., Rigamonti, D., Weingart, J. D., 鈥� Quinones-Hinojosa, A. (2014). Identifying Better Surgical Candidates Among Recursive Partitioning Analysis Class 2 Patients who Underwent Surgery for Intracranial Metastases. WORLD NEUROSURGERY, 82(1-2), E267鈥揈275.
- Planning Evaluation of C-Arm Cone Beam CT Angiography for Target Delineation in Stereotactic Radiation Surgery of Brain Arteriovenous Malformations
  Kang, J., Huang, J., Gailloud, P., Rigamonti, D., Lim, M., Bernard, V., 鈥� Ford, E. C. (2014). Planning Evaluation of C-Arm Cone Beam CT Angiography for Target Delineation in Stereotactic Radiation Surgery of Brain Arteriovenous Malformations. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90(2), 430鈥�37.
- TLR9 Is Critical for Glioma Stem Cell Maintenance and Targeting
  Herrmann, A., Cherryholmes, G., Schroeder, A., Phallen, J., Alizadeh, D., Xin, H., 鈥� Yu, H. (2014). TLR9 Is Critical for Glioma Stem Cell Maintenance and Targeting. CANCER RESEARCH, 74(18), 5218鈥�28.
- Selective cerebral hypothermia induced via hypothermic retrograde jugular vein saline flush in a porcine model
  Chen, C.-W., Puvanesarajah, V., Lo, S.-F. L., Cheng, T.-J., Cheng, C.-Y., Lim, M., & Lin, H.-J. (2014). Selective cerebral hypothermia induced via hypothermic retrograde jugular vein saline flush in a porcine model. NEUROLOGICAL RESEARCH, 36(10), 897鈥�902.
- Immunotherapy for Brain Cancer: Recent Progress and Future Promise
  Jackson, C. M., Lim, M., & Drake, C. G. (2014). Immunotherapy for Brain Cancer: Recent Progress and Future Promise. CLINICAL CANCER RESEARCH, 20(14), 3651鈥�59.
- Focal Radiation Therapy Combined with 4-1BB Activation and CTLA-4 Blockade Yields Long-Term Survival and a Protective Antigen-Specific Memory Response in a Murine Glioma Model
  Belcaid, Z., Phallen, J. A., Zeng, J., See, A. P., Mathios, D., Gottschalk, C., 鈥� Lim, M. (2014). Focal Radiation Therapy Combined with 4-1BB Activation and CTLA-4 Blockade Yields Long-Term Survival and a Protective Antigen-Specific Memory Response in a Murine Glioma Model. PLOS ONE, 9(7), e101764.
- DIFFERENTIAL EXPRESSION OF PD-L1 ON HEMATOPOIETIC VERSUS TUMOR CELLS IN MEDULLOBLASTOMA
  Martin, A. M., Nirschl, C., Polanczyk, M., Bell, R., Martinez, D., Sullivan, L. M., 鈥� Lim, M. (2014). DIFFERENTIAL EXPRESSION OF PD-L1 ON HEMATOPOIETIC VERSUS TUMOR CELLS IN MEDULLOBLASTOMA. NEURO-ONCOLOGY, 16, 89.
- Postradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progression?
  Walker, A. J., Ruzevick, J., Malayeri, A. A., Rigamonti, D., Lim, M., Redmond, K. J., & Kleinberg, L. (2014). Postradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progression? FUTURE ONCOLOGY, 10(7), 1277鈥�97.
- Multidisciplinary Approach for Improved Outcomes in Secondary Cranial Reconstruction: Introducing the Pericranial-Onlay Cranioplasty Technique
  Gordon, C. R., Fisher, M., Liauw, J., Lina, I., Puvanesarajah, V., Susarla, S., 鈥� Huang, J. (2014). Multidisciplinary Approach for Improved Outcomes in Secondary Cranial Reconstruction: Introducing the Pericranial-Onlay Cranioplasty Technique. OPERATIVE NEUROSURGERY, 10(2), 179鈥�89.
- The role of regulatory T-cells in glioma immunology
  Ooi, Y. C., Tran, P., Ung, N., Thill, K., Trang, A., Fong, B. M., 鈥� Yang, I. (2014). The role of regulatory T-cells in glioma immunology. CLINICAL NEUROLOGY AND NEUROSURGERY, 119, 125鈥�32.
- Invasive adenoma and pituitary carcinoma: a SEER database analysis
  Hansen, T. M., Batra, S., Lim, M., Gallia, G. L., Burger, P. C., Salvatori, R., 鈥� Redmond, K. J. (2014). Invasive adenoma and pituitary carcinoma: a SEER database analysis. NEUROSURGICAL REVIEW, 37(2), 279鈥�85.
- STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications
  Kim, J. E., Patel, M., Ruzevick, J., Jackson, C. M., & Lim, M. (2014). STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications. CANCERS, 6(1), 376鈥�95.
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
  Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., 鈥� Diaz, L. A. (2014). Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies. SCIENCE TRANSLATIONAL MEDICINE, 6(224), 224ra24.
- AMIDE PROTON TRANSFER MRI OF MALIGNANT GLIOMAS FOR DETECTING ACTIVE VERSUS INACTIVE TUMOR
  Wolf, D., Ye, X., Lim, M., Zhu, H., Wang, M., Quinones-Hinojosa, A., 鈥� Blakeley, J. (2013). AMIDE PROTON TRANSFER MRI OF MALIGNANT GLIOMAS FOR DETECTING ACTIVE VERSUS INACTIVE TUMOR. NEURO-ONCOLOGY, 15, 204.
- DEFERRED RADIATION IS AN APPROPRIATE OPTION FOR PATIENTS PRESENTING FOR TREATMENT OF NON-FUNCTIONING PITUITARY MACROADENOMAS WITH RESIDUAL POST SURGICAL TUMOR
  Nicholas, S., Salvatori, R., Lim, M., Redmond, K., Quinones, A., Gallia, G., 鈥� Kleinberg, L. (2013). DEFERRED RADIATION IS AN APPROPRIATE OPTION FOR PATIENTS PRESENTING FOR TREATMENT OF NON-FUNCTIONING PITUITARY MACROADENOMAS WITH RESIDUAL POST SURGICAL TUMOR. NEURO-ONCOLOGY, 15, 185.
- THE ROLE OF PD-1 PATHWAY IN CHORDOMAS
  Mathios, D., Lim, M., Ruzevick, J., Nicholas, S., Polanczyk, M., Jackson, C., 鈥� Xu, H. (2013). THE ROLE OF PD-1 PATHWAY IN CHORDOMAS. NEURO-ONCOLOGY, 15, 64鈥�65.
- Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma
  Chaichana, K. L., Jusue-Torres, I., Navarro-Ramirez, R., Raza, S. M., Pascual-Gallego, M., Ibrahim, A., 鈥� Quinones-Hinojosa, A. (2014). Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma. NEURO-ONCOLOGY, 16(1), 113鈥�22.
- The Transconjunctival Transorbital Approach: A Keyhole Approach to the Midline Anterior Skull Base
  Raza, S. M., Quinones-Hinojosa, A., Lim, M., & Boahene, K. D. O. (2013). The Transconjunctival Transorbital Approach: A Keyhole Approach to the Midline Anterior Skull Base. WORLD NEUROSURGERY, 80(6), 864鈥�71.
- Glycerol rhizotomy via a retrosigmoid approach as an alternative treatment for trigeminal neuralgia
  Goodwin, C. R., Yang, J. X., Bettegowda, C., Hwang, B., James, C., Biser, A., 鈥� Lim, M. (2013). Glycerol rhizotomy via a retrosigmoid approach as an alternative treatment for trigeminal neuralgia. CLINICAL NEUROLOGY AND NEUROSURGERY, 115(12), 2454鈥�56.
- Immune Modulation and Stereotactic Radiation: Improving Local and Abscopal Responses
  Zeng, J., Harris, T. J., Lim, M., Drake, C. G., & Tran, P. T. (2013). Immune Modulation and Stereotactic Radiation: Improving Local and Abscopal Responses. BIOMED RESEARCH INTERNATIONAL, 2013, 658126.
- Patients undergoing surgery of intracranial metastases have different outcomes based on their primary pathology
  Chaichana, K. L., Gadkaree, S., Rao, K., Link, T., Rigamonti, D., Purtell, M., 鈥� Quinones-Hinojosa, A. (2013). Patients undergoing surgery of intracranial metastases have different outcomes based on their primary pathology. NEUROLOGICAL RESEARCH, 35(10), 1059鈥�69.
- Three-Dimensional Amide Proton Transfer MR Imaging of Gliomas: Initial Experience and Comparison With Gadolinium Enhancement
  Zhou, J., Zhu, H., Lim, M., Blair, L., Quinones-Hinojosa, A., Messina, S. A., 鈥� Blakeley, J. O. (2013). Three-Dimensional Amide Proton Transfer MR Imaging of Gliomas: Initial Experience and Comparison With Gadolinium Enhancement. JOURNAL OF MAGNETIC RESONANCE IMAGING, 38(5), 1119鈥�28.
- Survival and Recurrence for Patients Undergoing Surgery of Skull Base Intracranial Metastases
  Chaichana, K. L., Flores, M., Acharya, S., Sampognaro, P., Bettegowda, C., Rigamonti, D., 鈥� Quinones-Hinojosa, A. (2013). Survival and Recurrence for Patients Undergoing Surgery of Skull Base Intracranial Metastases. JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 74(4), 228鈥�35.
- Postoperative Anticoagulation in Patients with Mechanical Heart Valves Following Surgical Treatment of Subdural Hematomas
  Amin, A. G., Ng, J., Hsu, W., Pradilla, G., Raza, S., Quinones-Hinojosa, A., & Lim, M. (2013). Postoperative Anticoagulation in Patients with Mechanical Heart Valves Following Surgical Treatment of Subdural Hematomas. NEUROCRITICAL CARE, 19(1), 90鈥�94.
- Predictors of Visual Outcome Following Surgical Resection of Medial Sphenoid Wing Meningiomas
  Chaichana, K. L., Jackson, C., Patel, A., Miller, N. R., Subramanian, P., Lim, M., 鈥� Quinones-Hinojosa, A. (2012). Predictors of Visual Outcome Following Surgical Resection of Medial Sphenoid Wing Meningiomas. JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 73(5), 321鈥�26.
- Real-Time Imaging with the O-Arm for Skull Base Applications: A Cadaveric Feasibility Study
  Raza, S. M., See, A. P., & Lim, M. (2012). Real-Time Imaging with the O-Arm for Skull Base Applications: A Cadaveric Feasibility Study. JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 73(5), 293鈥�301.
- Radiosurgery for Arteriovenous Malformations
  Ruzevick, J., Batra, S., Lim, M., & Rigamonti, D. (2013). Radiosurgery for Arteriovenous Malformations. HANDBOOK OF RADIOSURGERY IN CNS DISEASE, 123鈥�35.
- Skull-Base Tumors D. Radiosurgery for Vestibular Schwannomas
  Ruzevick, J., Lim, M., & Rigamonti, D. (2013). Skull-Base Tumors D. Radiosurgery for Vestibular Schwannomas. HANDBOOK OF RADIOSURGERY IN CNS DISEASE, 83鈥�91.
- Skull-Base Tumors C. Stereotactic Radiosurgery for Glomus Jugulare Tumors
  Guss, Z. D., Amin, A. G., & Lim, M. (2013). Skull-Base Tumors C. Stereotactic Radiosurgery for Glomus Jugulare Tumors. HANDBOOK OF RADIOSURGERY IN CNS DISEASE, 77鈥�81.
- Technology and Techniques of Cranial Radiosurgery
  Ruzevick, J., & Lim, M. (2013). Technology and Techniques of Cranial Radiosurgery. HANDBOOK OF RADIOSURGERY IN CNS DISEASE, 13鈥�25.
- Handbook of Radiosurgery in CNS Disease Preface
  Lim, M., Hsu, W., Rigamonti, D., & Kleinberg, L. R. (2013). Handbook of Radiosurgery in CNS Disease Preface. HANDBOOK OF RADIOSURGERY IN CNS DISEASE, IX-X.
- Increased Subventricular Zone Radiation Dose Correlates With Survival in Glioblastoma Patients After Gross Total Resection
  Chen, L., Guerrero-Cazares, H., Ye, X., Ford, E., McNutt, T., Kleinberg, L., 鈥� Redmond, K. (2013). Increased Subventricular Zone Radiation Dose Correlates With Survival in Glioblastoma Patients After Gross Total Resection. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 86(4), 616鈥�22.
- MYC AMPLIFICATION STATUS INFLUENCES TUMOR IMMUNE EVASION IN MEDULLOBLASTOMA
  Martin, A., Nirschl, C., Polanczyk, M., Cohen, K., Pardoll, D., Drake, C., & Lim, M. (2013). MYC AMPLIFICATION STATUS INFLUENCES TUMOR IMMUNE EVASION IN MEDULLOBLASTOMA. NEURO-ONCOLOGY, 15, 15鈥�16.
- Factors associated with survival for patients with glioblastoma with poor pre-operative functional status
  Chaichana, K. L., Martinez-Gutierrez, J. C., De la Garza-Ramos, R., Weingart, J. D., Olivi, A., Gallia, G. L., 鈥� Quinones-Hinojosa, A. (2013). Factors associated with survival for patients with glioblastoma with poor pre-operative functional status. JOURNAL OF CLINICAL NEUROSCIENCE, 20(6), 818鈥�23.
- Metastatic Melanoma to the Brain: Surgery and Radiation Is Still the Standard of Care
  Nicholas, S., Mathios, D., Jackson, C., & Lim, M. (2013). Metastatic Melanoma to the Brain: Surgery and Radiation Is Still the Standard of Care. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 14(2), 264鈥�79.
- Anti-PD-1 Blockade and Stereotactic Radiation Produce Long-Term Survival in Mice With Intracranial Gliomas
  Zeng, J., See, A. P., Phallen, J., Jackson, C. M., Belcaid, Z., Ruzevick, J., 鈥� Lim, M. (2013). Anti-PD-1 Blockade and Stereotactic Radiation Produce Long-Term Survival in Mice With Intracranial Gliomas. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 86(2), 343鈥�49.
- Seizure Control for Patients Undergoing Meningioma Surgery
  Chaichana, K. L., Pendleton, C., Zaidi, H., Olivi, A., Weingart, J. D., Gallia, G. L., 鈥� Quinones-Hinojosa, A. (2013). Seizure Control for Patients Undergoing Meningioma Surgery. WORLD NEUROSURGERY, 79(3-4), 515鈥�24.
- Multiple resections for patients with glioblastoma: prolonging survival Clinical article
  Chaichana, K. L., Zadnik, P., Weingart, J. D., Olivi, A., Gallia, G. L., Blakeley, J., 鈥� Quistones-Hinojosa, A. (2013). Multiple resections for patients with glioblastoma: prolonging survival Clinical article. JOURNAL OF NEUROSURGERY, 118(4), 812鈥�20.
- Deep venous thrombosis and pulmonary embolisms in adult patients undergoing craniotomy for brain tumors
  Chaichana, K. L., Pendleton, C., Jackson, C., Martinez-Gutierrez, J. C., Diaz-Stransky, A., Aguayo, J., 鈥� Quinones-Hinojosa, A. (2013). Deep venous thrombosis and pulmonary embolisms in adult patients undergoing craniotomy for brain tumors. NEUROLOGICAL RESEARCH, 35(2), 206鈥�11.
- Vaccine strategies for glioblastoma: progress and future directions
  Jackson, C., Ruzevick, J., Brem, H., & Lim, M. (2013). Vaccine strategies for glioblastoma: progress and future directions. IMMUNOTHERAPY, 5(2), 155鈥�67.
- Glycerol rhizotomy and radiofrequency thermocoagulation for trigeminal neuralgia in multiple sclerosis
  Bender, M. T., Pradilla, G., Batra, S., See, A. P., James, C., Pardo, C. A., 鈥� Lim, M. (2013). Glycerol rhizotomy and radiofrequency thermocoagulation for trigeminal neuralgia in multiple sclerosis. JOURNAL OF NEUROSURGERY, 118(2), 329鈥�36.
- INCREASED RADIATION DOSE TO THE SVZ IMPROVES PROGRESSION FREE SURVIVAL IN GBM PATIENTS
  Chen, L., Guerrero-Cazares, H., Ford, E., McNutt, T., Kleinberg, L., Lim, M., 鈥� Redmond, K. (2012). INCREASED RADIATION DOSE TO THE SVZ IMPROVES PROGRESSION FREE SURVIVAL IN GBM PATIENTS. NEURO-ONCOLOGY, 14, 139.
- A PROSPECTIVE STUDY OF MOTOR DYSFUNCTION FOLLOWING CRANIAL IRRADIATION FOR PEDIATRIC BRAIN TUMORS
  Redmond, K. J., Mahone, E. M., Kleinberg, L., Terezakis, S., McNutt, T., Agbahiwe, H., 鈥� Horska, A. (2012). A PROSPECTIVE STUDY OF MOTOR DYSFUNCTION FOLLOWING CRANIAL IRRADIATION FOR PEDIATRIC BRAIN TUMORS. NEURO-ONCOLOGY, 14, 137.
- ONCOGENIC DRIVERS OF MEDULLOBLASTOMA MAY DETERMINE A NOVEL IMMUNE PHENOTYPE
  Martin, A. M., Nirschl, C., Polanczyk, M., Cohen, K. J., Pardoll, D. M., Drake, C. G., & Lim, M. (2012). ONCOGENIC DRIVERS OF MEDULLOBLASTOMA MAY DETERMINE A NOVEL IMMUNE PHENOTYPE. NEURO-ONCOLOGY, 14, 41.
- The role of STAT3 activation in modulating the immune microenvironment of GBM
  See, A. P., Han, J. E., Phallen, J., Binder, Z., Gallia, G., Pan, F., 鈥� Lim, M. (2012). The role of STAT3 activation in modulating the immune microenvironment of GBM. JOURNAL OF NEURO-ONCOLOGY, 110(3), 359鈥�68.
- NOVEL IMMUNE CHARACTERISTICS OF MEDULLOBLASTOMA CORRELATE WITH MYC AMPLIFICATION STATUS
  Martin, A., Nirschl, C., Polanczyk, M., Cohen, K. J., Pardoll, D. M., Drake, C. G., & Lim, M. (2012). NOVEL IMMUNE CHARACTERISTICS OF MEDULLOBLASTOMA CORRELATE WITH MYC AMPLIFICATION STATUS. NEURO-ONCOLOGY, 14, 93.
- Subependymoma: clinical features and surgical outcomes
  Jain, A., Amin, A. G., Jain, P., Burger, P., Jallo, G. I., Lim, M., & Bettegowda, C. (2012). Subependymoma: clinical features and surgical outcomes. NEUROLOGICAL RESEARCH, 34(7), 677鈥�84.
- Clinical Trials with Immunotherapy for High-Grade Glioma
  Ruzevick, J., Jackson, C., Phallen, J., & Lim, M. (2012). Clinical Trials with Immunotherapy for High-Grade Glioma. NEUROSURGERY CLINICS OF NORTH AMERICA, 23(3), 459-+.
- Potential Role for STAT3 Inhibitors in Glioblastoma
  Jackson, C., Ruzevick, J., Amin, A. G., & Lim, M. (2012). Potential Role for STAT3 Inhibitors in Glioblastoma. NEUROSURGERY CLINICS OF NORTH AMERICA, 23(3), 379-+.
- Overall Survival and Prognostic Factors for Overall Survival Vary by Histology and Performance Status for Patients with Newly Diagnosed Brain Metastases Treated with Gamma Knife
  Todd, A., Lawrence, K., Aizik, W., Sachin, B., Borletto, P., Chettan, B., 鈥� Rigamonti, D. (2012). Overall Survival and Prognostic Factors for Overall Survival Vary by Histology and Performance Status for Patients with Newly Diagnosed Brain Metastases Treated with Gamma Knife. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 35(2), 201鈥�2.
- Effectiveness of Repeat Glycerol Rhizotomy in Treating Recurrent Trigeminal Neuralgia
  Bender, M., Pradilla, G., Batra, S., See, A., Bhutiani, N., James, C., 鈥� Lim, M. (2012). Effectiveness of Repeat Glycerol Rhizotomy in Treating Recurrent Trigeminal Neuralgia. NEUROSURGERY, 70(5), 1125鈥�33.
- Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment
  Jackson, C., Ruzevick, J., Phallen, J., Belcaid, Z., & Lim, M. (2011). Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment. CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 732413.
- GENOME-WIDE ANALYSIS OF CLINICALLY SIGNIFICANT CPG METHYLATION SITES IN GLIOBLASTOMA MULTIFORME
  See, A. P., Hwang, T., Shin, D., Shin, J. H., Gao, Y., & Lim, M. (2011). GENOME-WIDE ANALYSIS OF CLINICALLY SIGNIFICANT CPG METHYLATION SITES IN GLIOBLASTOMA MULTIFORME. NEURO-ONCOLOGY, 13, 79.
- COMBINING ANTI-PD-1 (B7-H1) IMMUNOTHERAPY WITH STEREOTACTIC RADIOSURGERY IN A MOUSE ORTHOTOPIC GLIOBLASTOMA MODEL
  Zeng, J., See, A. P., Phallen, J., Belcaid, Z., Durham, N., Meyer, C., 鈥� Lim, M. (2011). COMBINING ANTI-PD-1 (B7-H1) IMMUNOTHERAPY WITH STEREOTACTIC RADIOSURGERY IN A MOUSE ORTHOTOPIC GLIOBLASTOMA MODEL. NEURO-ONCOLOGY, 13, 37鈥�38.
- STEREOTACTIC RADIOSURGERY COMBINED WITH DOUBLE IMMUNOTHERAPY WITH ANTI-CTLA-4 AND ANTI-4-1BB YIELDS LONG-TERM SURVIVAL AND PROTECTIVE ANTITUMOR RESPONSE IN A MOUSE ORTHOTOPIC GLIOBLASTOMA MODEL
  Belcaid, Z., Phallen, J. A., Zeng, J., See, A. P., Albesiano, E., Durham, N. M., 鈥� Lim, M. (2011). STEREOTACTIC RADIOSURGERY COMBINED WITH DOUBLE IMMUNOTHERAPY WITH ANTI-CTLA-4 AND ANTI-4-1BB YIELDS LONG-TERM SURVIVAL AND PROTECTIVE ANTITUMOR RESPONSE IN A MOUSE ORTHOTOPIC GLIOBLASTOMA MODEL. NEURO-ONCOLOGY, 13, 32.
- MEDULLOBLASTOMA: A COMPARISON OF PEDIATRIC AND ADULT PATIENTS TREATED AT THE JOHNS HOPKINS HOSPITAL
  Ishaq, O., Montgomery, J., Terezakis, S., Wharam, M., Lim, M., Holdhoff, M., 鈥� Redmond, K. (2011). MEDULLOBLASTOMA: A COMPARISON OF PEDIATRIC AND ADULT PATIENTS TREATED AT THE JOHNS HOPKINS HOSPITAL. NEURO-ONCOLOGY, 13, 29.
- Stereotactic Radiosurgery of Cranial Arteriovenous Malformations and Dural Arteriovenous Fistulas
  See, A. P., Raza, S., Tamargo, R. J., & Lim, M. (2012). Stereotactic Radiosurgery of Cranial Arteriovenous Malformations and Dural Arteriovenous Fistulas. NEUROSURGERY CLINICS OF NORTH AMERICA, 23(1), 133-+.
- Surgical treatment of pediatric trigeminal neuralgia: case series and review of the literature
  Bender, M. T., Pradilla, G., James, C., Raza, S., Lim, M., & Carson, B. S. (2011). Surgical treatment of pediatric trigeminal neuralgia: case series and review of the literature. CHILDS NERVOUS SYSTEM, 27(12), 2123鈥�29.
- Delivery of stereotactic radiosurgery: a cross-platform comparison
  Trang Nguyen, Hsu, W., Lim, M., & Naff, N. (2011). Delivery of stereotactic radiosurgery: a cross-platform comparison. NEUROLOGICAL RESEARCH, 33(8), 787鈥�91.
- Nelfinavir induces radiation sensitization in pituitary adenoma cells
  Zeng, J., See, A. P., Aziz, K., Thiyagarajan, S., Salih, T., Gajula, R. P., 鈥� Lim, M. (2011). Nelfinavir induces radiation sensitization in pituitary adenoma cells. CANCER BIOLOGY & THERAPY, 12(7), 657鈥�63.
- Endoscopic Transvestibular Paramandibular Exploration of the Infratemporal Fossa and Parapharyngeal Space: A Minimally Invasive Approach to the Middle Cranial Base
  Chan, J. Y. K., Li, R. J., Lim, M., Hinojosa, A. Q., & Boahene, K. D. (2011). Endoscopic Transvestibular Paramandibular Exploration of the Infratemporal Fossa and Parapharyngeal Space: A Minimally Invasive Approach to the Middle Cranial Base. LARYNGOSCOPE, 121(10), 2075鈥�80.
- Clinical Outcomes after Treatment of Germ Cell Tumors
  Jackson, C., Jallo, G., & Lim, M. (2011). Clinical Outcomes after Treatment of Germ Cell Tumors. NEUROSURGERY CLINICS OF NORTH AMERICA, 22(3), 385-+.
- Heat shock protein-peptide complex in the treatment of glioblastoma
  See, A. P., Pradilla, G., Yang, I., Han, S., Parsa, A. T., & Lim, M. (2011). Heat shock protein-peptide complex in the treatment of glioblastoma. EXPERT REVIEW OF VACCINES, 10(6), 721鈥�31.
- THE RADIOSURGICAL TREATMENT OF ARTERIOVENOUS MALFORMATIONS: OBLITERATION, MORBIDITIES, AND PERFORMANCE STATUS
  Sun, D. Q., Carson, K. A., Raza, S. M., Batra, S., Kleinberg, L. R., Lim, M., 鈥� Rigamonti, D. (2011). THE RADIOSURGICAL TREATMENT OF ARTERIOVENOUS MALFORMATIONS: OBLITERATION, MORBIDITIES, AND PERFORMANCE STATUS. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 80(2), 354鈥�61.
- Acute toxicity of second generation HIV protease-inhibitors in combination with radiotherapy: a retrospective case series
  See, A. P., Zeng, J., Tran, P. T., & Lim, M. (2011). Acute toxicity of second generation HIV protease-inhibitors in combination with radiotherapy: a retrospective case series. RADIATION ONCOLOGY, 6, 25.
- Treatment of pituitary adenomas using radiosurgery and radiotherapy: a single center experience and review of literature
  Sun, D. Q., Cheng, J. J., Frazier, J. L., Batra, S., Wand, G., Kleinberg, L. R., 鈥� Lim, M. (2011). Treatment of pituitary adenomas using radiosurgery and radiotherapy: a single center experience and review of literature. NEUROSURGICAL REVIEW, 34(2), 181鈥�89.
- ESTABLISHMENT OF GBM SUSPENSION CELL LINES
  Binder, Z. A., Salmasi, V., Lim, M., Weingart, J., Brem, H., Olivi, A., 鈥� Gallia, G. L. (2010). ESTABLISHMENT OF GBM SUSPENSION CELL LINES. NEURO-ONCOLOGY, 12, 134.
- PODOCALYXIN EXPRESSION CORRELATES WITH ASTROCYTOMA TUMOR GRADE
  Binder, Z. A., Orr, B., Lim, M., Weingart, J. D., Brem, H., Olivi, A., 鈥� Gallia, G. L. (2010). PODOCALYXIN EXPRESSION CORRELATES WITH ASTROCYTOMA TUMOR GRADE. NEURO-ONCOLOGY, 12, 119鈥�20.
- ADJUVANT STEREOTACTIC RADIOSURGERY INCREASES TUMOR CONTROL RATES IN PATIENTS WITH CEREBRAL METASTASES AFTER SURGICAL RESECTION
  Jackson, C. M., Amin, A., See, P., Pradilla, G., Tryggestad, E., & Lim, M. (2010). ADJUVANT STEREOTACTIC RADIOSURGERY INCREASES TUMOR CONTROL RATES IN PATIENTS WITH CEREBRAL METASTASES AFTER SURGICAL RESECTION. NEURO-ONCOLOGY, 12, 112.
- STAT3 INHIBITION ALTERS THE IMMUNE PROFILE IN MURINE GLIOMAS
  Han, J. E., Albesiano, E., Pradilla, G., & Lim, M. (2010). STAT3 INHIBITION ALTERS THE IMMUNE PROFILE IN MURINE GLIOMAS. NEURO-ONCOLOGY, 12, 16鈥�17.
- THE ROLE OF STAT3 ACTIVATION IN MODULATING THE IMMUNE MICROENVIRONMENT OF GLIOMAS
  Albesiano, E., Han, J. E., See, A., Jackson, C., & Lim, M. (2010). THE ROLE OF STAT3 ACTIVATION IN MODULATING THE IMMUNE MICROENVIRONMENT OF GLIOMAS. NEURO-ONCOLOGY, 12, 31.
- Predictors of Inpatient Death and Complications among Postoperative Elderly Patients with Metastatic Brain Tumors
  Grossman, R., Mukherjee, D., Chang, D. C., Purtell, M., Lim, M., Brem, H., & Quinones-Hinojosa, A. (2011). Predictors of Inpatient Death and Complications among Postoperative Elderly Patients with Metastatic Brain Tumors. ANNALS OF SURGICAL ONCOLOGY, 18(2), 521鈥�28.
- Stereotactic Radiosurgery for Spine Tumors: Review of Current Literature
  Hsu, W., Nguyen, T., Kleinberg, L., Ford, E. C., Rigamonti, D., Gokaslan, Z. L., & Lim, M. (2010). Stereotactic Radiosurgery for Spine Tumors: Review of Current Literature. STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, 88(5), 315鈥�21.
- Immunologic Consequences of Signal Transducers and Activators of Transcription 3 Activation in Human Squamous Cell Carcinoma
  Albesiano, E., Davis, M., See, A. P., Han, J. E., Lim, M., Pardoll, D. M., & Kim, Y. (2010). Immunologic Consequences of Signal Transducers and Activators of Transcription 3 Activation in Human Squamous Cell Carcinoma. CANCER RESEARCH, 70(16), 6467鈥�76.
- Transpalpebral Orbitofrontal Craniotomy: A Minimally Invasive Approach to Anterior Cranial Vault Lesions
  Boahene, K. D. O., Lim, M., Chu, E., & Quinones-Hinojosa, A. (2010). Transpalpebral Orbitofrontal Craniotomy: A Minimally Invasive Approach to Anterior Cranial Vault Lesions. SKULL BASE-AN INTERDISCIPLINARY APPROACH, 20(4), 237鈥�44.
- Immunotherapy Combined with Chemotherapy in the Treatment of Tumors
  Frazier, J. L., Han, J. E., Lim, M., & Olivi, A. (2010). Immunotherapy Combined with Chemotherapy in the Treatment of Tumors. NEUROSURGERY CLINICS OF NORTH AMERICA, 21(1), 187-+.
- Mechanisms of Local Immunoresistance in Glioma
  Albesiano, E., Han, J. E., & Lim, M. (2010). Mechanisms of Local Immunoresistance in Glioma. NEUROSURGERY CLINICS OF NORTH AMERICA, 21(1), 17-+.
- Immunotherapy Preface
  Yang, I., & Lim, M. (2010). Immunotherapy Preface. NEUROSURGERY CLINICS OF NORTH AMERICA, 21(1), XV.
- Biologic Principles of Immunotherapy for Malignant Gliomas
  Han, S. J., Kaur, G., Yang, I., & Lim, M. (2010). Biologic Principles of Immunotherapy for Malignant Gliomas. NEUROSURGERY CLINICS OF NORTH AMERICA, 21(1), 1-+.
- STEREOTACTIC RADIOSURGERY IN THE MANAGEMENT OF BRAIN METASTASES: AN INSTITUTIONAL RETROSPECTIVE ANALYSIS OF SURVIVAL
  Frazier, J. L., Batra, S., Kapor, S., Vellimana, A., Gandhi, R., Carson, K. A., 鈥� Rigamonti, D. (2010). STEREOTACTIC RADIOSURGERY IN THE MANAGEMENT OF BRAIN METASTASES: AN INSTITUTIONAL RETROSPECTIVE ANALYSIS OF SURVIVAL. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 76(5), 1486鈥�92.
- Reversible posterior leukoencephalopathy occurring during resection of a posterior fossa tumor: Case report and review of the literature
  Moriarity, J. L., Lim, M., Storm, P. B., Beauchamp, N. J., & Olivi, A. (2001). Reversible posterior leukoencephalopathy occurring during resection of a posterior fossa tumor: Case report and review of the literature. NEUROSURGERY, 49(5), 1237鈥�39.
- Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases
  Zhong, H., De Marzo, A. M., Laughner, E., Lim, M., Hilton, D. A., Zagzag, D., 鈥� Simons, J. W. (1999). Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases. CANCER RESEARCH, 59(22), 5830鈥�35.
- Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee.
  Gastman, B., Agarwal, P. K., Berger, A., Boland, G., Broderick, S., Butterfield, L. H., 鈥� Kaufman, H. L. (2020). Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee. Journal for Immunotherapy of Cancer, 8(2).
- THE STATE OF NEURO-ONCOLOGY DURING THE COVID-19 PANDEMIC: A WORLDWIDE ASSESSMENT
  Mrugala, M., Ostrom, Q., Pressley, S., Thomas, A., Wefel, J. S., Coven, S., 鈥� Chheda, M. (2020). THE STATE OF NEURO-ONCOLOGY DURING THE COVID-19 PANDEMIC: A WORLDWIDE ASSESSMENT. NEURO-ONCOLOGY, 22, 27.
- EFFICACY OF CXCR6 BLOCKADE AS A POTENTIATOR OF ANTI-PD-1 THERAPY FOR THE TREATMENT OF GLIOBLASTOMA
  Pant, A., Saleh, L., Patel, K., Medikonda, R., & Lim, M. (2020). EFFICACY OF CXCR6 BLOCKADE AS A POTENTIATOR OF ANTI-PD-1 THERAPY FOR THE TREATMENT OF GLIOBLASTOMA. NEURO-ONCOLOGY, 22, 107.
- SINGLE CELL RNA-SEQUENCING IDENTIFIES NOVEL BONE MARROW DERIVED MYELOID CELLS IN GLIOBLASTOMA ASSOCIATED WITH TUMOR AGGRESSION
  Jackson, C., Cherry, C., Bom, S., Zhang, H., Choi, J., Yegnasubramanian, V., 鈥� Pardoll, D. (2020). SINGLE CELL RNA-SEQUENCING IDENTIFIES NOVEL BONE MARROW DERIVED MYELOID CELLS IN GLIOBLASTOMA ASSOCIATED WITH TUMOR AGGRESSION. NEURO-ONCOLOGY, 22, 110.
- A CROWDSOURCED CONSENSUS ON SUPRATOTAL RESECTION VERSUS GROSS TOTAL RESECTION FOR ANATOMICALLY DISTINCT PRIMARY GLIOBLASTOMA
  Mukherjee, D., Rakovec, M., Bettegowda, C., Jackson, C., Gallia, G., Lim, M., 鈥� Khalafallah, A. (2020). A CROWDSOURCED CONSENSUS ON SUPRATOTAL RESECTION VERSUS GROSS TOTAL RESECTION FOR ANATOMICALLY DISTINCT PRIMARY GLIOBLASTOMA. NEURO-ONCOLOGY, 22, 208.
- GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA
  Buxton, M., Alexander, B., Berry, D., Cavenee, W., Colman, H., de Groot, J., 鈥� Cloughesy, T. (2020). GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA. NEURO-ONCOLOGY, 22, 195鈥�96.
- MANAGEMENT OF BRAIN METASTASIS IN TRIPLE NEGATIVE BREAST CANCER
  Medikonda, R., Srivastava, S., Kim, T., Xia, Y., Patel, M., Jackson, C., 鈥� Lim, M. (2020). MANAGEMENT OF BRAIN METASTASIS IN TRIPLE NEGATIVE BREAST CANCER. NEURO-ONCOLOGY, 22, 130.
- EFFICACY OF ANTICONVULSANT THERAPY IN GLIOMA PATIENTS
  Medikonda, R., Patel, K., Saleh, L., Srivastava, S., Jackson, C., Mohan, A., 鈥� Lim, M. (2020). EFFICACY OF ANTICONVULSANT THERAPY IN GLIOMA PATIENTS. NEURO-ONCOLOGY, 22, 134.
- THE SAFETY AND EFFICACY OF DEXAMETHASONE IN THE MANAGEMENT OF GLIOMA PATIENTS
  Medikonda, R., Patel, K., Saleh, L., Srivastava, S., Jackson, C., Mohan, A., 鈥� Lim, M. (2020). THE SAFETY AND EFFICACY OF DEXAMETHASONE IN THE MANAGEMENT OF GLIOMA PATIENTS. NEURO-ONCOLOGY, 22, 136.
- Unique challenges for glioblastoma immunotherapy - Discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology.
  Chuntova, P., Chow, F., Watchmaker, P., Galvez, M., Heimberger, A. B., Newell, E. W., 鈥� Okada, H. (2020). Unique challenges for glioblastoma immunotherapy - Discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Neuro-Oncology.
- PD-1+ Monocytes Mediate Cerebral Vasospasm Following Subarachnoid Hemorrhage.
  Jackson, C. M., Choi, J., Routkevitch, D., Pant, A., Saleh, L., Ye, X., 鈥� Lim, M. (2020). PD-1+ Monocytes Mediate Cerebral Vasospasm Following Subarachnoid Hemorrhage. Neurosurgery.
- Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastases.
  Zhang, M., Rodrigues, A. J., Pollom, E. L., Gibbs, I. C., Soltys, S. G., Hancock, S. L., 鈥� Li, G. (2021). Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastases. Journal of Neuro-Oncology.
- In Reply: Absence of Ischemic Injury After Sacrificing the Superior Petrosal Vein During Microvascular Decompression.
  Xia, Y., & Lim, M. (2021). In Reply: Absence of Ischemic Injury After Sacrificing the Superior Petrosal Vein During Microvascular Decompression. Operative Neurosurgery (Hagerstown, Md.).
- Role of surgery for glioblastoma: response to letters from Dr. Gerritsen and his colleagues and Dr. Vargas Lopez.
  Wen, P. Y., Weller, M., Chiocca, E. A., Lim, M., Tonn, J.-C. C., Zadeh, G., 鈥� van den Bent, M. (2021). Role of surgery for glioblastoma: response to letters from Dr. Gerritsen and his colleagues and Dr. Vargas Lopez. Neuro-Oncology.
- Development of new brain metastases in triple negative breast cancer.
  Medikonda, R., Srivastava, S., Kim, T., Xia, Y., Kim, J., Jackson, C., 鈥� Lim, M. (2021). Development of new brain metastases in triple negative breast cancer. Journal of Neuro-Oncology.
- Reprogramming transcription factors Oct4 and Sox2 induces a BRD-dependent immunosuppressive transcriptome in GBM-propagating cells.
  Laterra, J., Ma, T., Hu, C., Lal, B., Zhou, W., Ma, Y., 鈥� Li, Y. (2021). Reprogramming transcription factors Oct4 and Sox2 induces a BRD-dependent immunosuppressive transcriptome in GBM-propagating cells. Cancer Research.
- Combination immunotherapy strategies for glioblastoma.
  Chan, H. Y., Choi, J., Jackson, C., & Lim, M. (2021). Combination immunotherapy strategies for glioblastoma. Journal of Neuro-Oncology, 151(3), 375鈥�91.
- Characterizing long non-coding RNA expression of tumor-infiltrating lymphocytes across solid cancers
  Dinalankara, W., Imada, E.-L., Jackson, C. M., Nirschl, T. R., Lim, M., Drake, C. G., & Marchionni, L. (2020). Characterizing long non-coding RNA expression of tumor-infiltrating lymphocytes across solid cancers. CANCER RESEARCH, 80(16).
- GBM AGILE: A global, phase II/III adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma.
  Buxton, M. B., Alexander, B. M., Berry, D. A., Cavenee, W. K., Colman, H., De Groot, J. F., 鈥� Cloughesy, T. F. (2020). GBM AGILE: A global, phase II/III adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma. JOURNAL OF CLINICAL ONCOLOGY, 38(15).
- Thalamic gliomas: Advances in the surgical management
  Hung, A., Wu, A., Jackson, C., & Lim, M. (2019). Thalamic gliomas: Advances in the surgical management. NEW TECHNIQUES FOR MANAGEMENT OF INOPERABLE GLIOMAS, 117鈥�135.
- The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment.
  Mrugala, M. M., Ostrom, Q. T., Pressley, S. M., Taylor, J. W., Thomas, A. A., Wefel, J. S., 鈥� Chheda, M. G. (2021). The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment. Neuro-Oncology Advances, 3(1), vdab035.
- Immunotherapy for Chordoma and Chondrosarcoma: Current Evidence.
  Traylor, J. I., Pernik, M. N., Plitt, A. R., Lim, M., & Garzon-Muvdi, T. (2021). Immunotherapy for Chordoma and Chondrosarcoma: Current Evidence. Cancers, 13(10).
- Mutation status and postresection survival of patients with non-small cell lung cancer brain metastasis: implications of biomarker-driven therapy.
  Shah, P. P., Franke, J. L., Medikonda, R., Jackson, C. M., Srivastava, S., Choi, J., 鈥� Lim, M. (2021). Mutation status and postresection survival of patients with non-small cell lung cancer brain metastasis: implications of biomarker-driven therapy. Journal of Neurosurgery, 1鈥�11.
- Bone Cement Internal Auditory Canal Reconstruction to Reduce CSF Leak After Vestibular Schwannoma Retrosigmoid Approach.
  Zhang, L., Galaiya, D., Jackson, C. M., Tamargo, R. J., Lim, M., Carey, J., & Creighton, F. X. (2021). Bone Cement Internal Auditory Canal Reconstruction to Reduce CSF Leak After Vestibular Schwannoma Retrosigmoid Approach. Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.
- Enhancing proteasomal processing improves survival for a peptide vaccine used to treat glioblastoma.
  Fidanza, M., Gupta, P., Sayana, A., Shanker, V., Pahlke, S.-M., Vu, B., 鈥� Wong, A. J. (2021). Enhancing proteasomal processing improves survival for a peptide vaccine used to treat glioblastoma. Science Translational Medicine, 13(598).
- Systematic review of combinations of targeted or immunotherapy in advanced solid tumors.
  Tan, A. C., Bagley, S. J., Wen, P. Y., Lim, M., Platten, M., Colman, H., 鈥� Khasraw, M. (2021). Systematic review of combinations of targeted or immunotherapy in advanced solid tumors. Journal for Immunotherapy of Cancer, 9(7).
- Sustained localized delivery of immunotherapy to lymph nodes reverses immunosuppression and increases long-term survival in murine glioblastoma
  Choi, J., Pant, A., Medikonda, R., Kim, Y.-H., Routkevitch, D., Saleh, L., 鈥� Lim, M. (2021). Sustained localized delivery of immunotherapy to lymph nodes reverses immunosuppression and increases long-term survival in murine glioblastoma. ONCOIMMUNOLOGY, 10(1).
- Emerging Technologies for Non-invasive Monitoring of Treatment Response to Immunotherapy for Brain Tumors.
  Mathios, D., Srivastava, S., Kim, T., Bettegowda, C., & Lim, M. (2021). Emerging Technologies for Non-invasive Monitoring of Treatment Response to Immunotherapy for Brain Tumors. Neuromolecular Medicine.
- Sustained localized delivery of immunotherapy to lymph nodes reverses immunosuppression and increases long-term survival in murine glioblastoma.
  Choi, J., Pant, A., Medikonda, R., Kim, Y.-H. H., Routkevitch, D., Saleh, L., 鈥� Lim, M. (2021). Sustained localized delivery of immunotherapy to lymph nodes reverses immunosuppression and increases long-term survival in murine glioblastoma. Oncoimmunology, 10(1), 1940673.
- A Crowdsourced Consensus on Supratotal Resection Versus Gross Total Resection for Anatomically Distinct Primary Glioblastoma.
  Khalafallah, A. M., Rakovec, M., Bettegowda, C., Jackson, C. M., Gallia, G. L., Weingart, J. D., 鈥� Mukherjee, D. (2021). A Crowdsourced Consensus on Supratotal Resection Versus Gross Total Resection for Anatomically Distinct Primary Glioblastoma. Neurosurgery.
- Synergy between glutamate modulation and anti-programmed cell death protein 1 immunotherapy for glioblastoma.
  Medikonda, R., Choi, J., Pant, A., Saleh, L., Routkevitch, D., Tong, L., 鈥� Lim, M. (2021). Synergy between glutamate modulation and anti-programmed cell death protein 1 immunotherapy for glioblastoma. Journal of Neurosurgery, 1鈥�10.
- Quantitative Bioluminescence Tomography-guided Conformal Irradiation for Pre-clinical Radiation Research.
  Xu, X., Deng, Z., Dehghani, H., Iordachita, I., Lim, M., Wong, J. W., & Wang, K. K.-H. (2021). Quantitative Bioluminescence Tomography-guided Conformal Irradiation for Pre-clinical Radiation Research. International Journal of Radiation Oncology, Biology, Physics.
- Roles of Neutrophils in Glioma and Brain Metastases.
  Lin, Y.-J., Wei, K.-C., Chen, P.-Y., Lim, M., & Hwang, T.-L. (2021). Roles of Neutrophils in Glioma and Brain Metastases. Frontiers in Immunology, 12, 701383.
- Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma
  Choi, J., Medikonda, R., Saleh, L., Kim, T., Pant, A., Srivastava, S., 鈥� Lim, M. (2021). Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma. ONCOIMMUNOLOGY, 10(1), 1956142.
- The safety and efficacy of dexamethasone in the perioperative management of glioma patients.
  Medikonda, R., Patel, K., Jackson, C., Saleh, L., Srivastava, S., Feghali, J., 鈥� Lim, M. (2021). The safety and efficacy of dexamethasone in the perioperative management of glioma patients. Journal of Neurosurgery, 1鈥�8.
- Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma.
  Singh, K., Batich, K. A., Wen, P. Y., Tan, A. C., Bagley, S. J., Lim, M., 鈥� Khasraw, M. (2021). Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
- The Challenges and Future of Immunotherapy for Gliomas.
  Wu, A., & Lim, M. (2021). The Challenges and Future of Immunotherapy for Gliomas. Cancer Journal (Sudbury, Mass.), 27(5), 371鈥�378.
- Checkpoint blockade in recurrent meningiomas: Lessons for future management.
  Pant, A., & Lim, M. (2021). Checkpoint blockade in recurrent meningiomas: Lessons for future management. Neuro-Oncology.
- Is There a Role for Immunotherapy in Central Nervous System Cancers?
  Flores, C., Dunn, G., Fecci, P., Lim, M., Mitchell, D., & Reardon, D. A. (2022). Is There a Role for Immunotherapy in Central Nervous System Cancers? Hematology/Oncology Clinics of North America, 36(1), 237鈥�252.
- Quantitative Bioluminescence Tomography for In Vivo Volumetric-Guided Radiotherapy.
  Deng, Z., Xu, X., Dehghani, H., Sforza, D. M., Iordachita, I., Lim, M., 鈥� Wang, K. K.-H. (2022). Quantitative Bioluminescence Tomography for In Vivo Volumetric-Guided Radiotherapy. Methods in Molecular Biology (Clifton, N.J.), 2393, 701鈥�731.
- GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma.
  Wen, P. Y., Mellinghoff, I. K., Buxton, M. B., Cavenee, W. K., Colman, H., De Groot, J. F., 鈥� Cloughesy, T. F. (2021). GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- In Vivo Evaluation of Near-Infrared Fluorescent Probe for TIM3 Targeting in Mouse Glioma.
  Zhang, M., Zhou, Q., Huang, C., Chan, C. T., Wu, W., Li, G., 鈥� Daldrup-Link, H. E. (2021). In Vivo Evaluation of Near-Infrared Fluorescent Probe for TIM3 Targeting in Mouse Glioma. Molecular Imaging and Biology.
- ATRX loss promotes immunosuppressive mechanisms in IDH1 mutant glioma.
  Hu, C., Wang, K., Damon, C., Fu, Y., Ma, T., Kratz, L., 鈥� Li, Y. (1800). ATRX loss promotes immunosuppressive mechanisms in IDH1 mutant glioma. Neuro-Oncology.
- Advances in Immunotherapies for Gliomas.
  Zhang, M., Choi, J., & Lim, M. (1800). Advances in Immunotherapies for Gliomas. Current Neurology and Neuroscience Reports.
- Introduction. Immunology of neurosurgical diseases.
  Quinones-Hinojosa, A., Rahman, M., Lim, M., Suarez-Meade, P., & Marenco-Hillembrand, L. (1800). Introduction. Immunology of neurosurgical diseases. Neurosurgical Focus, 52(2), E1.
- Clinical features and surgical outcomes of intracranial and spinal cord subependymomas.
  Rincon-Torroella, J., Rakovec, M., Khalafallah, A. M., Liu, A., Bettegowda, A., Kut, C., 鈥� Bettegowda, C. (2022). Clinical features and surgical outcomes of intracranial and spinal cord subependymomas. Journal of Neurosurgery, 1鈥�12.
- Impact of international 蓝莓视频 fellows in neurosurgery: results from a single academic center
  Yang, W., Rincon-Torroella, J., Feghali, J., Khalafallah, A. M., Ishida, W., Perdomo-Pantoja, A., 鈥� Huang, J. (2022). Impact of international 蓝莓视频 fellows in neurosurgery: results from a single academic center. JOURNAL OF NEUROSURGERY, 136(1), 295鈥�305.
- Quality of Life and Role of Palliative and Supportive Care for Patients With Brain Metastases and Caregivers: A Review
  Wu, A., Ruiz Colon, G. D., & Lim, M. (2022). Quality of Life and Role of Palliative and Supportive Care for Patients With Brain Metastases and Caregivers: A Review. Frontiers in Neurology, 13.
- A RANDOMIZED PHASE 3 STUDY OF NIVOLUMAB OR PLACEBO COMBINED WITH RADIOTHERAPY PLUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA WITH METHYLATED MGMT PROMOTER: CHECKMATE 548
  Weller, M., Lim, M., Idbaih, A., Steinbach, J., Finocchiaro, G., Raval, R., 鈥� Omuro, A. (2021). A RANDOMIZED PHASE 3 STUDY OF NIVOLUMAB OR PLACEBO COMBINED WITH RADIOTHERAPY PLUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA WITH METHYLATED MGMT PROMOTER: CHECKMATE 548. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- The roles of thermal and mechanical stress in focused ultrasound-mediated immunomodulation and immunotherapy for central nervous system tumors.
  Kim, C., Lim, M., Woodworth, G. F., & Arvanitis, C. D. (2022). The roles of thermal and mechanical stress in focused ultrasound-mediated immunomodulation and immunotherapy for central nervous system tumors. Journal of Neuro-Oncology.
- CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future.
  Lin, Y.-J., Mashouf, L. A., & Lim, M. (2022). CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future. Frontiers in Immunology, 13, 817296.
- Cranioplasty With Customized Craniofacial Implants and Intraoperative Resizing for Single-Stage Reconstruction Following Oncologic Resection of Skull Neoplasms.
  Ben-Shalom, N., Asemota, A. O., Belzberg, M., Harnof, S., Huang, J., Lim, M., 鈥� Gordon, C. (2022). Cranioplasty With Customized Craniofacial Implants and Intraoperative Resizing for Single-Stage Reconstruction Following Oncologic Resection of Skull Neoplasms. The Journal of Craniofacial Surgery.
- Case Series in the Utility of Invasive Blood Pressure Monitoring in Microvascular Decompression.
  Xu, R., Nair, S. K., Materi, J., Raj, D., Medikonda, R., Shah, P. P., 鈥� Lim, M. (2022). Case Series in the Utility of Invasive Blood Pressure Monitoring in Microvascular Decompression. Operative Neurosurgery (Hagerstown, Md.).
- Circulating Immune Cell and Outcome Analysis from the Phase 2 Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma.
  Nayak, L., Standifer, N., Dietrich, J., Clarke, J. L., Dunn, G. P., Lim, M., 鈥� Reardon, D. A. (2022). Circulating Immune Cell and Outcome Analysis from the Phase 2 Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
- The Molecular Basis and Pathophysiology of Trigeminal Neuralgia.
  Chen, Q. L., Yi, D. I., Perez, J. N., Liu, M., Chang, S. D., Barad, M. J., 鈥� Qian, X. (2022). The Molecular Basis and Pathophysiology of Trigeminal Neuralgia. International Journal of Molecular Sciences, 23(7).
- Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143.
  Omuro, A., Reardon, D. A., Sampson, J. H., Baehring, J., Sahebjam, S., Cloughesy, T. F., 鈥� Lim, M. (2022). Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143. Neuro-Oncology Advances, 4(1), vdac025.
- Radiotherapy Combined With Nivolumab or Temozolomide for Newly Diagnosed Glioblastoma With Unmethylated MGMT Promoter: An International Randomized Phase 3 Trial.
  Omuro, A., Brandes, A. A., Carpentier, A. F., Idbaih, A., Reardon, D. A., Cloughesy, T., 鈥� Weller, M. (2022). Radiotherapy Combined With Nivolumab or Temozolomide for Newly Diagnosed Glioblastoma With Unmethylated MGMT Promoter: An International Randomized Phase 3 Trial. Neuro-Oncology.
- Internal neurolysis versus intraoperative glycerin rhizotomy for trigeminal neuralgia.
  Xu, R., Materi, J., Raj, D., Alomari, S., Xia, Y., Nair, S. K., 鈥� Lim, M. (2022). Internal neurolysis versus intraoperative glycerin rhizotomy for trigeminal neuralgia. Journal of Neurosurgery, 1鈥�6.
- Phase 3 Trial of Chemoradiotherapy With Temozolomide Plus Nivolumab or Placebo for Newly Diagnosed Glioblastoma With Methylated MGMT Promoter.
  Lim, M., Weller, M., Idbaih, A., Steinbach, J., Finocchiaro, G., Raval, R. R., 鈥� Omuro, A. (2022). Phase 3 Trial of Chemoradiotherapy With Temozolomide Plus Nivolumab or Placebo for Newly Diagnosed Glioblastoma With Methylated MGMT Promoter. Neuro-Oncology.
- The future of cancer immunotherapy for brain tumors: a collaborative workshop.
  Brown, C. E., Bucktrout, S., Butterfield, L. H., Futer, O., Galanis, E., Hormigo, A., 鈥� Tanner, K. (2022). The future of cancer immunotherapy for brain tumors: a collaborative workshop. Journal of Translational Medicine, 20(1), 236.
- Calcium-Related Gene Signatures May Predict Prognosis and Level of Immunosuppression in Gliomas.
  Liu, P., Li, Y., Zhang, Y., Choi, J., Zhang, J., Shang, G., 鈥� Yang, X. (2022). Calcium-Related Gene Signatures May Predict Prognosis and Level of Immunosuppression in Gliomas. Frontiers in Oncology, 12, 708272.
- Diversity within the Neurosurgical Oncology Workforce in the United States: A Cross-Sectional Study with Proposed Strategies to Pave the Path Forward.
  Asfaw, Z. K., Rodriguez, A., Hodges, T. R., Mazumdar, M., Zhan, S., Lim, M., & Germano, I. M. (2022). Diversity within the Neurosurgical Oncology Workforce in the United States: A Cross-Sectional Study with Proposed Strategies to Pave the Path Forward. Neuro-Oncology.
- The Role of Myeloid Cells in GBM Immunosuppression.
  Lin, Y.-J., Wu, C. Y.-J., Wu, J. Y., & Lim, M. (2022). The Role of Myeloid Cells in GBM Immunosuppression. Frontiers in Immunology, 13, 887781.
- Safety and cost savings associated with reduced inpatient hospitalization for microvascular decompression.
  Xu, R., Nair, S. K., Materi, J., Raj, D., Park, G., Medikonda, R., 鈥� Bettegowda, C. (2022). Safety and cost savings associated with reduced inpatient hospitalization for microvascular decompression. World Neurosurgery.
- Predictors and Impact of Postoperative 30-Day Readmission in Glioblastoma.
  Botros, D., Khalafallah, A. M., Huq, S., Dux, H., Oliveira, L. A., Pellegrino, R., 鈥� Mukherjee, D. (2022). Predictors and Impact of Postoperative 30-Day Readmission in Glioblastoma. Neurosurgery.
- Learning-based analysis of amide proton transfer-weighted MRI to identify true progression in glioma patients.
  Guo, P., Unberath, M., Heo, H.-Y., Eberhart, C. G., Lim, M., Blakeley, J. O., & Jiang, S. (2022). Learning-based analysis of amide proton transfer-weighted MRI to identify true progression in glioma patients. NeuroImage. Clinical, 35, 103121.
- Identification of the NRF2 transcriptional network as a therapeutic target for trigeminal neuropathic pain.
  Vasavda, C., Xu, R., Liew, J., Kothari, R., Dhindsa, R. S., Semenza, E. R., 鈥� Snyder, S. H. (2022). Identification of the NRF2 transcriptional network as a therapeutic target for trigeminal neuropathic pain. Science Advances, 8(31), eabo5633.
- Radiomics analysis of amide proton transfer-weighted and structural MR images for treatment response assessment in malignant gliomas.
  Jiang, S., Guo, P., Heo, H.-Y. Y., Zhang, Y., Wu, J., Jin, Y., 鈥� Blakeley, J. O. (2022). Radiomics analysis of amide proton transfer-weighted and structural MR images for treatment response assessment in malignant gliomas. NMR in Biomedicine, e4824.
- Immunometabolism, a new therapeutic development for immunotherapies of high-grade gliomas: a narrative review.
  Wu, J. Y., Ren, A. L., & Lim, M. (2022). Immunometabolism, a new therapeutic development for immunotherapies of high-grade gliomas: a narrative review. Chinese Clinical Oncology, 11(4), 26.
- A potential role for steroids in acute pain management in patients with trigeminal neuralgia.
  Xu, R., Nair, S. K., Shah, P. P., Kannapadi, N., Materi, J., Alomari, S., 鈥� Bettegowda, C. (2022). A potential role for steroids in acute pain management in patients with trigeminal neuralgia. World Neurosurgery.
- The role of preoperative MRI imaging in assessing neurovascular compression prior to microvascular decompression in trigeminal neuralgia.
  Xu, R., Nair, S. K., Raj, D., Materi, J., So, R. J., Gujar, S. K., 鈥� Bettegowda, C. (2022). The role of preoperative MRI imaging in assessing neurovascular compression prior to microvascular decompression in trigeminal neuralgia. World Neurosurgery.
- Can tumor treating fields induce DNA damage and reduce cell motility in medulloblastoma cell lines?
  Nitta, R. T., Luo, E. J., Lim, M., & Li, G. (2022). Can tumor treating fields induce DNA damage and reduce cell motility in medulloblastoma cell lines? Journal of Neurosurgery. Pediatrics, 1鈥�12.
- GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma
  Cloughesy, T. F., Alexander, B. M., Berry, D. A., Colman, H., De Groot, J. F., Ellingson, B. M., 鈥� Yung, W. K. A. (2022). GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- Updates in intraoperative strategies for enhancing intra-axial brain tumor control.
  Wu, A., Wu, J. Y., & Lim, M. (2022). Updates in intraoperative strategies for enhancing intra-axial brain tumor control. Neuro-Oncology, 24(Supplement_6), S33鈥揝41.
- PROTEASOME REARRANGED PEPTIDES ARE A NOVEL SOURCE OF ANTIGENS FOR THE PEPTIDE VACCINE IMMUNOTHERAPY OF GLIOBLASTOMAS
  Fidanza, M., Gupta, P., Shanker, V., Wong, N., Skirboll, S., Lim, M., & Wong, A. (2022). PROTEASOME REARRANGED PEPTIDES ARE A NOVEL SOURCE OF ANTIGENS FOR THE PEPTIDE VACCINE IMMUNOTHERAPY OF GLIOBLASTOMAS. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- SINGLE-STAGE RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF BRAIN TUMORS WITH SKULL INVASION
  Ben-Shalom, N., Anthony, A., Micah, B., Harnof, S., Huang, J., Lim, M., 鈥� Gordon, C. (2022). SINGLE-STAGE RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF BRAIN TUMORS WITH SKULL INVASION. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA.
  Buxton, M., Alexander, B., Berry, D., Cavenee, W., Colman, H., de Groot, J., 鈥� Cloughesy, T. (2022). UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- Advances in co-opting anti-depressant drugs in glioma therapy.
  Pant, A., & Lim, M. (2022). Advances in co-opting anti-depressant drugs in glioma therapy. Cell Reports. Medicine, 3(12), 100837.
- Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors.
  Medikonda, R., Pant, A., & Lim, M. (2023). Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors. Advances in Experimental Medicine and Biology, 1394, 73鈥�84.
- A Case Series of Trigeminal Neuralgia With Pure Venous Compression: Postoperative Outcomes Associated With Intraoperative Venous Transposition Versus Coagulation.
  So, R. J., Kalluri, A. L., Materi, J., Nair, S. K., Lim, M., Huang, J., 鈥� Xu, R. (2022). A Case Series of Trigeminal Neuralgia With Pure Venous Compression: Postoperative Outcomes Associated With Intraoperative Venous Transposition Versus Coagulation. Operative Neurosurgery (Hagerstown, Md.).
- Factors Predicting Cerebrospinal Fluid Leaks in Microvascular Decompressions: A Case Series of 1011 Patients.
  Xu, R., So, R. J., Materi, J., Nair, S. K., Alomari, S. O., Huang, J., 鈥� Bettegowda, C. (2022). Factors Predicting Cerebrospinal Fluid Leaks in Microvascular Decompressions: A Case Series of 1011 Patients. Operative Neurosurgery (Hagerstown, Md.).
- Multiple Vessel Compression of the Trigeminal Nerve Is Associated With Worse Outcomes in Trigeminal Neuralgia After Microvascular Decompression.
  So, R. J., Kalluri, A. L., Zhu, S., Materi, J., Nair, S. K., Lim, M., 鈥� Xu, R. (2022). Multiple Vessel Compression of the Trigeminal Nerve Is Associated With Worse Outcomes in Trigeminal Neuralgia After Microvascular Decompression. Neurosurgery.
- A racial analysis of pain outcomes following microvascular decompression for trigeminal neuralgia.
  So, R. J., Kalluri, A. L., Storm, K., Nair, S. K., Budihal, B. R., Huang, J., 鈥� Xu, R. (2023). A racial analysis of pain outcomes following microvascular decompression for trigeminal neuralgia. Journal of Neurosurgery, 1鈥�7.
- PP2Ac/STRN4 negatively regulates STING-Type I interferon signaling in tumor associated macrophages.
  Ho, W. S., Mondal, I., Xu, B., Das, O., Sun, R. C., Chiou, P., 鈥� Lu, R. O. (2023). PP2Ac/STRN4 negatively regulates STING-Type I interferon signaling in tumor associated macrophages. The Journal of Clinical Investigation.
- The Tumor Immune Microenvironment in Primary CNS Neoplasms: A Review of Current Knowledge and Therapeutic Approaches.
  Kalluri, A. L., Shah, P. P., & Lim, M. (2023). The Tumor Immune Microenvironment in Primary CNS Neoplasms: A Review of Current Knowledge and Therapeutic Approaches. International Journal of Molecular Sciences, 24(3).
- Sex-specific pain outcomes following microvascular decompression for trigeminal neuralgia.
  Kilgore, C. B., So, R. J., Storm, K., Nair, S. K., Ran, K. R., Kalluri, A. L., 鈥� Xu, R. (2023). Sex-specific pain outcomes following microvascular decompression for trigeminal neuralgia. World Neurosurgery.
- CAR-T Therapy in GBM: Current Challenges and Avenues for Improvement.
  Pant, A., & Lim, M. (2023). CAR-T Therapy in GBM: Current Challenges and Avenues for Improvement. Cancers, 15(4).
- Outcomes after microvascular decompression for sole arterial versus venous compression in trigeminal neuralgia.
  Nair, S. K., Xie, M. E., Ran, K., Kalluri, A., Kilgore, C., Huang, J., 鈥� Xu, R. (2023). Outcomes after microvascular decompression for sole arterial versus venous compression in trigeminal neuralgia. World Neurosurgery.
- Response
  Xu, R., Nair, S. K., Bettegowda, C., & Lim, M. (2023). Response. JOURNAL OF NEUROSURGERY, 138(1), 295.
- Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants.
  Ta茂eb, D., Wanna, G. B., Ahmad, M., Lussey-Lepoutre, C., Perrier, N. D., N枚lting, S., 鈥� Pacak, K. (2023). Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants. The Lancet. Diabetes & Endocrinology.
- Tumor inflammation-associated neurotoxicity.
  Mahdi, J., Dietrich, J., Straathof, K., Roddie, C., Scott, B. J., Davidson, T. B., 鈥� Monje, M. (2023). Tumor inflammation-associated neurotoxicity. Nature Medicine.
- Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T听cell master regulators.
  Obradovic, A., Ager, C., Turunen, M., Nirschl, T., Khosravi-Maharlooei, M., Iuga, A., 鈥� Califano, A. (2023). Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T听cell master regulators. Cancer Cell.
- Sequential onset of bilateral trigeminal neuralgia: clinical presentation and outcomes.
  Xu, R., So, R. J., Lee, K. K., Kalluri, A. L., Materi, J., Nair, S. K., 鈥� Bettegowda, C. (2023). Sequential onset of bilateral trigeminal neuralgia: clinical presentation and outcomes. Clinical Neurology and Neurosurgery, 229, 107745.
- Advancing combination therapy for recurrent glioblastoma.
  Wu, A., & Lim, M. (2023). Advancing combination therapy for recurrent glioblastoma. Nature Medicine.
- Use of tubular retractors to access deep brain lesions: A case series.
  Rakovec, M., Camp, S., Day, D., Chakravarti, S., Parker, M., Porras, J. L., 鈥� Mukherjee, D. (2023). Use of tubular retractors to access deep brain lesions: A case series. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia, 114, 64鈥�69.
- Translational Models in Glioma Immunotherapy Research.
  Ren, A. L., Wu, J. Y., Lee, S. Y., & Lim, M. (2023). Translational Models in Glioma Immunotherapy Research. Current Oncology (Toronto, Ont.), 30(6), 5704鈥�5718.
- A Case Series of Stereotactic Radiosurgery First for Trigeminal Neuralgia: A History of Stereotactic Radiosurgery Does Not Complicate Microvascular Decompression.
  Nair, S. K., Xie, M. E., Ran, K., Kalluri, A., Kilgore, C., Halbert-Elliott, K., 鈥� Xu, R. (2023). A Case Series of Stereotactic Radiosurgery First for Trigeminal Neuralgia: A History of Stereotactic Radiosurgery Does Not Complicate Microvascular Decompression. Operative Neurosurgery (Hagerstown, Md.).
- Management outcomes of peripontine arteriovenous malformation patients presenting with trigeminal neuralgia.
  Yang, W., Sattari, S. A., Feghali, J., Hung, A., Chen, Y., Xu, R., 鈥� Huang, J. (2023). Management outcomes of peripontine arteriovenous malformation patients presenting with trigeminal neuralgia. Journal of Neurosurgery, 1鈥�7.
- Correcting the drug development paradigm for glioblastoma requires serial tissue sampling.
  Singh, K., Hotchkiss, K. M., Parney, I. F., De Groot, J., Sahebjam, S., Sanai, N., 鈥� Khasraw, M. (2023). Correcting the drug development paradigm for glioblastoma requires serial tissue sampling. Nature Medicine.
- Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid.
  Douville, C., Curtis, S., Summers, M., Azad, T. D., Rincon-Torroella, J., Wang, Y., 鈥� Bettegowda, C. (2023). Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid. Cell Reports. Medicine, 101148.
- TUMOR INFLAMMATION-ASSOCIATED NEUROTOXICITY (TIAN): A TOXICITY SYNDROME IN PATIENTS TREATED WITH IMMUNOTHERAPY FOR CENTRAL NERVOUS SYSTEM TUMORS
  Mahdi, J., Dietrich, J., Straathof, K., Roddie, C., Scott, B., Davidson, T. B., 鈥� Monje, M. (2023). TUMOR INFLAMMATION-ASSOCIATED NEUROTOXICITY (TIAN): A TOXICITY SYNDROME IN PATIENTS TREATED WITH IMMUNOTHERAPY FOR CENTRAL NERVOUS SYSTEM TUMORS. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- Stereotactic Radiosurgery for Medically Refractory Trigeminal Neuralgia Secondary to Stroke: A Systematic Review and Clinical Case Presentation.
  Zamarud, A., Park, D. J., Ung, T. H., McCleary, T.-L. L., Yoo, K. H., Soltys, S. G., 鈥� Meola, A. (2023). Stereotactic Radiosurgery for Medically Refractory Trigeminal Neuralgia Secondary to Stroke: A Systematic Review and Clinical Case Presentation. World Neurosurgery.
- Optimizing the synergy between stereotactic radiosurgery and immunotherapy for brain metastases.
  Yoo, K. H., Park, D. J., Choi, J. H., Marianayagam, N. J., Lim, M., Meola, A., & Chang, S. D. (2023). Optimizing the synergy between stereotactic radiosurgery and immunotherapy for brain metastases. Frontiers in Oncology, 13, 1223599.
- Overcoming EGFR inhibitor resistance in Glioblastoma by targeting co-amplified genes.
  Pant, A., & Lim, M. (2023). Overcoming EGFR inhibitor resistance in Glioblastoma by targeting co-amplified genes. Proceedings of the National Academy of Sciences of the United States of America, 120(38), e2312277120.
- The role of multiple sclerosis subtype in microvascular decompression outcomes for patients with trigeminal neuralgia.
  Kalluri, A. L., So, R. J., Nair, S. K., Materi, J., Wang, D., Behera, N., 鈥� Xu, R. (2023). The role of multiple sclerosis subtype in microvascular decompression outcomes for patients with trigeminal neuralgia. Clinical Neurology and Neurosurgery, 233, 107967.
- Frailty predicts worse pain outcomes for older TN patients treated with microvascular decompression.
  Kilgore, C. B., Kalluri, A. L., Nair, S. K., Halbert-Elliot, K. M., Ejimogu, E., Dong, B., 鈥� Xu, R. (2023). Frailty predicts worse pain outcomes for older TN patients treated with microvascular decompression. World Neurosurgery.
- Proteomic Analysis to Identify Prospective Biomarkers of Treatment Outcome After Microvascular Decompression for Trigeminal Neuralgia: A Preliminary Study.
  Doshi, T. L., Dorsey, S. G., Huang, W., Kane, M. A., & Lim, M. (2023). Proteomic Analysis to Identify Prospective Biomarkers of Treatment Outcome After Microvascular Decompression for Trigeminal Neuralgia: A Preliminary Study. The Journal of Pain.
- The influence of prior percutaneous rhizotomy on outcomes following microvascular decompression for trigeminal neuralgia.
  Nair, S. K., Xie, M. E., Kalluri, A., Ran, K., Kilgore, C., Halbert-Elliott, K., 鈥� Xu, R. (2023). The influence of prior percutaneous rhizotomy on outcomes following microvascular decompression for trigeminal neuralgia. Journal of Neurosurgery, 1鈥�5.
- The pathophysiology of trigeminal neuralgia: a molecular review.
  Dong, B., Xu, R., & Lim, M. (2023). The pathophysiology of trigeminal neuralgia: a molecular review. Journal of Neurosurgery, 139(5), 1471鈥�1479.
- Neurovascular Compression in Patients With Trigeminal Neuralgia May Be Associated With Worse Outcomes After Primary Percutaneous Rhizotomy.
  Nair, S. K., Al-Khars, H., Kalluri, A., Ran, K., Kilgore, C., Budihal, B. R., 鈥� Xu, R. (2023). Neurovascular Compression in Patients With Trigeminal Neuralgia May Be Associated With Worse Outcomes After Primary Percutaneous Rhizotomy. Neurosurgery.
- Soluble PD-L1 reprograms blood monocytes to prevent cerebral edema and facilitate recovery after ischemic stroke.
  Kim, J. E., Lee, R. P., Yazigi, E., Atta, L., Feghali, J., Pant, A., 鈥� Jackson, C. M. (2023). Soluble PD-L1 reprograms blood monocytes to prevent cerebral edema and facilitate recovery after ischemic stroke. Brain, Behavior, and Immunity.
- Stanford University School of Medicine: Our Neurosurgical Heritage.
  Veeravagu, A., Kim, L. H., Rao, V. L., Lim, M., Shuer, L. M., Harris, O. A., & Steinberg, G. K. (2023). Stanford University School of Medicine: Our Neurosurgical Heritage. Neurosurgery.
- Adult neuro-oncology trials in the United States over 5 decades: Analysis of trials completion rate to guide the path forward.
  Smith, E. J., Naik, A., Goel, M., Wen, P. Y., Lim, M., Chang, S. M., & Germano, I. M. (2024). Adult neuro-oncology trials in the United States over 5 decades: Analysis of trials completion rate to guide the path forward. Neuro-Oncology Advances, 6(1), vdad169.
- ADULT NEURO-ONCOLOGY TRIAL LANDSCAPE IN THE UNITED STATES OVER FIVE DECADES
  Smith, E., Naik, A., Goel, M., Wen, P., Lim, M., Chang, S., & Germano, I. (2023). ADULT NEURO-ONCOLOGY TRIAL LANDSCAPE IN THE UNITED STATES OVER FIVE DECADES. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- MITOCHONDRIAL ATP BIOGENESIS REGULATED BY VDAC1 IN TMEM119+TUMOR-ASSOCIATED MICROGLIA AND MACROPHAGES MEDIATES HIGH-GRADE GLIOMA GROWTH
  Wu, C., Chen, Y., Lin, Y.-J., Wei, K.-C., Chang, K.-Y., Feng, L.-Y., 鈥� Lim, M. (2023). MITOCHONDRIAL ATP BIOGENESIS REGULATED BY VDAC1 IN TMEM119+TUMOR-ASSOCIATED MICROGLIA AND MACROPHAGES MEDIATES HIGH-GRADE GLIOMA GROWTH. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- A RANDOMIZED WINDOW OF OPPORTUNITY TRIAL WITH DOSE ESCALATION TO EVALUATE FLUOXETINE AND TEMOZOLOMIDE IN GLIOMA
  Singh, K., Railton, C., Hotchkiss, K., Herndon, J., Peters, K., Friedman, H., 鈥� Khasraw, M. (2023). A RANDOMIZED WINDOW OF OPPORTUNITY TRIAL WITH DOSE ESCALATION TO EVALUATE FLUOXETINE AND TEMOZOLOMIDE IN GLIOMA. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB
  Wen, P., Alexander, B., Berry, D., Buxton, M., Cavenee, W., Colman, H., 鈥� Lassman, A. (2023). GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- LONG TERM FOLLOW-UP OF A PROSPECTIVE SAFETY AND TOXICITY STUDY OF IMMUNE CHECKPOINT INHIBITOR THERAPY INITIATED 8 DAYS PRIOR TO RADIOSURGERY FOR MELANOMA BRAIN OR SPINE METASTASIS
  Kleinberg, L., Ye, X., Sharfman, W., Jackson, C., Redmond, K., Bettegowda, C., 鈥� Lim, M. (2023). LONG TERM FOLLOW-UP OF A PROSPECTIVE SAFETY AND TOXICITY STUDY OF IMMUNE CHECKPOINT INHIBITOR THERAPY INITIATED 8 DAYS PRIOR TO RADIOSURGERY FOR MELANOMA BRAIN OR SPINE METASTASIS. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- Preoperative Opioid Use and Postoperative Outcomes in Patients Undergoing Microvascular Decompression for Trigeminal Neuralgia.
  Kalluri, A. L., Ejimogu, E., Kilgore, C., Nair, S. K., Ran, K. R., Abdulrahim, M., 鈥� Xu, R. (2024). Preoperative Opioid Use and Postoperative Outcomes in Patients Undergoing Microvascular Decompression for Trigeminal Neuralgia. Neurosurgery.
- Intra- and post-pandemic impact of the COVID-19 outbreak on 蓝莓视频.
  Phongpreecha, T., Berson, E., Xue, L., Shome, S., Saarunya, G., Fralick, J., 鈥� Kerr, A. (2024). Intra- and post-pandemic impact of the COVID-19 outbreak on 蓝莓视频. Academic Pathology, 11(2), 100113.
- CCR2 and CCR5 co-inhibition modulates immunosuppressive myeloid milieu in glioma and synergizes with anti-PD-1 therapy.
  Pant, A., Hwa-Lin Bergsneider, B., Srivastava, S., Kim, T., Jain, A., Bom, S., 鈥� Lim, M. (2024). CCR2 and CCR5 co-inhibition modulates immunosuppressive myeloid milieu in glioma and synergizes with anti-PD-1 therapy. Oncoimmunology, 13(1), 2338965.
- External assessment of preoperative scores for predicting outcome after microvascular decompression for trigeminal neuralgia.
  Xie, M. E., Halbert-Elliott, K., Nair, S. K., Jun, J., Dong, B. C., Ran, K. R., 鈥� Xu, R. (2024). External assessment of preoperative scores for predicting outcome after microvascular decompression for trigeminal neuralgia. Journal of Neurosurgery, 1鈥�7.
- Glioma.
  Weller, M., Wen, P. Y., Chang, S. M., Dirven, L., Lim, M., Monje, M., & Reifenberger, G. (2024). Glioma. Nature Reviews. Disease Primers, 10(1), 33.
- A history of stereotactic radiosurgery may predict failure of procedure following percutaneous glycerol rhizotomy for trigeminal neuralgia.
  Nair, S. K., Oh, H. J., Kalluri, A., Ejimogu, N.-E. E., Al-Khars, H., Abdulrahim, M., 鈥� Xu, R. (2024). A history of stereotactic radiosurgery may predict failure of procedure following percutaneous glycerol rhizotomy for trigeminal neuralgia. Neurosurgical Review, 47(1), 289.
- Repeat percutaneous rhizotomy for trigeminal neuralgia is not associated with an increased risk of postoperative complications.
  Nair, S. K., Kalluri, A., Ejimogu, N.-E. E., Reddy, S. C., Tantry, D., Wang, X., 鈥� Xu, R. (2024). Repeat percutaneous rhizotomy for trigeminal neuralgia is not associated with an increased risk of postoperative complications. Clinical Neurology and Neurosurgery, 245, 108466.
- The cytokine Meteorin-like inhibits anti-tumor CD8+ T听cell responses by disrupting mitochondrial function.
  Jackson, C. M., Pant, A., Dinalankara, W., Choi, J., Jain, A., Nitta, R., 鈥� Lim, M. (2024). The cytokine Meteorin-like inhibits anti-tumor CD8+ T听cell responses by disrupting mitochondrial function. Immunity.
- The CCR6-CCL20 axis promotes regulatory T cell glycolysis and immunosuppression in tumors.
  Pant, A., Jain, A., Chen, Y., Patel, K., Saleh, L., Tzeng, S., 鈥� Jackson, C. M. (2024). The CCR6-CCL20 axis promotes regulatory T cell glycolysis and immunosuppression in tumors. Cancer Immunology Research.
- Evaluation of VAL-083 in GBM AGILE, a phase 3 registration platform trial for newly diagnosed and recurrent glioblastoma.
  De Groot, J. F., Cloughesy, T. F., Berry, D. A., Buxton, M. B., Colman, H., Ellingson, B. M., 鈥� Perry, J. R. (2024). Evaluation of VAL-083 in GBM AGILE, a phase 3 registration platform trial for newly diagnosed and recurrent glioblastoma. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- TUMOR INFLAMMATION-ASSOCIATED NEUROTOXICITY (TIAN): A TOXICITY SYNDROME IN PATIENTS TREATED WITH IMMUNOTHERAPY FOR CENTRAL NERVOUS SYSTEM TUMORS
  Mahdi, J., Dietrich, J., Straathof, K., Roddie, C., Scott, B. J., Davidson, T. B., 鈥� Monje, M. (2024). TUMOR INFLAMMATION-ASSOCIATED NEUROTOXICITY (TIAN): A TOXICITY SYNDROME IN PATIENTS TREATED WITH IMMUNOTHERAPY FOR CENTRAL NERVOUS SYSTEM TUMORS. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- Radiation immunodynamics in patients with glioblastoma receiving chemoradiation.
  Sloan, L., Sen, R., Liu, C., Doucet, M., Blosser, L., Katulis, L., 鈥� Kleinberg, L. R. (2024). Radiation immunodynamics in patients with glioblastoma receiving chemoradiation. Frontiers in Immunology, 15, 1438044.
- Outcomes of Management of Progressive Radiosurgery-Treated Brain Metastasis With Resection Followed by Pathology-Informed Management: A Retrospective Study
  Bhatia, R. K., George, J., Siu, C., Lee, E., Redmond, K. J., Baker, B., 鈥� Kleinberg, L. (2024). Outcomes of Management of Progressive Radiosurgery-Treated Brain Metastasis With Resection Followed by Pathology-Informed Management: A Retrospective Study. NEUROSURGERY PRACTICE, 5(4).
- The landscape of immune checkpoint inhibitor clinical trials in glioblastoma: A systematic review.
  Schonfeld, E., Choi, J., Tran, A., Kim, L. H., & Lim, M. (2024). The landscape of immune checkpoint inhibitor clinical trials in glioblastoma: A systematic review. Neuro-Oncology Advances, 6(1), vdae174.
- Tumor-Associated Microglia Secrete Extracellular ATP to Support Glioblastoma Progression.
  Wu, C. Y.-J., Chen, Y., Lin, Y.-J. J., Wei, K.-C. C., Chang, K.-Y. Y., Feng, L.-Y. Y., 鈥� Lim, M. (2024). Tumor-Associated Microglia Secrete Extracellular ATP to Support Glioblastoma Progression. Cancer Research, 84(23), 4017鈥�4030.
- EVALUATION OF PAXALISIB IN GBM AGILE PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA
  Mellinghoff, I. K., Cloughesy, T., Alexander, B., Berry, D. A., Buxton, M., Cavenee, W., 鈥� Lee, E. (2024). EVALUATION OF PAXALISIB IN GBM AGILE PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- TRENDS IN LOW GRADE GLIOMA PROGNOSIS AND THE EVOLVING IMPACT OF GROSS TOTAL RESECTION ACROSS FIFTY YEARS: A MULTICOHORT ANALYSIS
  Jin, M., Young, J., Umbach, G., Ravi, K., Lim, M., & Hervey-Jumper, S. (2024). TRENDS IN LOW GRADE GLIOMA PROGNOSIS AND THE EVOLVING IMPACT OF GROSS TOTAL RESECTION ACROSS FIFTY YEARS: A MULTICOHORT ANALYSIS. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA
  Lassman, A., Alexander, B., Berry, D., Berry, N., Buxton, M., Colman, H., 鈥� Cloughesy, T. (2024). UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- REPROGRAMMING OF MYELOID CELL METABOLISM VIA HEME OXYGENASE-1 INHIBITION POTENTIATES ANTI-TUMOR IMMUNITY IN A MURINE GLIOMA MODEL
  Kim, L., Choi, J., Nitta, R., Pant, A., Schonfeld, E., Li, G., 鈥� Lim, M. (2024). REPROGRAMMING OF MYELOID CELL METABOLISM VIA HEME OXYGENASE-1 INHIBITION POTENTIATES ANTI-TUMOR IMMUNITY IN A MURINE GLIOMA MODEL. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- INFIGRATINIB INHIBITION OF THE THBS1 PATHWAY IN MELANOMA BRAIN METASTASIS
  Tran, A., Choi, J., Bergsneider, B., Kim, L., Schonfeld, E., Abikenari, M., 鈥� Lim, M. (2024). INFIGRATINIB INHIBITION OF THE THBS1 PATHWAY IN MELANOMA BRAIN METASTASIS. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- Distinct myeloid-derived suppressor cell populations in human glioblastoma.
  Jackson, C., Cherry, C., Bom, S., Dykema, A. G., Wang, R., Thompson, E., 鈥� Pardoll, D. (2025). Distinct myeloid-derived suppressor cell populations in human glioblastoma. Science (New York, N.Y.), 387(6731), eabm5214.
- Effects of the length of preoperative conservative management on postoperative outcomes after primary microvascular decompression for trigeminal neuralgia.
  Kalluri, A. L., Ejimogu, E., Chandan Reddy, S., Nair, S. K., Alkhars, H., Kilgore, C., 鈥� Xu, R. (2025). Effects of the length of preoperative conservative management on postoperative outcomes after primary microvascular decompression for trigeminal neuralgia. Journal of Neurosurgery, 1鈥�8.
- Outcomes of Management of Progressive Radiosurgery-Treated Brain Metastasis With Resection Followed by Pathology-Informed Management: A Retrospective Study.
  Bhatia, R. K., George, J., Siu, C., Lee, E., Redmond, K. J., Baker, B., 鈥� Kleinberg, L. (2024). Outcomes of Management of Progressive Radiosurgery-Treated Brain Metastasis With Resection Followed by Pathology-Informed Management: A Retrospective Study. Neurosurgery Practice, 5(4), e00117.
- Effects of diagnosed depression on postoperative outcomes after microvascular decompression for patients with trigeminal neuralgia.
  Kalluri, A. L., Ejimogu, E., Reddy, S. C., Wang, E., Nair, S. K., Kilgore, C., 鈥� Xu, R. (2025). Effects of diagnosed depression on postoperative outcomes after microvascular decompression for patients with trigeminal neuralgia. Clinical Neurology and Neurosurgery, 250, 108733.
- Molecular-based decision-making in glioblastoma surgery: when to aim for supramaximal resection.
  Drexler, R., Lim, M., & Hervey-Jumper, S. L. (2025). Molecular-based decision-making in glioblastoma surgery: when to aim for supramaximal resection. Neuro-Oncology.
- Deep learning-based segmentation of the trigeminal nerve and surrounding vasculature in trigeminal neuralgia.
  Halbert-Elliott, K. M., Xie, M. E., Dong, B., Das, O., Wang, X., Jackson, C. M., 鈥� Xu, R. (2025). Deep learning-based segmentation of the trigeminal nerve and surrounding vasculature in trigeminal neuralgia. Journal of Neurosurgery, 1鈥�9.
- Nervus intermedius sectioning for the treatment of geniculate neuralgia.
  Ren, A. L., Ehsani, A., Park, D. J., Persad, A. R., Wu, J. Y., Hall, J. C., 鈥� Lim, M. (2025). Nervus intermedius sectioning for the treatment of geniculate neuralgia. Journal of Neurosurgery, 1鈥�8.
- Detection of brain cancer using genome-wide cell-free DNA fragmentomes.
  Mathios, D., Niknafs, N., Annapragada, A. V., Bobeff, E. J., Chiao, E. J., Boyapati, K., 鈥� Velculescu, V. E. (2025). Detection of brain cancer using genome-wide cell-free DNA fragmentomes. Cancer Discovery.
- Complex neural-immune interactions shape glioma immunotherapy.
  Song, K.-W. W., Lim, M., & Monje, M. (2025). Complex neural-immune interactions shape glioma immunotherapy. Immunity.
- Integrated management of metastatic spinal tumors: current status and future directions.
  Kim, M. J., Marianayagam, N. J., Chandra, A., Ranalli, C., Schonfeld, E., Avila-Madrigal, J. P., 鈥� Veeravagu, A. (2025). Integrated management of metastatic spinal tumors: current status and future directions. Medical Oncology (Northwood, London, England), 42(6), 210.
- The hormonal nexus in PIK3CA-mutated meningiomas: implications for targeted therapy and clinical trial design.
  Abikenari, M., Regev, A., Himic, V., Choi, J., Jeyaretna, S., Fountain, D. M., & Lim, M. (2025). The hormonal nexus in PIK3CA-mutated meningiomas: implications for targeted therapy and clinical trial design. Journal of Neuro-Oncology.
- Top advances of the year: The status of chimeric antigen receptor T cells in neuro-oncology.
  Medikonda, R., Abikenari, M. A., Schonfeld, E., & Lim, M. (2025). Top advances of the year: The status of chimeric antigen receptor T cells in neuro-oncology. Cancer, 131(12), e35935.
- BRAF/MEK inhibition induces cell state transitions boosting immune checkpoint sensitivity in BRAFV600E-mutant glioma.
  Xing, Y. L., Panovska, D., Park, J.-W. W., Grossauer, S., Koeck, K., Bui, B., 鈥� Petritsch, C. K. (2025). BRAF/MEK inhibition induces cell state transitions boosting immune checkpoint sensitivity in BRAFV600E-mutant glioma. Cell Reports. Medicine, 102183.
- The Metabolic Orchestration of Immune Evasion in Glioblastoma: From Molecular Perspectives to Therapeutic Vulnerabilities.
  Medikonda, R., Abikenari, M., Schonfeld, E., & Lim, M. (2025). The Metabolic Orchestration of Immune Evasion in Glioblastoma: From Molecular Perspectives to Therapeutic Vulnerabilities. Cancers, 17(11).
- A phase 1 study of B7H3 CAR-T cells administered intracranially in recurrent glioblastoma.
  Li, G., Stocksdale, B. R., Song, K.-W., Mahdi, J., Tanner, K., Bertrand, S., 鈥� Thomas, R. P. (2025). A phase 1 study of B7H3 CAR-T cells administered intracranially in recurrent glioblastoma. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- Update on GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma.
  Hyddmark, E. M. V., Berry, D. A., Berry, N. S., Colman, H., de Groot, J. F., Ellingson, B. M., 鈥� Cloughesy, T. F. (2025). Update on GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- Impact of sociodemographic factors and Medicaid expansion on postoperative outcomes for glioblastoma, 2004-2021
  Jain, B., Patel, P., Ruiz Colon, G. D., Kim, L. H., Choi, J., Dee, E. C., 鈥� Lim, M. (2025). Impact of sociodemographic factors and Medicaid expansion on postoperative outcomes for glioblastoma, 2004-2021. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- Emerging trends in cell-based therapies: contemporary advances and ethical considerations in translational neurosurgical oncology.
  Abikenari, M., Liu, J., Ha, J. H., Annagiri, S., Himic, V., Medikonda, R., 鈥� Lim, M. (2025). Emerging trends in cell-based therapies: contemporary advances and ethical considerations in translational neurosurgical oncology. Journal of Neuro-Oncology.
- Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions.
  Wen, P. Y., Weller, M., Lee, E. Q., Touat, M., Khasraw, M., Rahman, R., 鈥� Preusser, M. (2025). Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions. Neuro-Oncology.
- Revealing the suppressors: A new PET imaging approach for detecting MDSCs before and after immunotherapy in a model of brain metastases
  Kuo, R., Verma, R., Reyes, S., Nagy, S., Kalita, M., D'moore, D., 鈥� James, M. (2025). Revealing the suppressors: A new PET imaging approach for detecting MDSCs before and after immunotherapy in a model of brain metastases. JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC.
- Detection of human brain cancers using genomic and immune cell characterization of cerebrospinal fluid through CSF-BAM.
  Pearlman, A. H., Wang, Y., Kalluri, A., Parker, M., Cohen, J. D., Dudley, J., 鈥� Bettegowda, C. (2025). Detection of human brain cancers using genomic and immune cell characterization of cerebrospinal fluid through CSF-BAM. Cancer Discovery.
- Spatially Encoded Oncogenesis and Transcriptional Plasticity in Meningioma: Drivers of Therapeutic Resistance and Opportunities for Targeted Intervention.
  Abikenari, M. A., Regev, A., Bergsneider, B. H., Himic, V., Annagiri, S., Kim, L. H., 鈥� Lim, M. (2025). Spatially Encoded Oncogenesis and Transcriptional Plasticity in Meningioma: Drivers of Therapeutic Resistance and Opportunities for Targeted Intervention. Cancers, 17(16).
- Radiofrequency thermocoagulation with glycerin rhizotomy compared with glycerin rhizotomy alone for pain improvement in repeat rhizotomy.
  Chandan Reddy, S., Seebald, M., Nair, S. K., Kalluri, A., Ejimogu, E., Tantry, D., 鈥� Xu, R. (2025). Radiofrequency thermocoagulation with glycerin rhizotomy compared with glycerin rhizotomy alone for pain improvement in repeat rhizotomy. Neurosurgical Focus, 59(3), E10.
- The association of frailty with worse pain outcomes in older patients with trigeminal neuralgia treated using primary percutaneous glycerin rhizotomy.
  Chandan Reddy, S., Nair, S. K., Tantry, D., Kalluri, A., Ejimogu, E., Al-Khars, H., 鈥� Xu, R. (2025). The association of frailty with worse pain outcomes in older patients with trigeminal neuralgia treated using primary percutaneous glycerin rhizotomy. Neurosurgical Focus, 59(3), E9.
- Impact of preoperative medical management on postoperative outcomes after index percutaneous rhizotomy for trigeminal neuralgia.
  Parker, M., Xia, Y., Alfonzo Horowitz, M., Raj, D., Myneni, S., Ahmadi, S., 鈥� Bettegowda, C. (2025). Impact of preoperative medical management on postoperative outcomes after index percutaneous rhizotomy for trigeminal neuralgia. Neurosurgical Focus, 59(3), E8.

View More Publications

Clinical Trials

Clinical trials are 蓝莓视频 studies that evaluate a new medical approach, device, drug, or other treatment. As a 蓝莓视频 patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

Practice Locations

Facial Pain Program at the Neuroscience Health Center Palo Alto, CA

Palo Alto, CA

Facial Pain Program at the Neuroscience Health Center

213 Quarry Rd

Palo Alto , CA 94304

(650) 497-7777

More Clinic Information

Brain and Spine Tumor Center at Stanford Neuroscience Health Center Palo Alto, CA

Palo Alto, CA

蓝莓视频, 蓝莓视频 Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by 蓝莓视频, 蓝莓视频 Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of 蓝莓视频, 蓝莓视频 Tri- Valley, or Stanford Medicine Partners. 蓝莓视频, 蓝莓视频 Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.

Patient Ratings

(73 Ratings)

Overall Rating

4.8/5

View Ratings by Category

4.8/5

Friendliness

4.8/5

Explanations

4.8/5

Listens

4.8/5

Care provider's efforts to include you in decisions about your care

4.8/5

Recommended to others

How Our Ratings Work

The Patients Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.

Patient Satisfaction Survey Disclaimer

Patient Reviews

(214 reviews)

Dr. Lim gave great advice on the current diagnosis I'm experiencing. He was direct and straight to the point with compassion. His experience shows with the detail in the answers given!

Jun 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

I'm grateful to be in his care

Jun 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

If i decide to have the procedure, Dr Lime will be the only one that i trust to do it for me

Jun 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Excellent

Jun 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He is very polite and is going to direct me to a group that can help further.

May 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr Lim is easy to talk to. I like that he shows MRI images and explains clearly what I am seeing. I always enjoy our visits and feel reassured about my condition.

May 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Answered all our questions thoroughly, and was patient with us. He presented his information in a clear manner.

May 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Thank you, Dr. Lim, for your clear and reassuring manner. Thank you for listening to my concerns and offering support in the future when needed.

May 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He has a very good deminer, listens first then speaks, very professional and knowledgeable.

May 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Nothing as he is very professional

May 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

I wish I had seen Dr. Lim four or five years ago when I first had the nerve problem. It was a long journey to find relief!

Apr 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Very kind doctor

Apr 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Michael Lim is a special doctor/person for me and my family since he was my neurosurgeon and did all my cranioplasty surgeries. He was very good at explaining the procedure that needs to be performed and putting me at ease so I won芒鈧劉t have any issues or apprehensions on all my operations and gave me hope in what my future will be like during my recovery that helped me recover faster and restore my health.

Mar 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr Lim showed so much compassion and kindness towards me, and tremendous expertise during our visit. I had/have full confidence in his abilities to treat me and I feel very grateful to have had this time with him, and to know that he will care for me.

Mar 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr Lim has brought back my quality of life which I lost for over 3 years. Thank you Dr Lim.

Feb 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He is easy to talk to and clear to understand. He also inspires confidence that I芒鈧劉m in good hands especially with his spirit of optimism.

Feb 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Attentive

Feb 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

the doctor is patient and answers all my questions.

Feb 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Thank you for walking me through different options of the treatment. I appreciate your attentive listening to me. You also provided the next steps very clearly as well. Thank you Dr. Lim.

Feb 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He is very caring and I feel like he really listens and cares for my needs.

Feb 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr Lim is very thoughtful

Feb 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

I found Dr. Lim very easy to talk to, very patient and helpful. I enjoyed meeting him and consider myself fortunate to be his patient.

Feb 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Everyone was very professional and I appreciated everyone's concerns. Thanks to my referral from Dr. Terry Shimamoto here in Hawaii, I have hope something other than the status quo can be done. I appreciate the knowledge and the advancements in medical care that is offered by the staff at Stanford.

Jan 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He was very understanding, and make me feel comfortable.

Jan 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Incredible

Jan 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Very caring and humble doctor

Jan 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Excellent!!!!

Jan 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Love Dr. Lim! He is so compassionate and understanding about my diagnosis! He has an excellent bedside manner, and is an expert with my specific issue. I am so grateful for him!!! He芒鈧劉s one of a kind!

Jan 2025

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

staff and doctor were excellent

Dec 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Direct and to the point.

Dec 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

From the very first visit I had with Dr LimI knewI made the right decision to have Stanford be my choice. I will never forget Dr Lim saying to me 芒鈧撁⑩偓 thank you for letting me take of you.

Dec 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Compassionate and knowledgeable

Dec 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

neuroscience medical staff were all great!

Dec 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

I liked his direct approach and him asking me if that was okay first. He answered my questions satisfactorily. He assured me I would be in ongoing monitored care in the future. He was friendly.

Dec 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Excellent doctor and knowledgeable about Fred's Trigeminal Neuralgia

Dec 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Professional, informative, and encouraging

Dec 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He芒鈧劉s really good. So was Kelly. There was a lot of compassion in this visit and that was so refreshing and wonderful because I usually have to fight to be taken seriously or heard since I have a lot of disabilities and health issues and people can芒鈧劉t seem to believe it because I 'look healthy' on first glance. I was BELIEVED and someone finally wanted to really help.

Nov 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Very friendly, intelligent, and professional physician!

Nov 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Great

Nov 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

I felt Michael Lim is a very compassionate and caring person. He was out of the county but made time to meet with us. He was honest and clear, our questions were answered and he left me feeling hopeful and confident that my husband is going to receive the very best of care.

Nov 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Lim was very attentive to my symptoms and concerns. He gave me 3 medical procedures to solve my medical issue. He recommended the procedure he believes would give the best results to my ongoing pain. He was very informative about the pros and cons with the procedures.Was direct and informative about my medical condition.

Oct 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Extremely competent, kind, and informative.

Oct 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

I am reassured that he is extremely competent. Also impressed with his demeanor, competence, and compassion.

Oct 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

BEST NEUROLOGIST ONE COULD HAVE!!

Oct 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

I appreciated Dr. Lim's candor about how he could assist me in relieving the most volatile type of pain related to my condition. His compassion was evident in his every action. He ensured that I understood the limits of the procedures he could offer in relieving my pain. He asked questions that were straightforward and clear. He answered my own in the same manner.

Oct 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Lim has given me hope. I am so grateful to him and his team.

Oct 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He is the most incredible physician. He truly cares and makes time for his patients. I feel confident that my health is in great hands with him and his team.

Oct 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Great neurosurgeon and scientist!!

Oct 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Very caring and understanding. Very clear in his communication.

Sep 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Staff and Doctor were very personable and empathetic

Sep 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr Lim was very through to give the information

Sep 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He is a caring and extremely talented physician. I am blessed he is my doctor.

Sep 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Lim is a very compassionate doctor, as well as his nurse Ms. Jew. Very much appreciated his knowledge and expertise in this area! He芒鈧劉s given us a lot of information to think about. Thank you so much for his time!

Sep 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Extremely pleased & grateful with the care provided by Dr. Lim and Stanford Healthcare!

Aug 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Very easy to talk with, explains issues in a way that a non medical person can understand.Does not discourage follow up questions.

Aug 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

So happy to have met Dr. Lim. Appointment went beautifully.

Aug 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Lim is always compassionate, clear and caring.

Aug 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Thanks and appreciated it

Aug 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Candidly, I did not know him; so, I went online to 蓝莓视频 who he was and his background and his position at Stanford. Once I found that information, I was prepared for and very impressed with our interview.

Aug 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He is such a caring, committed, and extremely skilled doctor. He saved my quality of life, in fact he greatly improved it.

Jul 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He is very personable, professional, and knowledgeable.

Jun 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Honest, straightforward and direct.

Jun 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Lim is very caring, patient, and listens carefully.

Jun 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Very nice and got rite to it and where I needed to go next

Jun 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Lim is phenomenal. Kind, professional, and supportive. It feels nice to feel listened to by a provider.

Jun 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Thank you for monitoring my NF2 in conjunction with Dr. Stankovic. You reminded me that the brain accommodates slow growing benign meningiomas. It is unlikely we will have to do anything more about mine other than watch them. I will make an appointment to check in with you April 2025 when I have brain and spine MRI's to observe status of the acoustic neuroma, Cyber Knifed in March 2023, and the meningiomas. Thank you.

May 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr Lim is very attentive and direct which I appreciate

May 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr.Lim has a wealth of experience in the field of Trigeminal Neuralgia. Grateful Stanford has his expertise available and that I live within close proximity. His staff are very knowledgeable, offering suggestions and explanations as to why I芒鈧劉m experiencing certain effects after surgery.

May 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Always a pleasure to get to see and discuss Kim's ongoing health post surgery with Dr. Lim. He is a very compassionate person.

May 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

very knowledgeable and compassionate

May 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr Lim made me feel comfortable and not afraid of the surgery.

May 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr Lim is attentive & compassionate. He explains everything in detail, making sure everything is understood without making one feel he is talking down to them. Dr Lim listens to everything I have to say, he asks questions, and verifies I do not have any questions. When I do ask questions, he listens carefully & answers fully, verifying with me that I feel my questions are fully answered. From surgery I have some speech impairments, although cognitively fully functioning, expressing my words takes effort and time. Dr Lim was very respectful of my situation & feelings. He was patient & provided time and no pressure for me to speak and express what I needed to. Dr Lim explained my progress and reasonable expectations of healing and continued progress. He and his entire team makes me feel as though they care, I am not another name or patient, but a person who they value and want the best for. I cannot say how grateful I am for Dr Lim! Being referred to Stanford & Dr Lim was not only positive, but life changing.

Apr 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Great doctor!!

Apr 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Lim is the best!!! I always enjoy my video visits with him, it often feels like I'm catching up with an old friend. He's personable, kind, and is great at making me feel at ease.

Apr 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Excellent doctor with great skills to effectively complete my surgery with 100% success! He made me feel very comfortable and was easy to communicate with. He followed up with another request within 24 hours, exemplifying competence, efficiency and empathy. I was completely satisfied!

Mar 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Hands down the best provider and human I芒鈧劉ve ever met

Mar 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Excellent doctor.

Mar 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Very humble given his abilities. When the video call began with him, you are the only person on the planet. He answered all of our questions and left me feeling more confident about the surgery he performed.

Mar 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He was a very pleasant Doctor and explained all the different options for types of surgery.

Feb 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Very pleasant conversation

Feb 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr Lim gave me his full attention and answered all of my questions.

Feb 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Excellent provider. Very pleased with Dr. Lim and Elizabeth.

Jan 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Lim answered my questions and he was clear and concise about my issue. I am grateful for his help.

Jan 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

I am glad that Dr. Lim showed up himself at the video visit. It gave me a chance to talk to him in person instead of keeping sending messages and waiting for the reply. Thank you, Dr. Lim.

Jan 2024

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Great doctor!!

Dec 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

The doctor was very easy to talk with and kept telling my best friend and I how honored he was to be providing medical care to me.

Dec 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

From first arrival, staff were attentive & compassionate.

Dec 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Great doctor who saved my life.

Dec 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Super nice and trust worthy surgeon

Dec 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Lim is an excellent doctor what a great bedside manner

Dec 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

professional, capable, kind

Nov 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Very nice man, very professional and extremely well-versed in his specialty. He was polite and easy to talk to, and did not rush the conversation as many doctors do. Thank you, Dr. Lim.

Nov 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Excellent experience. Thank you Stanford Health and Doctor Lim.

Nov 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Everyone I met was very nice and caring.

Nov 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Excellent, intelligent, nice, and caring physician..

Nov 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Highly recommend Stanford health care. Dr. Michael Lim and NP Elizabeth Lee genuinely care for their patient and it shows as they take the time to explain process/ procedures as well as listening and answering all our questions.

Nov 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Lim and staff made me feel comfortable and cared for

Oct 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Vert good

Oct 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Very helpful and cordial

Oct 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr Lim very thorough and engaged

Oct 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He is very caring and listens and has helped me very much.

Oct 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

1st class all the way. My son is a 2009 graduate and I was pleased then. First time at the medical campus and I am more pleased than I was then.

Oct 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Lim is the epitome of professionalism. I have dealt with scores of 蓝莓视频 related to my condition.. Dr. Lim is the first to build 100% confidence and trust

Oct 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

I couldn芒鈧劉t have asked for a more expert, professional, and yet kind neurosurgeon!

Oct 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Lim, I appreciate you taking the time to meet with me virtually and address my concerns. I am incredibly grateful for you looking into my case and consulting with your colleague about my concerns. Your staff has moved very quickly at getting all the follow up appointments scheduled, which is very much appreciated. Look forward to meeting you in person soon!

Oct 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Excellent Doctor!!

Sep 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Lim is a great physician.

Sep 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Very generous, caring and talented.

Sep 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Caring, kind, attentive. Explaining upcoming surgery to me.

Sep 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Michael Lim is a terrific doctor. Perhaps the best I have encountered.

Aug 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Very informative and kind

Aug 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Prior to meeting with Dr. Michael Lim, I learned of his expertise, stellar reputation, his passion for 蓝莓视频, and commitment to his work. I knew that my husband was in very capable hands for his 3rd GBM resection. In addition to his surgical skills, I appreciate Dr. Michael LIm's kind and thorough manner of communication. When speaking Dr. Lim to our family and friends, I describe him as "The' Mr Rodgers' of Neurosurgeons." I hope this does not offend, I mean this as a compliment and hold Dr. Micheal Lim in the highest regard.

Aug 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He is the vet best of the best neurosurgeons.

Aug 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He is an amazing Dr. Kind, caring, understanding, etc. Best doctor/surgeon I've ever had!

Aug 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Not only Dr. Michael Lim is a highly skillful doctor, he also instills hopes and confidence in patients. His mannerisms are so down to earth, I am amazed that a world famous doctor could be so humble!

Aug 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Thank Dr. Lim, it's a great video visit.

Aug 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

An amazing Dr and person. Very grateful to have had the opportunity to speak w him.

Aug 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr Lim explained my condition as well as treatment options very well. He was very personable. I felt very comfortable speaking with him.

Aug 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Michael Lim is extremely compassionate, nurturing, and quite caring about his patience, and it is a pleasure to work with him芒鈧�. In fact, I am grateful, he is my neurologist monitoring the fourth ventricle brain tumor above my brain stem芒鈧�

Jul 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Good communicator with an agreeable, gentle demeanor.

Jul 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Continues to be an excellent listener of his patients as well as an advocate for them to expeditiously receive timely care in their complex medical management. I would highly recommend Dr. Michael Lim because of his professionalism, friendliness, good listening skills and ongoing advocacy on behalf of his patients' ongoing medical and emotional well being.

Jul 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He was very thorough and succinct and very compassionate.

Jul 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Great, caring, professional

Jul 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Excellent experience. Given the opportunity to be heard and understood. Included in reviewing the plan as to what I was hoping to have done.

Jun 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He is very nice & good Doctor .

Jun 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr Lim patiently answered all my questions and put me at ease. Kelli Jew also spent time going over all my concerns and prepping me for my discussion with Dr Lim. It is the most competent care team I芒鈧劉ve ever experienced.

Jun 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

I felt very comfortable with him

Jun 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Lim seems like a compassionate person he is intelligent and presents him self well

May 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Very kind, helpful and understanding.

May 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Lim is a very busy man and I appreciate the fact that he makes the time to connect with me personally. Thank You Dr. Lim!!!

May 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

The doctor and his team were very clear and helpful

May 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Lim was clear, knowledgeable, and very straight forward. I thought the interview was a success.

May 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Extremely helpful

May 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

VERY KNOWLEDGEABLE AND SEEN AS EXPERIENCED AND CONFIDENCE DOCTOR

Apr 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He is a great doctor.

Apr 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Lim is always cheerful and optimistic. He listens carefully, then makes a decision on what to do next.

Apr 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

I am very impressed by the rapid response time from Stanford staff! I am even more impressed by the kindness and respect with which I was handled! Stanford should be very proud! From a patient's point of view, I am amazed that each and every individual who talked with me was so kind and respectful!

Apr 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Extremely knowledgeable and very personable!!!!

Apr 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Excellent doctor

Mar 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Very through, compassionate and confident. Happy he will be my doctor.

Mar 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He and his team are amazing, I couldn芒鈧劉t ask for a better team to help me navigate my healthcare.

Mar 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Learned a lot

Mar 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Lim is a fantastic, compassionate provider. Highly recommend!

Feb 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Very friendly, considerate, compassionate, and overall wonderful experience.

Feb 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Very empathetic. Answered all questions.

Feb 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr Lim and his staff are amazing, kind and compassionate

Jan 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Caring, relatable, explains situation, an over-all excellent doctor.

Jan 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

I am grateful to you and will always be.

Jan 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He's very articulate, which i enjoy about a surgeon. He takes time to explain up coming surgery, he takes his time does not rush through the apt. Very comforting.

Jan 2023

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr Lim is the very best provider in the world in my opinion. His counsel, follow up and care exceeds anyone I have ever met. The ease in which Stanford allows access to him is exceptional and I wish all health care systems provided the same. I am humbled that one of the best neurosurgeons in the entire country did my surgery, continues to follow up as needed and that Stanford makes accessing top Tier healthcare so accessible to all patients. A model guide for modern healthcare solutions. Couldn芒鈧劉t be happier.

Dec 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

My thanks and gratitude

Dec 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

If you have to be at a dr visit or hospital for for surgery. Im at 9 !! Stanford is the only place and only professionals i want to be with.. They are so wonderful.

Dec 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr Lim is the best!

Dec 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

A wonderful, caring doctor!

Dec 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Michael Lim addressed all my questions and conditions regarding my condition. He is very thorough and straightforward in his approach which was helpful to me.

Nov 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Thank you for helping me uderstanding my healing process not to give up.

Nov 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He was very thorough and explained his rationales. He was extremely kind and I greatly appreciated his hope and optimism.

Nov 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Thank you for being patient and answering questions in ways that made me feel I was taken care of & that you wished for my best (including recommendation about other 2nd opinion surgeons).

Oct 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He was caring, helpful and assured me he could help me. I liked him very much and feel confident in his care and expertise. Look forward to the surgery!

Oct 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Very Friendly and very knowledgeable

Sep 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

It was FANTASTIC getting to see and speak with you about my new scan. You have REALLY helped to calm my mind/nerves about it all, I knew that you would. I am forever grateful for what you have done and continue to do for me! I just cannot thank you enough!

Sep 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Very compassionate, great listener and thorough. Highly recommend Dr. Lim.

Sep 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

His professionalism, demeanor and knowledge are impeccable. An absolute asset that has changed the lives of so many

Sep 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Michael Lim is an excellent neurologist, and extraordinarily patient oriented professional, and I would highly recommend him to anyone I know who may have neurological issues芒鈧� Dr. Lim is simply first rate!

Sep 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Very thorough with questions being taken by staff and consulted with the doctor before his consultation.

Aug 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Lim is #1 in the world. His team is outstanding.

Aug 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

I was highly impressed with Dr. Lim芒鈧劉s clear to the point discussion of my issue. I felt respected and regarded by Dr. Lim. I was at peace and very relieved to be in the hands of a highly regarded Dr. at a superlative hospital.

Aug 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr Lim and his office is the core reason I visit stamford. He is one of the most thorough and caring providers.

Aug 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Caring knowledgeable gentle

Aug 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Clear communication!

Aug 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Lim is amazing!!!!

Jul 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Gave an overall possible plan if symptoms don芒鈧劉t resolve

Jul 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

I芒鈧劉m so grateful to Dr Lim and his team!

Jul 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He is a very nice and caring physician. He answered all of my questions and concerns. Excellent doctor overall.

Jul 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Thank you for the complimentary zoom visit!

Jul 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

The personal are very sweet

Jun 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

I really appreciated how relational Dr. Lim was during our video visit. He was thorough, empathetic, honest, and remained approachable even when the topic was over my head.

Jun 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Michael Lim is extraordinarily compassionate. I never feel rushed in my appointments with him, and it feels that he makes every effort to listen to and address all of my concerns, and explains all of the possible treatment options in an easy to understand way.

Jun 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Very thankful for my appointment with Dr. Lim & his team.

May 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Michael Lim is the best doctor of my life.

May 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Lim has an excellent side manner. He explains everything in a way that I can understand and is careful to answer questions and make me feel at ease. I trust him. He is a miracle worker!

May 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He is amazing, and his team is A++++ too!

Apr 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Lim is a thorough and kind doctor. He provides all the information in an easy to understand matter. He is always willing to answers any and all questions. I am continuously happy with care he provides.

Apr 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Very nice and helpful!

Apr 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Both doctors and their staff were Top notch

Apr 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He is very kind

Mar 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

It was an absolute perfect experience. I have already recommended Dr. Lim and his staff to others.

Mar 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Great doctor who I believe cares about his patients and improving their health and well being.

Mar 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Lim was incredibly informed before we met. The appointment was succinct, efficient and I left with a high degree of confidence about the options that were presented to me.

Mar 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He is a phenomenal doctor that goes above and beyond for his patients. He is what the definition of healthcare should be

Mar 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Lim is so compassionate and caring to his patients - his goal is to give you the best care possible and for you to have the best quality of life. Have never encountered a physician with such personal attention and availability- thank you Dr. Lim you have demonstrated what a Dr. Should do for his patients - treating them as individuals and not just the next patient! May God bless him and his entire staff

Mar 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Whatever you are paying him you should double! He is an excellent surgeon, but beyond that he is an exceptional person. When we talked it was obvious he was listening to what I was saying and I believe he genuinely cares for his patients. For me that is rare, my typical experiences with other neurosurgeons have been frustrating and left me feeling unheard. Dr. Lim should be the the bar that others hope to rise up to that level. Great surgeon and an exceptional person!

Jan 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr Lim was very Kind and companionate, Helped me to understand what I should do next.

Jan 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Liam was friendly, professional, and answered all of my questions.

Jan 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Amazing doctor and staff, wish I lived closer.

Jan 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Lim seems to be a very caring and thoughtful surgeon. I felt comfortable discussing my diagnosis with him and have a great sense of trust in his capabilities to provide superior care. He presented the options clearly so I feel I can weigh each in order to decide which treatment path to follow.

Jan 2022

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Lim and Elizabeth have GREAT compassion and respect for us.

Dec 2021

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Every single person I encountered was so nice! Great service.

Dec 2021

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He's amazing!

Dec 2021

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Wonderful doesn't adequately cover it. Getting quick appt (Thank you!), then an Outstanding Dr! . Need a new category like "Super Amazing"

Dec 2021

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr Lim was very helpful and resourceful. I appreciated his compassion.

Dec 2021

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Absolutely the best Surgeon. He gave me my life back.

Nov 2021

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Excellent visit Dr. Lim is very kind and caring along with being very knowledgeable.

Nov 2021

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

It was an excellent visit with Dr. Lim. Dr. Lim changed my life that I can live painfree for the first time in over a decade. His compassion and care are beyond reproach. Elizabeth Lee and Kelli Jew have been amazing as well and share that same spirit. The whole Stanford team is outstanding and made me feel very comfortable with every visit. I highly recommend Stanford Hospital!

Nov 2021

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

I found Dr. Lim to be extremely personable and knowledgable. His demeanor is very reassuring and his self-confidence and intention to help his patients as much as he possibly can, while doing no harm, is evident in the clear and honest answers he gave to my questions and concerns. I felt that he gave me his full attention throughout the consult. I am certain that if I choose to proceed with any surgical intervention to treat my condition that I will feel as confident as possible by choosing Dr. Lim.

Nov 2021

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr. Michael Lim is a very caring compassionate and knowledgeable individual. He is a blessing to the medical field

Oct 2021

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Very helpfully and insightfully

Oct 2021

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

He芒鈧劉s an amazing physician. He explains the information very well and is sure to check for understanding before continuing.

Oct 2021

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr Lim is most caring and professional medical expert I have been experienced. I live in east coast and used to be a patient his tenure in Johns Hopkins. I was very sad when he left for Stanford but he happily agreed to be my doctor in Stanford. I am very happy and satisfied with his service and Stanford is very fortunate to have a medical professional like Dr Lim in its faculty member.

Oct 2021

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Dr Lim is the highest caliber doctor and physician and surgeon, and the best neurosurgeon in the world

Oct 2021

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Very nice and respectful. He answered all my questions, he made me feel very comfortable before and after my procedure.

Sep 2021

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

I am very pleased with Dr. Lim . HE HAS BEEN VERY HELPFUL TO ME. Being from Fresno it was nice to be able to do a video follow up.

Sep 2021

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

Excellent, caring doctor who takes the time to address patient's concerns.

Sep 2021

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

I am following Dr Michael Lim across the continent. I have been his patient since 2018 when he was in John Hopkins. I did 蓝莓视频 online and found out great comments on him. My three years experiences echoed that. I can芒鈧劉t thank him more for taking me as his patient since then. Amongst all the stress and frustration that I have to seek help from a neurosurgery department. One lucky thing is that I am in good hands of Dr Lim. He is professional and compassionate. He is super talented. But you know when you talk to him , his decision is around your well being instead of showing off his talent and skills. Don芒鈧劉t ask me why I say this. I talked to other doctors prior to seeing Dr Lim. Thank you Dr Lim!

Jun 2021

&苍产蝉辫;鈥�&苍产蝉辫;

Verified SHC Patient

View More Patient Reviews

Referring Physicians

PHYSICIAN HELPLINE

Phone:听1-866-742-4811
Fax: 650-320-9443
Monday鈥揊riday, 8 a.m.鈥�5 p.m.

蓝莓视频 provides comprehensive services to听refer听and听track patients, as well as the latest information and news for physicians and office staff.听For help with all referral needs and questions, visit Referral Information.

You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.

听

Send referrals online
Place radiology and lab orders
View referral status
Access medical records

Learn More About MedLink

蓝莓视频

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

Michael Lim, M.D.

Neurosurgeon

Get In Touch

Biography

Professional Summary

Education & Certifications

Honors & Awards

Memberships

Publications

Clinical Trials

Specializing In

Practice Locations

Facial Pain Program at the Neuroscience Health Center Palo Alto, CA

Facial Pain Program at the Neuroscience Health Center

Brain and Spine Tumor Center at Stanford Neuroscience Health Center Palo Alto, CA

Brain and Spine Tumor Center at Stanford Neuroscience Health Center

Skull Base Surgery at the Neuroscience Health Center Palo Alto, CA

Skull Base Surgery at the Neuroscience Health Center

CyberKnife Program at the Neuroscience Health Center Palo Alto, CA

CyberKnife Program at the Neuroscience Health Center

Stanford Neuroscience Health Center Palo Alto, CA

Stanford Neuroscience Health Center

Neurosurgery Program Palo Alto, CA

Neurosurgery Program

Pituitary Center Palo Alto, CA

Pituitary Center

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(214 reviews)

Referring Physicians

PHYSICIAN HELPLINE

蓝莓视频

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

WELCOME BACK

Michael Lim, M.D.

Neurosurgeon

Get In Touch

Biography

Professional Summary

Education & Certifications

Honors & Awards

Memberships

Publications

Clinical Trials

Specializing In

Practice Locations

Facial Pain Program at the Neuroscience Health Center Palo Alto, CA

Facial Pain Program at the Neuroscience Health Center

Brain and Spine Tumor Center at Stanford Neuroscience Health Center Palo Alto, CA

Brain and Spine Tumor Center at Stanford Neuroscience Health Center

Skull Base Surgery at the Neuroscience Health Center Palo Alto, CA

Skull Base Surgery at the Neuroscience Health Center

CyberKnife Program at the Neuroscience Health Center Palo Alto, CA

CyberKnife Program at the Neuroscience Health Center

Stanford Neuroscience Health Center Palo Alto, CA

Stanford Neuroscience Health Center

Neurosurgery Program Palo Alto, CA

Neurosurgery Program

Pituitary Center Palo Alto, CA

Pituitary Center

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(214 reviews)

Referring Physicians

PHYSICIAN HELPLINE